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Abstract
Psychiatric advance directives (PADs) are legal documents that allow individuals to
express their wishes and desires regarding potential future psychiatric care. PADs have
been theorized as a way to empower individuals through improved clinical outcomes,
reduced coercion, and minimized involvement of individuals with mental illness in the
criminal justice system. Since 2010, the Commonwealth of Virginia has had legislation in
place to support the use of these advance planning documents. The purpose of this
convergent parallel mixed methods study was to enhance our understanding of PADs in
Virginia. Quantitative and qualitative data were collected concurrently via survey and
follow-up interview procedures. Member checking, triangulation, and audit trail were
used to ensure trustworthiness. These stands were analyzed separately and then mixed in
the interpretation phase to provide a comprehensive understanding of PADs in Virginia
and make recommendations for fostering their use in the state.
Keywords: psychiatry, law, mental health, incapacity
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CHAPTER 1
Introduction
The Revolving Door
Individuals with serious mental illness (SMI) are a marginalized, stigmatized, and often
voiceless population of mental health care consumers (Corrigan, 1999). In 2014, there were an
estimated 9.8 million adults aged 18 or older in the United States with serious mental illnesses,
such as bipolar disorder, schizophrenia, or major depressive disorder. This number represents
4.2% of all U.S. adults (Center for Behavioral Health Statistics and Quality, 2015). Individuals
with SMI often experience periods of stability between episodic or acute crises. During these
times of crisis, individuals may become incapacitated such that they are unable or unwilling to
make healthcare decisions to protect themselves from undue harm, and in these cases they may
be subject to involuntary treatment (Center for Behavioral Health Statistics and Quality, 2015).
Researchers have argued that involuntary or coercive treatment contributes to the
“revolving door” phenomenon in mental health treatment (Davis, 1975). The revolving door
describes a population of individuals experiencing chronic SMI frequently readmitted to
psychiatric units due to noncompliance following discharge. Disempowered, discouraged, and
stigmatized by the experience of forced hospitalization, coerced individuals may find themselves
feeling mistrustful of the mental health care system. This, in turn, discourages people from
following through on discharge plans. Features of certain disorders, such as impaired reasoning
and judgment, poor insight, and decisional incapacity can also intensify the likelihood of poor
follow-through (Zelle, Kemp, & Bonnie, 2015a). This cycle of coercion and system mistrust can
lead to additional psychiatric crises and subsequent hospitalizations (Davis, 1975; Montgomery
& Kirkpatrick, 2002).
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The revolving door has a high cost to individuals, their families, and society (Insel, 2008;
Knapp, 1997; Rossler, Salize, van Os, & Riecher-Rossler, 2005). Those involved in the
revolving door phenomenon die an average of 25 years earlier than the general population due to
treatable medical conditions (Parks, Svendsen, Singer, Foti, & Mauer, 2006) and are at an
increased risk of suicide (Ward, Ishak, Proskorovsky, & Caro, 2006) and interpersonal violence
(Alia-Klein, O'Rourke, Goldstein, & Malaspina, 2007). The difference between individuals with
SMI and the general population is particularly pronounced among women. Research suggests
that women with SMI had four-, ten- and four-fold increases in the odds of experiencing
domestic, community, and sexual violence, respectively (Khalifeh et al., 2015). These negative
outcomes are compounded among those with co-occurring substance disorders (Adams & Scott,
2000; Swanson, 2004). The revolving door is also financially costly. Estimates suggest that SMI
costs the American economy $193.2 billion each year (Insel, 2008).
For the most part, the systemic response to the revolving door has been to expand
coercive treatment through legal means (McGarvey, Leon-Verdin, Wanchek, & Bonnie, 2013;
Swartz et al., 1999; Swanson et al., 2000). Virginia expanded its coercive treatment laws twice
over the past decade, once in 2008 following the Virginia Tech Shooting, and then again in 2014
following the Creigh Deeds tragedy (Bonnie, Reinhard, Hamilton, & McGarvey, 2009; Vozzella,
2014). In addition to new civil commitment laws, coercive treatment practices have also
expanded in more informal ways. For instance, Virginia requires evidence that an individual's
condition poses a threat of “imminent danger” for the courts to override that individual’s
objection to mental health intervention (McGarvey et al., 2013). Yet in practice, treatment
objections by individuals with SMI are overridden even in instances where there is no imminent
danger (Hashmi, Shad, Rhoades, & Parsaik, 2014; Stulz, Nevely, Hilpert, Bielinski, Spisla,
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Maeck, & Hepp, 2015). Researchers argue that this gap between the law and its practical
execution is not due to a clinical error (Turkheimer & Parry, 1992). This informal expansion of
involuntary treatment is due to a lack of less restrictive alternatives to hospitalization, such as
outpatient crisis stabilization centers (Turkheimer & Parry, 1992).
Unfortunately, studies suggest that the routine use of legal coercion to treat seriously ill
individuals can have adverse consequences (Swartz, Swanson, & Hanson, 2003). Coercion may
be experienced as traumatic, counter-therapeutic, and stigmatizing, and may further discourage
those with mental illness from seeking the treatment needed to manage and recover from acute
psychiatric episodes (Swanson et al., 2003; Swartz et al., 2003; Theodoridou et al., 2012). The
deprivation of choice through coercion has also been associated with quality of life implications,
including higher poverty rates, lower education levels, increased mortality rates, and increased
unemployment (Colton & Manderscheid, 2006; Kosciulek, 1998; Priebe, Katsakou, Amos,
Leese, M., Morriss, Rose, & Yeeles, 2009). In total, repeat experiences with treatment imposed
over objection appear to thwart the healthy development and recovery of individuals with SMI.
Psychiatric Advance Directives
Studies demonstrating the negative impact of coercive treatment have fueled interest in
psychiatric advance directives (PADs). PADs are legal documents that allow individuals to
express their wishes and desires regarding potential future psychiatric care (Bonnie, 2012). PADs
also allow individuals to legally authorize a proxy who can make healthcare decisions on their
behalf when they are in crisis. The advanced instructions (AI) and proxy designations (also
known as Health Care Power of Attorney or HCPA) within PADs are designed to help
individuals with serious mental illness (SMI) manage future psychiatric crises. Advocates argue
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PADs could reduce the need for coercion through client empowerment (Bonnie, 2012; Scheyett,
Kim, Swanson, & Swartz, 2007; Swanson, Tepper, Backlar, & Swartz, 2000).
PADs also offer a promising approach to the revolving door syndrome by providing a
platform for collaborative treatment planning (Srebnik, & La Fond, 1999). With a PAD,
individuals can specify their treatment preferences when they are well and have full capacity for
decision-making (Scheyett et al., 2007, Swanson et al., 2000). Then, in the event of a psychiatric
emergency, consumers can expect that the health care system will acknowledge and honor their
stated treatment preferences. By specifying these wishes in a legally binding document, PADs
empower individuals with SMI to retain as much control as possible over their lives and their
psychiatric care. It is speculated that PADs could also play a significant role in reducing
coercion (Bonnie, 2012; Swanson et al., 2000) and improving long-term clinical outcomes for
individuals with SMI through better treatment engagement and enhanced therapeutic alliance
(Scheyett et al., 2007; Swanson et al., 2000).
History of Psychiatric Advance Directives
When a person is unable to indicate his or her preferences or give consent due to
incapacity, treatment decisions are typically given over to family members, health care
providers, or the legal system. Medical advance directives emerged as a way for individuals to
retain control in situations of incapacity. Medical advance directives emerged in state and federal
law following two high-profile legal cases, involving Karen Ann Quinlan (“In Re Quinlan,”
1976) and Nancy Cruzan (“Cruzan v. Missouri Department of Health,” 1990). Karen Ann
Quinlan was a 21-year-old woman in a persistent vegetative state. After several months of
deterioration, Quinlan’s family requested to discontinue the use of a ventilator so she could die
naturally. Initially, the hospital refused this request. The New Jersey Supreme court asserted that
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in the absence of any conclusive evidence of Quinlan’s wishes, her rights to privacy and choice
could be “asserted on her behalf by her guardians” (In Re Quinlan, 1976, p. 34). Citing selfdetermination, best interests, and equality, the court recognized that patients have a constitutional
right to refuse treatment even if they are unable or incompetent to make the decision.
The Quinlan decision influenced the outcome of the Cruzan case over a decade later.
Cruzan v. Director of Missouri Department of Health (1990) involved Nancy Cruzan, a 25-yearold in a persistent vegetative state following a motor vehicle accident. After a period of
deterioration without improvement, Cruzan's family requested that her feeding tube be removed.
This request was based on a conversation between Ms. Cruzan and a friend, in which Cruzan
stated that she would not want to be kept alive through artificial means without the hope of
recovery. Initially, the Missouri Supreme Court denied the request based on the requirements of
informed consent. The U.S. Supreme Court eventually upheld the state court's decision, ruling
that the Due Process Clause allowed for treatment refusal by competent adults, but not by
incompetent or incapacitated adults in the absence of "clear and convincing evidence" of the
person's wishes (Cruzan v. Director, 1990).
Van Dorn et al. (2010) point out that the Cruzan decision did not mandate that patients'
wishes be written, but did highlight the challenge of meeting the "clear and convincing" standard
with only a verbal conversation. In response to these court decisions, Congress passed the Patient
Self-Determination Act (PSDA) in 1991, which required hospitals and other health care
organizations to inform patients of their rights to create medical advance directives (Van Dorn, et
al., 2010). Although the Quinlan and Cruzan decisions focused on medical advance directives,
these cases also provided a framework for the development of psychiatric advanced directives
(Van Dorn, et al., 2010). In 1970, Paul Applebaum wrote of ADs in the New England Journal of
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Medicine, stating, “The idea’s undoubted appeal in medical settings is exceeded only by its
potential utility on the psychiatric ward... It would permit rational treatment based on a patient’s
own rational wishes” (Appelbaum, 1979, p. 788).
PADs in practice
PADs exist in nearly 2/3 of the states, however, what can be included in them, as well as
the practices guiding the creation and use of advance directives, varies depending on location. In
general, however, psychiatric advance directives involve three basic forms of anticipatory
planning: informed consent to future treatment, a forecast of personal values, and the designation
of a proxy decision-maker (Henderson, Swanson, Szmukler, Thornicroft & Zinkler, 2008). The
three features of PADs are described below:
Informed consent to future treatment. As mentioned earlier in this chapter, SMI is often a
chronic condition. Many individuals who experience mental illness will also go through times
when, due to their illness, they are not able or willing to consent to treatment. With an advance
directive, an individual has the option of providing consent to treatment in advance that is
legally-binding even if they later refuse. This aspect of PADs is also sometimes referred to as the
Ulysses Clause or protestation provision, which is described in more detail in the following
section on Virginia's PAD policy.
A forecast of personal values. PADs also provide individuals with an opportunity to
specify personal preferences for future treatment. These instructions can include details about
who the individual would like to involve in treatment as well as where and which methods he or
she would prefer to receive. Many PADs name preferred hospitals, medications that have been
helpful in the past, as well as other psychosocial interventions that might be helpful in a crisis,
such as recreational therapy or journaling (Srebnick & La Fond, 1999). Individuals with PADs
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can also specify what treatments they do not want in the event of a behavioral emergency. For
instance, a consumer could specify that they do not want to be secluded or would prefer
medication restraint rather than physical restraint. Some PADs also specify treatments to avoid
such as electroconvulsive therapy (ECT) or specific classes or formularies of medications. Many
who complete PADs also choose to outline "warning signs" that may precede a crisis, such as
sleep disturbance or paranoia (Henderson, Swanson, Szmukler, Thornicrof, & Zinkler, 2008).
While many who specify treatment preferences in their PAD hope that their wishes will be
followed, this section is not legally binding.
The entrusting of someone to act as a proxy decision maker. Also known as advanced
designation, PADs also allow an individual to legally authorize a proxy who can make healthcare
decisions on their behalf when they are in crisis. Many choose to name a trusted member as a
proxy decision maker. However, in the event that no reliable family members are available to
serve as a proxy decision maker, an individual can name their treating clinician as their health
care power of attorney or proxy decision maker.
PADs in Virginia
While federal law distinguishes between medical advanced directives and psychiatric
advance directives, Virginia makes no distinction between the two (Zelle et al., 2015). Since the
passing of the Health Care Decisions Act in 2009 (HCDA), Virginians have been able to create a
single, integrated document that specifies medical, psychiatric, and end-of-life directions. This
approach was intended to convey the belief that mental health is a critical part of a person’s
overall health. Virginia’s integrated AD1 also reinforced the notion that general medical health

Virginia’s integrated AD will be referred to as a PAD in this dissertation. This categorization references
the psychiatric portion of the integrated AD, rather than the medical or end-of-life instructions.
1
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and behavioral health should ideally be integrated. This integration is thought to have a two-fold
purpose: to improve health outcomes and reduce the stigma of separate treatment (Zelle, Kemp,
& Bonnie, 2015b). Virginia’s PAD can include instructions and/or designation of a health care
proxy who can make medical decisions for the person during periods of incapacity (Bonnie,
2012). These advance care documents may also contain individualized, patient-centered plans to
prevent, manage, and recover from acute symptomatic crises. While consumers can specify their
treatment preferences, physicians in Virginia retain the power to override the PAD in situations
where a person has specified contra-indicated interventions (for example, refusing all psychiatric
treatment).
Ulysses Clause. Virginia’s HCDA also includes an enforceable “Ulysses Clause,” in
which a patient gives advance consent to hospitalization over his or her own future objection.
The so-called Ulysses Clause is taken from a famous scene in Homer’s Odyssey, in which
Ulysses tied himself to the ship’s mast while instructing his men -- whose ears are filled with
wax -- to ignore whatever he says as they sail by the maddening sirens. These instructions are
analogous to the protestation or Ulysses Clause in PADs: when I have a crisis, I want you to
follow the instructions I am writing now while I am capable of making informed decisions, and
not follow my objections later when I am incapable of making informed decisions (Virginia
Advance Directives, 2016). Unlike other aspects of the PAD, a physician or a clinical
psychologist who can testify that the consumer was competent and understands the implications
of their consent to future treatment must sign the Ulysses Clause.
Creating a PAD in Virginia. The state of Virginia requires little for an advance directive
to be considered legally binding. While there are pre-made forms available online to help
consumers make decisions in organized ways, they are not required to make the document legal.
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The only requirement is that the person signs the documents with two adults present to witness
the signature. Consumers do not need an attorney to complete an AD, nor do they need a treating
provider’s consent unless they add a protestation provision (i.e. Ulysses Clause). After
completing a PAD, consumers are encouraged to provide copies of this document to their health
care providers. It is recommended that consumers upload these documents onto the Virginia
Department of Health (VDH) Advance Health Care Directive Registry and the US Living Will
Registry. Storing the document in these registries ensures that if someone has a mental health
crisis away from their home hospital or provider, the treating facility will have access to their
PAD.
PAD trends in Virginia. In 2010, The Institute for Law, Psychiatry, and Public Policy
conducted a study examining the utilization of PADs in Virginia (Wilder et al., 2013). Using
survey procedures drawn from prior studies (Elbogen et al., 2006; Swanson, Swartz, Ferron,
Elbogen, & Van Dorn, 2006b; Swartz et al., 2005), the researchers collected quantitative baseline
data that identified knowledge, attitudes, use, and key barriers affecting the use of these legal
innovations among five stakeholder groups (consumers, clinicians, administrators, advocates,
and family members) in Virginia. This study indicated that there was high demand for PADs
among all five groups as well as significant barriers to implementation. Similar studies
conducted nationwide and in North Carolina pointed to a gap between the level of demand for
PADs and their actual utilization, as well as significant barriers to implementation (Kim et al.,
2008; Swanson, Swartz, Ferron, Elbogen, & Van Dorn, 2006a; Van Dorn et al., 2006). These
findings were consistent with the Wilder et al. (2013) study in Virginia. In response to the gap
between utilization and demand, Swanson et al. (2006) conducted a randomized controlled trial
of a facilitated advance directive intervention in North Carolina. The researchers discovered that
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providing one-to-one facilitation increased PAD completion (84% for those who received
facilitation versus 3% who did not receive facilitation), and improved satisfaction with treatment
and treatment providers.
Utilizing a model based on Swanson et al.’s (2006) facilitation study, PAD advocates in
Virginia worked to increase implementation of these legal tools through efforts to embed these
documents into routine mental health care practices (Kemp, Zelle, & Bonnie, 2014). Initially,
these efforts targeted Virginia's Community Services Boards (CSB), the state public mental
health system (Zelle et al., 2015). Of the 40 CSBs in Virginia, five were identified as “vanguard
sites” for piloting the one-on-one consumer case manager facilitation modeled after the Swanson
et al. (2006) study. However, this approach was eventually abandoned due to high caseloads
within the CSBs as well as the time-intensive nature of the one-on-one facilitation.
This initial effort to embed PAD completion into routine mental health services was
quickly replaced by a more flexible approach to facilitation (Zelle et al., 2015). This more
flexible approach enabled each CSB to deliver PAD facilitation services in ways that addressed
consumer preferences or resource constraints. Zelle et al. (2015) identified three types of PAD
facilitation that have continued across the state over the past four years. The first approach is
one-on-one facilitation by staff, including case managers or designated PAD clinical facilitators
(LPCs, LCSWs, MFTs, and LCPs). A second approach is a one-on-one education and facilitation
by peer support specialists. Peer Support Specialists are people living in recovery with mental
illness and / or substance use disorder and who provide support to others whom can benefit from
their lived experiences. In this model, consumers are either self-referred or referred by a case
manager. The third model is group education and facilitation in which consumers are provided
with basic information about advance directives during the already-implemented CSB WRAP
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(Wellness Recovery Action Plan) groups. Interested participants are then provided with
opportunities for group facilitation. Since adopting this more flexible approach in how PADs are
incorporated into routine mental health care, advocates have hoped that PAD utilization has
increased across the state.
Statement of the Problem
Advance care planning has been a part of the U.S. healthcare system since 1990 when
Congress enacted the Patient Self-Determination Act (PSDA). The PSDA was designed to allow
for legally binding advance care planning in instances of incapacity. This federal legislation was
followed by state-level statutes designed to promote greater use of advance directives. In 1992,
Virginia enacted the Health Care Decisions Act (HCDA), which enabled Virginians to craft
legally binding instructions for end-of-life care.
While HCDA was an important step in allowing individuals to document their values and
wishes in the event of incapacity, this legislation was limited in scope. Unless a person had a
terminal illness or was in a persistent vegetative state, there was no mechanism for individuals to
record legally-binding instructions in other instances of incapacity, such as during a psychiatric
crisis.
When it came to psychiatric incapacity, either due to treatment refusal or inability to give
consent, individuals with mental illness were subject to involuntary or coercive treatment.
Between 40-50% of these individuals with serious mental illness experience repeat
hospitalization for psychiatric crisis due to noncompliance with treatment (Montgomery &
Kirkpatrick, 2002). For this subset of the population, coercive or involuntary treatment is routine.
However, research suggests that coercive treatment negatively impacts client recovery and often
leads to repeat hospitalization (Swanson et al., 2003; Theodoridou et al., 2012). This revolving
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door of hospitalization is also financially burdensome. Estimates suggest the revolving door
phenomenon costs $193.2 billion each year to the American economy.
In the mid-2000s, advocacy groups in Virginia had grown concerned about the increasing
reliance on involuntary and coercive methods to address treatment issues for individuals with
serious mental illness. Influenced by the rise of the consumer empowerment movement, the state
General Assembly authorized the Virginia Commission for Mental Health Reform. The
Commission was tasked with the goal of identifying mental health reforms that could foster
recovery while reducing reliance on coercive treatment.
Following three years of consensus-building among stakeholder groups, the Commission
issued specific recommendations for mental health law reform. One key recommendation
expands the scope of the HCDA to all forms of incapacity, not just end-of-life treatment. While
innovative from a legal perspective, this extension of advance directives to psychiatric incapacity
was not a new idea. Since the 1980s, the psychiatric and legal literature had proposed the idea of
the psychiatric will, or the psychiatric advance directive (PAD). PADs had been theorized as a
way to empower individuals, improve clinical outcomes, and reduce coercion. Though the
research was limited at that time, preliminary studies on PADs suggested that PAD benefits were
not merely theoretical, but were empirically supported (Scheyett, Kim, Swanson, & Swartz,
2007; Swanson, Tepper, Backlar, & Swartz, 2000).
The Commission recommended that Virginia adopt what was dubbed an “integrated
advance directive.” These integrated (ADs2) allowed individuals to execute legally binding
instructions for end-of-life care, general medical instructions, and psychiatric treatment. The

Virginia’s integrated AD will be referred to as a PAD in this dissertation. This categorization references
the psychiatric portion of the integrated AD, rather than the medical or end-of-life instructions
2
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amended HCDA allowed people to designate a proxy decision maker in the event of incapacity,
as well as protestation provision that enabled voluntary consent to treatment even over future
objection. The hope was that these reforms might play a role in shifting practices around caring
for serious mental illness in the state from coercion to one of empowerment and selfdetermination.
The Commission recognized that a new law was not enough to create meaningful social
change. Since the passage of the amended HCDA in 2009/2010, PAD advocates have embarked
upon unprecedented efforts to encourage advance planning throughout the state. For the
implementation of HCDA to be successful, it was necessary to develop a clearer picture of how
PADs were being used in Virginia.
In 2013, Wilder et al. published a quantitative study examining the knowledge,
experience, and attitudes regarding the use of PADs among five stakeholder groups (clinicians,
consumers, advocates, family members, and administrators). This baseline data suggested that
there was strong support for PADs in Virginia, but that there were significant practical barriers to
widespread use. The barriers included low PAD completion rates among consumers, a lack of
clinician knowledge, limited facilitation resources, and cross-system communication issues. The
barriers identified in this study have been addressed through bottom-up and top-down efforts
throughout the state to foster the use of PADs by mental health consumers, and to provide
practical assistance in completing and executing these legal documents.
These efforts have included additional legislative reforms, including the establishment of
an online advance directive registry, increasing educational opportunities for clinicians,
facilitation training, pilot studies within the Community Services Boards, and formal guidelines
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from the Department of Behavioral Health and Developmental Services (Zelle, Kemp & Bonnie,
2015; Kemp, Zelle & Bonnie, 2015).
At the outset of this research study, it was unclear whether these efforts have had an
impact on how PADs are perceived and used across the state. In this sense, our understanding of
how implementation initiatives have influenced attitudes and utilization of PADs in Virginia
remains incomplete. This knowledge gap indicates a need for additional research utilizing both
qualitative and quantitative data in order to obtain a more robust picture of PADs in Virginia.
Whether or not the potential benefits of advance directives will ever be fully realized
depends greatly on the stakeholders who utilize them. A greater understanding of how
stakeholders perceive, use, and understand PADs in light of the implementation efforts over the
past seven years could have significant implications for future clinical, education, and public
policy initiatives.
Purpose statement and Research Questions
The purpose of this convergent parallel mixed methods design (Creswell & Plano-Clark,
2011) was to understand stakeholder perceptions, knowledge, utilization, and perceived barriers
to psychiatric advance directives. This research was designed as a convergent parallel mixed
methods study in order to provide a more complete, valid, and clinically useful understanding of
PAD utilization in Virginia. Quantitative and qualitative data were gathered concurrently to
determine how PAD utilization has converges and diverges among key stakeholder groups.
Concurrent data was analyzed separately and then merged for integration.
In this study, quantitative and qualitative data were collected concurrently through a
mixed method online stakeholder survey administered to participants from all five stakeholder
groups. The quantitative survey data were collected to determine whether significant differences
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exist between stakeholder groups on measures of PAD knowledge, attitudes, utilization and
barriers.
The quantitative strand in phase one of this study was guided by the following research
question:
•

Is there a statistically significant difference on measures of knowledge, attitudes,
experience, and barriers regarding PADs between five stakeholder groups (clinicians,
consumers, administrators, advocates, and family members) in Virginia?

Qualitative data were also collected from two sources: via open-ended questions nested in the
online stakeholder survey and topical semi-structured follow-up interviews. Both sources of
qualitative data were collected to enhance understanding of what has continued to promote or
thwart the use of PADs in Virginia, and to generate recommendations from participants
regarding methods for increasing PAD utilization. The qualitative strand was guided by the
following research questions:
•

What has encouraged the use of psychiatric advance directives in Virginia?

•

What has discouraged the use of PADs in Virginia?

•

What can be done to increase their utilization?

Data collected from these strands were analyzed separately, and then merged to determine how
qualitative data converged or diverged from the quantitative data.
This mixed methods study provided a richer understanding of the attitudes, knowledge,
experiences and barriers regarding PADs in Virginia. This study is unique in that it will be the
first mixed methods study of PADs in Virginia, and will likely yield valuable insights into what
challenges remain in process of fully adopting these legal innovations within the mental health
system.
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Hypotheses
With regard to the quantitative research question (RQ1), I hypothesized that there would
be a difference in all four domains of this study (attitudes, knowledge, experience, and barriers)
between each of the stakeholder groups (clinicians, administrators, consumers, advocates, and
family members). I predicted that there would be significant differences in the attitudes,
knowledge, and experience towards PADs among stakeholders. Based on prior research, I
hypothesized that the perception of PAD barriers would be most pronounced among clinicians
and least pronounced among administrators.
In keeping with the constructivist paradigm of qualitative research, I did not generate a
hypothesis for the qualitative research questions of this study (RQ2, RQ3, and RQ4). Rather I
drew from the literature to identify several sensitizing concepts that might emerge in the
qualitative parts of the survey and the follow up interviews with clinicians and advocates. These
sensitizing concepts included the idea of power tensions between clinicians and consumers, and
systematic barriers such as communication difficulties and time-concerns with regard to PAD
completion. These idea helped frame the themes that emerged in the qualitative analysis of this
study against the backdrop of prior research on PADs.
Overview of chapters
This dissertation consists of five chapters. Chapter one includes an introduction to the
topic as well as the study’s research question, purpose statement, and hypotheses. Chapter two
contains a review of the literature, which explores empowerment theory from a historical
perspective. Included in chapter two is a critique of related prior research on PADs, as well as a
rationale for this study based on the limitations of previous inquiries. Chapter three addresses
methodology. In this chapter, I define the research paradigm, outline the theoretical lens of
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inquiry, and describe the design, instrument, sample, data collection process, analysis
procedures, study limitations, and ethical considerations. Chapter four presents the results of the
separate strands as well as the mixed methods analysis. Chapter five summarizes the key
findings of the study and applies these findings to the field of counseling.
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CHAPTER 2
Literature Review
Introduction
Psychiatric advance directives (PADs) have been theorized as mechanisms of
empowerment that can improve clinical outcomes, reduce reliance on coercion, and minimize the
involvement of individuals with mental illness in the criminal justice system (Scheyett, Kim,
Swanson, & Swartz, 2007; Swanson, Tepper, Backlar, & Swartz, 2000). Despite their
hypothesized benefits, studies suggest that PADs remain underutilized due to multiple clinical
and practical barriers (Swanson, Swartz, Ferron, Elbogen, & Van Dorn, 2006; Wilder et al.,
2013). This chapter examines two areas of literature that are pertinent to the topic of this
dissertation: empowerment theory and psychiatric advance directives research. Empowerment
theory provides a rationale for using PADs in mental health care, while PAD studies provide a
contextualized understanding of how the documents are used in practice. Taken together, these
two bodies of literature provide both a theoretical and empirical framework for this proposed
dissertation research.
The first section on empowerment theory provides a synopsis of this concept within a
historical framework. This section draws from secondary and historical works written by
clinicians, theorists, and scholars, and provides an ethical rationale for the use of PADs within
the mental health care system. After examining empowerment, this chapter turns to a review of
prior research on psychiatric advance directives to provide an understanding of how these legal
tools have been used in clinical practice. This section begins with an exploration of early
theoretical works written by prominent psychiatric and legal scholars, and then transitions to an
analysis of empirical research. Covered in this review are prior stakeholder studies,
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implementation studies, and finally, an examination of extant research on PADs in Virginia. The
inclusion and exclusion criteria for this systematic review of PAD research are covered in the
introduction to this section. Throughout this chapter, I identify both the contributions and the
limitations of prior research on PADs. In doing so, I attempt to reveal both the knowledge and
methodological gaps in our understanding of PADs here in Virginia, thereby providing a clear
rationale for the mixed methods study of this dissertation.
Empowerment
What is empowerment?
PADs are said to empower people with mental illness. Although the term empowerment
is a familiar one, it is not so easily defined. Empowerment can apply to a broad range of contexts
from social reform to education to advertising. In the helping professions, such as counseling,
social work, and psychology, empowerment has been incorporated into Codes of Ethics and the
professional practices of these disciplines (McWhirter, 1997; Schwiebert & Giordano, 1994).
Because empowerment is thought to be a potential benefit of PADs, it is worthwhile to provide a
definition of this term as it pertains to this dissertation.
Linhorst (2006) argues that empowerment for individuals with mental illness involves
eight related concepts. These eight related concepts include:
Power, control, and influence
Deegan (1992) suggests that the empowerment of persons with mental illness should
involve the sharing of power. Deegan (1992) also argues that power is not a fixed entity, but can
be generated between and among people. Others have suggested that this aspect of empowerment
implies partnership, negotiation, and shared decision-making, with consumers having authority
to make meaningful decisions about their lives (Linhorst, 2006).

20
Resources and empowerment
Hasenfeld (1987) emphasizes the importance of resources to empowerment. He suggests
that it is "a process through which clients obtain resources -- personal, organizational and
community -- that enable them to gain greater control over their environment and to attain their
aspirations" (p. 478-479).
Empowerment as a process
Some theorists have suggested that one of the elements of empowerment is a process
(Ratts, DeKruyf, & Chen-Hayes, 2007; Ratts, 2009). Zimmerman (2000) points out that any
process can be empowering if it prepares people to participate more meaningfully in a way that
increases power, control, or influence.
Empowerment as an outcome
Some theorists have suggested that another element of empowerment is ensuring
empowerment as an outcome (M. Ratts, DeKruyf, & Chen-Hayes, 2007; M. J. Ratts, 2009;
Zimmerman, 2000), meaning that empowerment can be the result of empowerment processes
(Zimmerman, 2000). Linhorst (2006) argues that these outcomes can be subjective or objective,
and might include "increased confidence, improved social skills, greater knowledge of resources,
stabilization of psychiatric symptoms, having decision-making power" (p. 6).
Empowerment as ideology
The third element of empowerment is often described as the ideology of empowerment.
Empowerment can be a way of viewing the world. An empowerment ideology might emphasize
strengths and efficacy over pathology, "wellness over illness, and competence over deficiency"
(Linhorst, 2006, p. 7). Helping professionals who adopt an empowerment ideology see
themselves not as experts, but as collaborators, resources, and advocates (Zimmerman, 2000).
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Interconnected relationship between individuals and their environment
Empowerment suggests an ecological perspective that links people with their
surroundings. Individuals are empowered when they can influence or control aspects of the
world around them (Zimmerman, 2000).
Empowerment is situational
Empowerment theorists have suggested that these processes and outcomes are not fixed,
but are contextually specific (Linhorst, 2006; Zimmerman, 2000). Handler (1996) argues that
empowerment is sometimes precarious, and relies heavily on the stability of relationships,
availability of resources, and the demands of people in power. Empowerment, in other words,
can be gained and lost.
One cannot empower another
Although helping professionals can facilitate and support the advancement of people with
mental illness, they cannot directly empower them. Simon (1990) suggests that empowerment
can only be "initiated and sustained... [by the] subject who seeks power or self-determination" (p.
32). In essence, individuals with mental illness can only empower themselves (Linhorst, 2006).
Linhorst combines these eight aspects of empowerment and defines the term as the
"meaningful participation of people with severe mental illness in decision making and activities
that give them increased power, control, or influence over important areas of their lives" (2006,
p. 9).
This emphasis on empowerment for individuals with mental illness has emerged in the
literature for both practical and philosophical reasons (Croft & Beresford, 1992). Possible
reasons for this emergence in the literature include the fact that empowerment benefits both
individuals and the organizations that serve them (Linhorst, 2006). For instance, the involvement
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of persons with mental disorders in treatment planning has been demonstrated to increase followthrough and satisfaction (Roth & Crane-Ross, 2002). Philosophically speaking, empowerment
also matters because the participation it fosters has come to be seen as a right rather than a
privilege (Katan & Prager, 1986). This right to participation, unfortunately, has not always been
granted for individuals with mental illness.
A history of powerlessness
Throughout Western civilization, people with mental illness have been subjected to
oppression, coercion, and maltreatment, all of which are, by definition, disempowering
(Foucault, Lagrange, & Burchell, 2008). Indeed, Linhorst suggests that individuals with mental
illness have a unique "history of powerlessness" (2006, p. 12). This powerlessness has been
exhibited in a variety of ways, from inhumane treatments and stigma (Hogan, 2003) to social
control (Avriam, 1990). This history of powerlessness extends back to the Middle Ages, when
communities often expelled the "mad," sometimes onto boats known as Ships of Fools which
reportedly sailed around Europe, docking in seaports for only as long as passengers were
tolerated by the locals (Foucault, 1965). Later during the Enlightenment Period, coercive and
forced treatment ushered those with mental illness into "privatized madhouses" (Kemshall, 2001,
p. 90). In later eras, these madhouses gave way to state asylums. During this so-called asylum
period of the late 19th and early 20th centuries, a person could be committed permanently at the
request of family members and the consent of a doctor (Levenson, 1986). These mental asylums
were later converted into state psychiatric hospitals, which dominated the landscape of
psychiatric treatment until the 1950s. Between the 1950s and 1970s, involuntary treatment
continued to be initiated and managed medically rather than judicially (Linhorst, 2006), which
led to "broader grounds for commitment and the loosening of the procedural restrictions"
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(Levenson, 1986, p. 108). During this time, a person committed to a state asylum had no rights or
recourse and could be held indefinitely based on a two-physician certificate indicating a need for
treatment.
However, in the 1970s, psychiatric treatment began to change following the publication
of Goffman's groundbreaking ethnographic book Asylum (1961), which examined the lives of
psychiatric patients at a facility in Washington, DC. Goffman argued that in a psychiatric
hospital, patients "underwent a mortification of self, through physical and social abuse, which
then lead to the loss of their usual identity" (Goffman, as cited in Chow & Priebe, 2013, p. 1).
This process involved stripping individuals of past roles and leaving them with a purely
institutional identity. Like prisons, concentration camps, and monasteries, Goffman argued that
patients were subjected to stigma and severe restrictions on their liberties (1961). The publication
of Asylum has been credited with raising public awareness and increasing public concern for the
rights of citizens, particularly those with mental illness (Levenson, 1986). Motivated by public
outcry, states enacted more clearly defined involuntary commitment laws (Linhorst, 2006).
Simply being diagnosed with a mental illness was no longer legitimate grounds for
hospitalization. New laws narrowed the criteria for involuntary commitment by requiring that
patients be judged dangerous (Zhang, Mellsop, Brink, & Wang, 2015). This dangerous criterion
could include danger to the self or others, or alternatively, potential danger brought about by an
inability to care for self (Linhorst, 2006). During this period, patients were also granted legal due
process including the right to an attorney, hearing, and appeals to the commitment decision
(Zhang et al., 2015). These legal changes were intended to protect the rights of psychiatric
patients that had been ignored for centuries.
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At the same time as the initial codification of the civil commitment laws, psychiatric care
entered the deinstitutionalization phase in which long-term facilities were replaced by
community care (Linhorst, 2006). This movement towards community care was initially
motivated by an increasing respect for the autonomy and rights of individuals with psychiatric
conditions (Linhorst, 2006). However, some activists have argued that the transition from
institutions to community settings has done little to improve the quality and effectiveness of care
for persons with mental illness (Kemshall, 2001).
Although there are many ways in which deinstitutionalization has fallen short of its goal
of improving the lives and treatment of individuals with psychiatric illness, one specific critique
aimed at community-based care is that it has not afforded opportunities for self-determination for
people with mental illness (Kemshall, 2001). Indeed, advocates have viewed this lack of
consumer autonomy in community-based care as a form of oppression called mentalism
(Deegan, 1992). Like sexism, ableism, and racism, which devalue and stereotype groups of
people, mentalism suggests that those with psychiatric conditions are dangerous, unpredictable,
and must rely on others to help them decide what is in their own best interests (Linhorst,
2006). Deegan (1992) argues that mentalism is not just an interpersonal phenomenon, but that it
is also institutionalized in systems, policies, and laws. The consequence of mentalism is that
even during periods of mental stability, individuals with psychiatric conditions are denied
meaningful ways to become more involved in their treatment (Deegan, 1992). Unlike people
without psychiatric conditions that are allowed to make mistakes and learn from them, those with
mental illness are denied what Deegan calls the dignity of risk (1992).
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Social justice and empowerment through treatment planning
In the previous section, the literature review indicated that institutions for treating mental
illness are and have been structured in ways that systematically deprive persons with mental
illness of autonomy and self-determination. Denying individuals with mental illness the freedom
of choice privileges the power of clinicians at the expense of the client's right to selfdetermination (Chamberlin, 1978; Charlton, 1998). Adams, Bell, and Griffin (2007) argue that
oppression is present whenever social relations are structured in ways that privilege some groups
at the expense of others. These oppressive systems, Adams and her colleagues argue, sustain
injustice and thwart healthy human development. To address this history of powerlessness
requires a "reconfiguration of society in accordance with equity, recognition, and inclusion"
(Adams et al., 2007, p. 4). Adams and her colleagues' social justice framework align with the
consumer empowerment movement in community mental health (Charlton, 1998). Shafer,
Staples, and George (2016) point out that there has been a greater emphasis over the past decade
on the rights of clients to make choices — not only about their lives but also about their care,
their providers, and their treatment methods.
Although this emphasis on consumer rights is philosophical, some have applied these
values in practical ways to clinical work and suggested that one way to empower individuals
with mental illness is to engage them in treatment planning (O'Connell & Stein, 2005).
Empowerment through treatment planning can take place in the present through person-centered
treatment plans, but also in the future through planning tools such as PADs (Linhorst,
2006). Advocates argue that PADs can be used to target this history of powerlessness by
creating meaningful opportunities for client self-determination (Bonnie, 2012; Scheyett et al.,
2007; Swanson, Tepper, Backlar, & Swartz, 2000).
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PADs and social justice advocacy
Van Dorn, Scheyett, Swanson, and Swartz (2010) have drawn a direct connection
between social justice advocacy and the need to empower consumers through collaborative
treatment planning. In particular, Van Dorn et al. (2010) argue that psychiatric advance
directives are consistent with social justice principles. Citing prior research on the benefits of
PADs, Van Dorn et al. (2010) suggest that these legal documents support client empowerment
through increased individual autonomy, improved clinical outcomes, and a reduction in the use
of coercive practices. Referencing social work specifically, the authors suggest that social
workers have an imperative to address oppression as outlined in their Code of Ethics, and as
such, social workers should promote the use of psychiatric advance directives as tools for
remediating the persecution of individuals with mental illness.
Although no one has made this argument in the field of counseling, Van Dorn et al.'s
(2010) point could certainly apply to counselors. Indeed, the ACA Code of Ethics (American
Counseling Association, 2014) and the ACA Advocacy Competencies (Lewis, Arnold, House, &
Toporek, 2003) provide an ethical framework for counselors considering the use of psychiatric
advance directives. In section A.2.d., the ACA Code of Ethics specifies that when working with
incapacitated adults, counselors must "seek the assent of clients to services and include them in
decision-making as appropriate (ACA, 2014, p. 4)." In this sense, advance directives are highly
consistent with the ethics of the counseling profession.
Similarly, ACA Advocacy Competencies encourage counselors to engage in forms of
social justice advocacy across individual, systems, and societal domains (Toporek et al., 2010).
These competencies expand the role of the counselor to include empowerment and advocacy
practices aimed at addressing roadblocks that inhibit healthy human development. Toporek et al.
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(2010) describe empowerment as a way of assisting clients in a) identifying the external forces
that may influence their development, b) collaborating on a plan of action to reduce these
barriers, and c) assisting clients in developing self-advocacy skills. Advocacy, on the other hand,
takes place when counselors assist clients in accessing resources in situations where the clinician
has greater access than clients (Toporek et al., 2010). As mental health professionals who work
with individuals with mental illness, PADs represent a critical topic for counselors and counselor
educators to consider in their work.
Psychiatric Advance Directives
Introduction
Although there is no research on psychiatric advance directives within the counseling
field, there has been keen interest in the topic in other disciplines such as law and psychiatry.
The abundance of research on psychiatric advance directives in other disciplines perhaps
suggests that this subject warrants further study in the field of counseling. For the purpose of
establishing a rationale for this dissertation, I drew from previous PADs studies conducted in
other helping professions as well as related disciplines such as law and health policy
administration. This analysis and critique of the literature on PADs begins with a broad overview
of the early theoretical works on PADs. These early works establish a set of research
considerations that shape subsequent PAD studies. The focus of this review then narrows to
consider empirical studies on PAD, starting with the stakeholder studies. After examining prior
stakeholder studies conducted in other states, this literature review then transitions to research on
the implementation of PADs into a mental health care system. At that point, the emphasis shifts
to the setting of this dissertation, namely, the Commonwealth of Virginia, which has undertaken
an unprecedented implementation effort since the passage of the amended HDCA in
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2009/2010. Several prior studies have examined PADs in Virginia. These studies were analyzed
in depth to identify knowledge gaps and methodological considerations that provide a rationale
for this proposed dissertation research.
Inclusion criteria for this review include PAD stakeholder and implementation studies
conducted in the United States and published in peer-reviewed psychiatric and health
administration journals over the past 20 years. It is important to point out that there is an equally
large body of studies examining the impact of PADs. This impact research examines PAD
outcomes such as the reduction of coercion, improved clinical outcomes, and strengthened the
therapeutic alliance (Bonnie, 2012; Campbell & Kisely, 2009; Houben, Spruit, Groenen,
Wouters, & Janssen, 2014). However, a review of these outcome studies is beyond the scope of
this literature review, as they do not directly pertain to the research question of this dissertation,
which concerns embedding PADs into the routine delivery of mental health care in Virginia.
Early theory on psychiatric advance directives
The first person to propose the psychiatric advance directive was the psychiatrist Thomas
Szasz. Szasz was one of the leading figures in the anti-psychiatry movement. Concerned with the
excesses and the power of psychiatry, Szasz (1982) examines the literature on living wills and
last wills to find justification for his idea. He turns to the work of Robert Bryn who asserted that
"every competent adult is free to reject life-saving medical treatment. This freedom is grounded,
depending upon the patient's claim, either on the right to determine what shall be done with one's
body or the right of free religious exercise-both fundamental rights" (Bryn, as cited in Szasz,
1982, p. 766). He argued that the psychiatric will "rests on the same principle and seeks to
extend it to 'mental treatment'" (p. 766). Despite his optimism for the potential of PADs, Szasz
was more realistic when it comes to psychiatry's willingness to embrace this innovation. Szasz
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concluded that it will not be easy to introduce the psychiatric will into the field of mental health.
He was quick to acknowledge that even good ideas that are in people's best interest are often not
readily adopted until laws and social policies are crafted to support them. While Szasz (1982)
pointed to the benefits of the psychiatric will, as well as their precedence in American medical
care, he does not make specific recommendations or place a call for legal change.
Paul Sherman (1995) was another early proponent of PADs. Sherman argued that
although these documents were promising, they would face significant barriers to widespread
acceptance and use within the field of mental health. In his speech at the National Symposium on
Involuntary Intervention (1995), Sherman identified what he foresaw as potential barriers to the
widespread use of PADs, including educational concerns, logistical issues, legal hurdles,
consumer behavioral barriers, and enforcement problems. At the time of his talk, no research
studies had been conducted to verify whether or not these barriers existed (Elbogen et al., 2006;
Shields, Pathare, Van Der Ham, & Bunders, 2014). Although Sherman's work is influential for
future research examining PAD utilization, his claims remain theoretical rather than actual.
Both Sherman and Szasz before him acknowledged that for PADs to go mainstream,
there would need to be legal changes to promote adoption by the broader mental health
community as well as mechanisms for accountability when it came to following the specified
instructions (i.e. liability). In other words, for PADs to be successful, lawyers would need to
enter the conversation (Sherman, 1995; Szasz, 1982). As Alexander Brooks argued it: "Lawyers
have taught mental health professionals, particularly psychiatrists, what many of them had long
ignored and should have known, that their patients have a moral as well as a legal right to
participate in their own treatment" (Brooks, as cited in Miller, 1998). To that end, BJ Winick
wrote an often-cited legal perspective on PADs. Winick (1996) lists what he envisioned as

30
positive potentials for PADs, including the reduction in stigma, effective planning, encouraging
preparation, more equality between psychiatrists and patients, reduced stress, improved selfesteem, and better follow-through. Winick was also one of the first legal thinkers to argue that
the court decisions governing Quinlan and Cruzan should be extended to psychiatric treatment,
although he recognized that law reform would be necessary for PADs to take hold in the United
States.
Legal reform
As mentioned in the introduction chapter, in 1990, following the Quinlan (In re Quinlan,
1976) and Cruzan (Cruzan v. Director, Mo. Dept. of Health, 1990) decisions, the federal
government passed the Patient Self-Determination Act (PSDA). This law enabled individuals to
craft legally binding advance instructions for end-of-life care. Throughout the 1990s, prominent
psychiatrists and legal scholars argued that the PSDA should be extended to include psychiatric
care. In 1993, the Oregon Legislature enacted Senate Bill 859, which created state provisions for
advance declarations of mental health treatment (Backlar, 1995). Oregon was one of the first
states to take Szasz's idea and make it a legal tool (Backlar, 1997).
Consequently, many of the articles from the mid-late 1990s focused on PADs in Oregon.
One of the key publications from this period was a 1997 article published in the Community
Mental Health Journal by its editor, Patricia Backlar. While the medical advance directive
promotes a "good death," Backlar (1997) argues that a psychiatric advance directive encourages
"a good life." Despite the differences, Backlar predicts that PADs will face many of the same
challenges faced by medical advance directives in the adoption by the broader health care
community. Backlar suggests that there may be legitimate reasons that community mental health
providers will be slow to adopt and encourage the use of PADs. These barriers were later
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confirmed by empirical PAD barrier studies and included: organizational and administrative
issues within community mental health, the time-consuming nature of PAD completion, and a
general resistance to legal encroachment within clinical practice. In closing, she points out that
even with enforceable laws, education and training for clinicians, and procedures to encourage
their use, the adoption of PADs may be modest. She points out that "Just as many people do not
get vaccines or stop smoking, many people will not engage in such [advance] planning despite
our best efforts" (Backlar, 1997, p. 266).
Stakeholder studies
O'Connell and Stein (2005) argue that whether or not the benefits of PADs will ever be
fully realized depends greatly on the stakeholders who utilize them. If this is true, then O'Connell
and Stein's assertion provides several framing questions for this literature review. How do
stakeholders perceive PADs, and how are these attitudes different for clinicians than for
consumers? Have stakeholders received adequate information on PADs to make use of them? If
they have not, how does a lack of information impact utilization? How do barriers within the
system thwart the use PADs, and what strategies can be applied to address these obstacles? This
proposed research study examines some of these questions for stakeholders in the state of
Virginia to determine whether or not the implementation efforts since Virginia passed the
amended HDCA have yielded to greater system utilization of this powerful legal tool. To provide
a rationale for this study, the remainder of this chapter reviews extant utilization literature. This
exploration begins with a discussion of prior research on PAD demand and utilizations and
concludes with a discussion of the barriers and enabling factors that influence PAD
implementation. The review then focuses on contextually relevant prior research on PAD studies
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in Virginia, This section concludes with the discussion of the limitations of prior research, which
identifies the knowledge and methodological gaps motivating this proposed dissertation research.
PAD prevalence and demand
In addition to the federal Patient Self Determination Act (PSDA), PAD legislation
currently exists in nearly every state. Despite the legal provisions enabling the creation of PADs
by consumers of mental health services, research suggests that very few individuals have done so
(Srebnik, Russo, Sage, Peto & Zick, 2003; Swanson, Swartz, Ferron, Elbogen, & Van Dorn,
2006; Swanson, Swartz, Hannon, Elbogen, Wagner, McCauley, & Butterfield, 2003).
Latent demand
Several prior studies have attempted to quantify PAD prevalence and demand here in the
United States. These studies indicated that there while there is high demand for PADs among
mental health consumers, completion rates remain low (Srebnik et al., 2003; Swanson, Swartz,
Ferron, et al., 2006; Swanson, Swartz, Hannon, et al. 2003). In a sample of 303 participants with
SMI diagnoses, no PAD, and a history of crisis services, Srebnik et al. (2003) found that 53% of
these individuals were interested in completing a PAD. This finding echoed results found in a
similar-sized study of 104 individuals with SMI in North Carolina (Swanson, Swartz, Hannon, et
al., 2003). Swanson, Swartz, Hannon et al. (2003) found that only 7 people with schizophrenia
had a PAD, but that most (64.7%, n=62) were interested in completing a PAD if they had
support doing so. In this same study, only 10 clinicians (n=85) reported working with a client
who had a PAD, although 95.8% of clinicians would recommend patients complete a PAD
(Swanson, Swartz, Hannon, et al., 2003). These data suggest a latent demand for PADs among
both clinicians and consumers (Swanson, Swartz, Hannon, et al., 2003). Similarly low
completion rates were also found in a large-scale study of PAD prevalence, demand, and
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correlates in five American cities (Swanson, Swartz, Ferron, et al., 2006). Swanson, Swartz,
Ferron, et al. (2006) surveyed a convenience sample of 1,011 persons with SMI receiving
services at community mental health centers in five urban US cities. Of this sample, only 4-14%
of the participants reported having a completed a PAD. Of the individuals in this sample who did
not have a PAD, 66-77% of participants stated they would like to complete a PAD if offered the
necessary assistance (Swanson, Swartz, Ferron, et al., 2006).
Correlates with demand and completion
Prior research has also explored what might account for PAD completion and demand. In
their large-scale study (N=1,011) of PADs in five American cities, Swanson, Swartz, Ferron, et
al. (2006) identified statistically significant correlates associated with PAD demand and
completion. Correlates with PAD demand included: prior coercive, unwanted and inadequate
intervention in the past, as well as experiences of disempowerment in the decision-making
process (Swanson, Swartz, Ferron, et al., 2006). Correlates with PAD completion include high
insight scores, previous police involvement in hospitalization, and high social resources.
Strikingly, participants with the strongest demand for a PAD — women of color with a history of
self-harm — were the least likely to have completed a PAD (Swanson, Swartz, Ferron, et al.,
2006). These findings, however, were somewhat inconsistent with the findings of Srebnik et al.
(2003). In a mixed methods study of PAD interest among 303 consumers in Washington state,
Srebnik et al. (2003) found that demographics and functional impairment were nonsignificant
factors in influencing PAD demand. Through consumer interviews and quantitative analysis of
PAD interest, Srebnik et al. (2003) identified numerous reasons for consumer PAD demand,
including case manager's suggestion (27%), a general belief that PADs would be helpful (27%),
to avoid repeating negative experiences (17%), curiosity (11%), to have input in future treatment
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(10%), and to develop a plan for future incapacity (8%). Although in analysis, Srebnik et al.
(2003) concluded that the only statistically significant variables influencing PAD interest were
an absence of outpatient commitment orders and having a case manager with favorable opinions
of PADs.
PAD attitudes and knowledge
Attitudes
Although most studies suggest that all stakeholder groups hold positive opinions of
PADs, research points to variations in attitudes across stakeholder groups (Swanson, Swartz,
Hannon, et al., 2003; Van Dorn et al., 2006; Wilder, et al., 2013). In their stakeholder study on
understanding, attitudes, and experience with PADs (N=272), Swanson, Swartz, Hannon, et al.
2003 found that of all stakeholder groups, consumers of mental health services tended to have
the most positive attitudes regarding PADs. In the analysis of study interviews and self-report
questionnaires, Swanson, Swartz, Hannon, et al. (2003) found that although the majority of
consumers (n=104) and family members (n=83) felt that PADs would help people stay well,
while clinicians (n=85) were less likely to agree with this statement. The authors also concluded
that mental health providers were more skeptical than other stakeholder groups regarding the
purposes and the utility of PADs. Swanson, Swartz, Hannon, et al. (2003) also found that while
there were no significant differences between the groups in their endorsement of PADs, there
were between-group differences on reasons for favoring these legal documents. Clinicians were
much less likely than patients to agree that avoiding unwanted treatment was a good reason for
crafting a PAD. Clinicians were also more likely to support the idea that the only reason for
crafting a PAD was to make consumers feel more empowered, not to avoid unwanted treatment
or obtain needed treatment (Swanson, Swartz, Hannon, et al., 2003). Other group differences
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included divergent beliefs regarding the penalties for failing to follow through on PAD
instructions. Consumers were more likely than family members and much more likely than
clinicians to agree that there should be financial penalties for ignoring a PAD (Swanson, Swartz,
Hannon, et al., 2003).
In a study on the impact of clinician attitudes on decision-making with patients and
clients who had PADs, Elbogen et al. surveyed 597 psychiatrists, social workers, and
psychologists. Of this sample, 280 (47%) clinicians reported that they approved of North
Carolina's laws on advance directives. However, 46% of the respondents said that the benefits of
PADs could be negated by treatment refusals (e.g. consumers using PADs to refuse ALL
treatments during a crisis). In a treatment refusal scenario, 61% of clinicians reported that they
would follow the instructions, but that their reasons for doing so varied across professional
groups. Based on the data collected for this study, Elbogen et al. (2003) concluded that
professional identity (e.g. psychiatry, social work, psychology) was not a statistically significant
influence on PAD attitudes, but that clinicians who were well-informed were more likely to have
positive attitudes towards PADs.
Knowledge
Prior studies suggest that PAD knowledge remains low among all stakeholder groups
(Elbogen et al., 2003; O’Connell & Stein, 2005). In a study on the impact of clinician attitudes
on decision-making with patients and clients who had PADs, Elbogen et al. (2003) found that
among a sample of 591 clinicians, only 220 participants were able to correctly answer the PAD
knowledge question regarding treatment refusals that are inconsistent with community practice
(Elbogen et al., 2003). These data suggested that many clinicians who believed they had accurate
knowledge of PADs, in fact, did not. Consistent with Elbogen et al. (2003), O’Connell and Stein
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(2005) found that among a sample of 272 participants from six stakeholder groups, only a
minority of the respondents reported they had ever heard of PADs before the survey (45%), and
only 11.4% considered themselves very familiar with the legal tools. This study also found that
respondents who had higher levels of contact with individuals with mental illness were more
likely to be familiar with PADs than those with less contact with this population (O'Connell &
Stein, 2005). In a meta-analysis of six studies on PADs, Shields, Pathare, van der Ham, and
Bunders (2014) concluded that between 29 and 54% of clinicians who had participated in
research had any prior knowledge of PADs. Shields et al. (2014) also suggested that inpatient
and outpatient clinicians tend to receive less training than administrators (30% and 100%,
respectively). Henderson et al. (2010) found that limited knowledge of PADs by emergency care
and inpatient providers were rated as highly significant barriers to PAD implementation.
Connecting knowledge and attitudes
Several studies have indicated that there is a relationship between PAD knowledge and
PAD attitudes. Across the research, there is consistency in the conclusion that higher levels of
PAD knowledge were associated with more positive opinions regarding PADs (Elbogen et al.,
2003; O’Connell & Stein, 2005; Swanson et al., 2003). Studies have shown that clinicians who
were well informed and aware of state laws were significantly more likely to endorse positive
attitudes towards PADs (Elbogen et al., 2003; O’Connell & Stein, 2005; Swanson et al., 2003).
Barriers
PAD researchers have sought explanations for the low prevalence rates found in previous
stakeholder studies. A review of prior research points to numerous number of operational,
clinical, and consumer-related barriers that appear to have derailed widespread PAD
implementation (Van Dorn et al., 2011).
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Operational barriers
Operational barriers are defined as barriers that stem from the work environment and
include communication difficulties and problems with accessing the PAD document (Van Dorn
et al., 2011).
Communication
Several studies identified communication issues as barriers for PAD utilization (Kim,
Appelbaum et al., 2007; Srebnik & Brodoff, 2003; Van Dorn et al., 2006). In one survey of 591
US mental health professionals, 66% of providers cited communication difficulties between
hospital staff (ED and inpatient units) as an obstacle (Van Dorn et al. 2006). In another survey of
stakeholders within the US Veterans administration (N=55), communication difficulties between
inpatient staff and outpatient staff were considered a highly significant barrier by both consumers
and providers in a Delphi Method analysis (Henderson et al., 2010).
Resource issues
Another systemic issue that emerges in the literature on PADs is resource limitations.
Resource limitations can include issues related to time, money, personnel, and agency process
limitations (Van Dorn et al., 2010). Prior studies indicated concerns among mental health
providers regarding how PADs would be accessed in crisis situations; in particular, clinicians
reported questions regarding how hospital staff would know someone had a PAD, and how these
treating providers could find a copy of the document (Kim, Appelbaum et al., 2007; Van Dorn et
al. 2006). In the O’Connell and Stein (2005) self-report survey of stakeholders in Ohio (N=272),
25% of respondents also reported resource barriers, including issues such as locating a PAD in a
crisis, and adding PADs into agency documentation. Backlar et al., (2001) drew similar
conclusions. Among a sample of 40 consumer and provider participants, 80% of respondents
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reported low confidence in the ability of organizations such as hospitals, EDs, and community
clinics to enable PAD access (Backlar et al., 2001). This perception by consumers and clinicians
is partially substantiated by research. Srebnik and Russo (2008) found that completed PADs
were accessed only 20% of the time in a two-year study of crisis PAD utilization.
Clinician barriers
In a study on clinician perceptions of PADs (N=591), Van Dorn et al. (2006) suggested
that clinicians tend to perceive more operational barriers (i.e. barriers related to the work
environment) than clinical barriers (i.e. barriers that relate to treatment). Van Dorn et al. (2006)
also found that higher status mental health professionals (i.e. psychiatrists) perceived more
barriers than the lower status professionals (i.e. social workers). This research suggests that
professional affiliation might account for significant variation in the perception of barriers.
Treatment barriers
Treatment barriers refer to the features of clinical practice that might produce obstacles
for PAD completion or utilization. Often these treatment barriers relate to concerns on the part of
clinicians regarding the instructions written in a PAD. For example, in a study of 591 mental
health providers (psychiatrists, n=167; psychologists, n=237; social workers, n=193), Van Dorn
et al. (2006) concluded that treatment refusals or inappropriate instructions were perceived as
significant barriers to PAD utilization among practicing clinicians. Van Dorn et al. (2006) also
found that 46% of the respondents reported that they believed that the benefits of PADs could be
negated by treatment refusals (i.e. consumers using PADs to refuse ALL treatments during a
crisis). Psychiatrists were also significantly more likely than the other two groups to identify a
lack of quality information in a PAD as a barrier, while social workers were more likely than the
other groups to identify not having enough time to review a document as being a barrier (Van
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Dorn et al., 2006). In the analysis of correlates, Van Dorn et al. (2006) suggested that
psychiatrists working in the public sector perceived higher barriers than those working in the
private sector. Likewise, those who believed that the benefits of PADs could be outweighed by
treatment refusals endorsed barriers at higher rates than those who did not (Van Dorn et al.,
2006). The researchers also identified a significant and positive relationship between legal
defensiveness and perceived barriers (Van Dorn et al., 2006).
Other treatment-related barriers that emerge in the literature include concerns about
consumer competency to complete a PAD (Shields et al., 2014; Winnick, 1999). Competency is
defined as the capacity to make and write PAD instructions (Shields et al., 2014). Although one
study of 106 consumers with SMI indicated that nearly all individuals were able to complete a
PAD (Peto et al., 2004), clinicians continue to view competency as a barrier to PAD completion
(Shields et al., 2014; Winnick, 1999). In a study of stakeholder attitudes in Virginia, Wilder et al.
found that 90% of clinicians (n=268) reported they would be more likely to follow PAD
instructions if a clinician had attested to competence at the time of completion. Clinician
attestation of competence is not necessary for a PAD to be considered valid in Virginia, so these
data indicated a perceived difference among clinicians between advance instructions written in
the past and the current preferences of a competent person (Van Dorn et al., 2011).
Knowledge barriers
Many studies have identified a lack of knowledge as a barrier to PAD completion and
utilization (Elbogen et al., 2006; O’Connell & Stein 2005). In a metaanalysis of six studies
examining PAD barriers, Shields et al. (2014) found that between 29 and 54% of clinicians
reported any knowledge of PADs prior to participating in research on the topic. Shields et al.
(2014) went on to conclude that inpatient and outpatient clinicians tend to receive less training
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than administrators, and that emergency care providers receive even less training. While a
number of studies point to discrepant opinions between stakeholder groups regarding PAD
barriers, Henderson et al. (2010) found that the primary point of consensus for all groups of
experts was that poor knowledge of PADs was a barrier to PAD use, particularly in ER and
inpatient settings. This finding is consistent with prior stakeholder studies identifying a lack of
PAD knowledge as a significant barrier to implementation (Elbogen et al., 2006; O'Connell &
Stein, 2005; Shields et al., 2014).
Attitudinal barriers to completion
A review of the literature suggests that the influence of clinician attitudes on PAD
completion is mixed. Some studies have found that clinician involvement is not a statistically
significant factor in PAD completion (Peto, Srebnik, Zick & Russo 2004; Srebnik & La Fond,
1999). While others, such as Srebnik et al., 2003, have reported evidence of a positive correlation
between clinician attitudes and consumers interest in completing a PAD. Though not a statically
significant factor, Peto et al. (2004) argued that clinician support had practical significance for
PAD completion due to the fact that most consumers required assistance in completing the
documents.
Attitudinal barriers to accessing PADs
Clinician attitudes have also been identified as a barrier to utilization of PADs in crisis
situations. In a study examining clinical decision making and views about advance directives,
Elbogen et al. (2003) concluded that clinicians (N=597) who held more negative views of PADs
were less likely to follow a consumers advance instructions during crisis situations. This finding
was consistent with Swanson, McCrary, Swartz, Van Dorn, and Elbogen’s (2007) survey of 164
psychiatrists in North Carolina, which found that 47% of participants reported that they would
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override a valid PAD that refused medication and hospitalization. Of this sample (N=164), a
willingness to override a PAD was most likely among psychiatrists who worked in emergency
departments, were concerned about risk of violence and lack of insight, and rated high on a
measure of legal defensiveness (Swanson et al., 2007). On the other hand, PAD override was
found less likely among respondents who believed that in a high-quality mental health system,
involuntary treatment was largely unnecessary (Swanson et al., 2007).
Disputing attitudinal barriers
Interestingly, not all stakeholders are in agreement that clinician attitudes represent a
significant barrier to PAD utilization. In Henderson et al.’s (2010) study on best practices for
implementation, the researchers concluded that there was no consensus regarding attitudinal
barriers among the consumer and non-consumer groups. Consumers believed that clinician
attitudes were barriers to PAD completions, while non-consumer groups did not. This disparity
in the perception of attitudinal barriers was consistent with other studies examining the impact of
clinician attitudes on PAD implementation, which found that clinicians tend to minimize the
impact of their attitudes, while consumers seem them as highly problematic (Backlar et al., 2001;
O'Connell & Stein, 2005; Swanson et al., 2003).
Consumer barriers
Comprehension issues
PADs are legal documents, and as such, can prove difficult to understand and complete
correctly. Comprehension issues emerge in the literature as a perceived barrier to PAD
completion among service users (Shields et al., 2014). Swartz, Swanson, Van Dorn, Elbogen,
and Shumway (2006) found that 56% of a 469-person sample indicated difficulty with
understanding the purpose of a PAD. Van Dorn et al. (2008) found similar comprehension issues
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among a sample of 85 consumers, 50% of whom reported that they struggled to understand the
legal language of the PAD. Researchers have also identified the challenging of knowing what to
include in a PAD (Swanson et al., 2003; Van Dorn et al. 2008). In one study of 85 service users,
79% of participants reported that completing a PAD was too much of a burden (Van Dorn et al.
2008). Some studies have also pointed to reluctance among mental health consumers to sign
legal documents, even though signatures were necessary to complete a legally binding PAD
(Swanson et al., 2003; Van Dorn et al. 2008).
Trust
Another theme that emerges in the literature on consumer perceptions of PAD barrier is
the issue of trust (Backlar et al., 2001; Swanson, Swartz, Ferron, et al., 2003; Swartz et al., 2006;
Van Dorn et al., 2008). Trust-related barriers are multi-faceted and can emerge in response to
consumer experience with family members, clinicians, or the mental health system. Researchers
have concluded that consumer participants often did not have someone they trusted to serve as a
proxy decision maker. Van Dorn et al. (2008) found that among 389 consumer participants, 43%
did not feel they had someone in their life they could trust to serve as a proxy. Other studies have
identified clinician mistrust as a PAD barrier (Swanson, Swartz, Ferron, et al., 2003; Swartz et
al., 2006). Backlar et al. (2001) reported that many consumers expressed concerns regarding
whether or not a PAD could be accessed and honored in times of crisis. Other studies have found
that a majority of consumers doubt that completing a PAD will have any impact on future
treatment (Swartz et al., 2006; Van Dorn et al., 2008).
Fear of negative attitudes
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PAD barrier studies have also identified concerns among consumers regarding the
willingness of care providers to use and access their PADs. For example, in a follow-up study to
an intervention of facilitated PADs (Swanson, Swartz, Elbogen, et al., 2006), Swanson, Swartz,
Elbogen, Van Dorn, and Wagner (2008) found that among 147 participants who had completed a
PAD and experienced a period of decisional incapacity, only 35% of consumers reported an
awareness that their providers had read their PAD instructions. Other related studies have found
that consumers were often reluctant or afraid to tell their providers that they have a PAD
(Elbogen et al., 2007; Kim, Appelbaum et al., 2007). The primary reasons cited for this
apprehension was a fear of negative response from clinicians or involuntary treatment (e.g.
medication over-objection) during future hospitalizations (Kim, Appelbaum et al., 2007).
Henderson et al. (2010) found that among clinicians and consumers, negative provider attitudes
were rated as a significant barrier. On a scale of 1-9 with 1 being highly significant and 9 being
insignificant, the mean score for this barrier was found to be a 3.4 (SD=1.4) (Henderson et al.,
2010). This same study went on to report that many consumers were afraid to tell hospital staff
that they had a PAD out of fear of being ignored or punished for objecting to medications or
restraints (Henderson et al., 2010). These concerns were also identified in Kim, Appelbaum, et
al. (2007), which found that a fear of clinician intimidation during a crisis, such as threatening to
involuntarily hospitalize, deterred consumers from informing hospital staff that they had a PAD.
Legal issues

Although PADs are considered legally-binding documents, a review of the literature
points to skepticism on the part of consumers regarding whether or not these documents will be
honored in times of crisis (Shields et al., 2014). In a study of 69 consumers who had completed a
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PAD and experienced a subsequent psychiatric episode in which a PAD could be accessed,
Srebnik and Russo (2008) found that 74% of respondents reported that they were concerned
about the enforceability of a PAD. Similar numbers of participants reported concerns over
whether or not the document would be regarded as legally-binding even if providers override
certain provisions in the course of treatment (Srebnik & Russo, 2008).
These consumer concerns regarding the legality of PADs are likely warranted. Unlike
medical advance directives, many states allow providers to override or ignore instructions in
PADs (Shields et al., 2014). Atkinson, Garner, Stuart, and Patrick (2003) point out that medical
advance directives allow a person to refuse life-saving treatment based on personal or religious
beliefs, while individuals with mental illness are not afforded treatment refusals even when
instructions are written during periods of competency. Shields et al. (2014) characterized these
divergent medical practices as “discriminatory towards individuals with mental illness” (p. 762).
Enabling factors
Previous studies have demonstrated a high demand for PADs among stakeholders
coupled with strikingly low completion and utilization rates (Peto et al., 2004; Swanson, Swartz,
Ferron, et al., 2006; Swanson, Swartz, Hannon, et al., 2003). Researchers have suggested that
these low prevalence rates were likely due to perceived systemic, clinician, and consumer
barriers. Only a few studies have been explored ways to address these barriers in the mental
health system. Though small in number, these studies identified several enabling factors that
appeared to foster higher PAD completion and utilization rates.
Positive attitudes
In their study on PADs among high-users of crisis and hospital consumers, Srebnik et al.
(2003) conducted a multiphase intervention study with 303 adults who had had at least two
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psychiatric ED visits or hospitalizations in the past two years. The study found that several
bivariate factors were positively related to interest in PADs. These statistically significant factors
influencing PAD interest included the case manager's support for the directives, having major
depression but not schizophrenia, and having no hospitalizations or commitment orders over the
past two years. Nonsignificant factors included demographics and functional impairment. The
logistic regression suggested that the only variables found to be positively associated with PAD
interest were an absence of outpatient commitment orders and having a case manager with
favorable opinions of PADs. Srebnik et al. (2003) yielded the insight that positive clinician
attitudes were related to consumer interest in executing a PAD.
Involvement of a surrogate decision maker
In a study of PAD utilization during psychiatric crisis events, Srebnik et al. (2008)
followed 106 frequent users of emergency and hospital services with PADs over two years. Of
this sample, 69 participants had at least one psychiatric crisis during the course of the study for a
total of 450 crisis events. Of these 540 incidents, PADs were accessed in 90 events, suggesting
that there was a 20% rate of accessing directives. Interestingly, the researchers found that when a
surrogate decision maker was involved in the crisis, the PAD was ten times more likely to be
accessed than if a surrogate decision maker was not involved.
Access to facilitation
In 2006, Swanson, Swartz, Elbogen, et al. conducted a randomized trial of a structured,
manualized facilitation intervention for psychiatric advance directives to determine whether or
not facilitation could overcome completion barriers. In this study, the researchers compared the
outcomes of the randomly assigned treatment group provided with PAD facilitation to those of
the control. In the treatment group, 61% of the participants completed a PAD compared to 3% in
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the control group. Data analysis suggested that PAD completion was determined by several
factors such as motivation, cognitive ability, help-seeking motivation, and duration of illness.
When the researchers analyzed the content in the treatment group's PADs, the instructions from
the treatment group were far more consistent with community practice standards (as rated by two
psychiatrists) when compared to the control group. According to this study, facilitation increased
completion rates and allowed for advance instructions that were consistent with standard care
(Swanson, Swartz, Elbogen, et al., 2006).
Increasing knowledge and training
Shields et al. (2010) argued that another way to address PAD barriers would be to
introduce a practice-based training program targeting stakeholders on the utility and
implementation of these documents. Although no studies have been conducted to demonstrate
the efficacy of such a curriculum, Srebnik and Russo (2008) provided some insights into the
benefits of structured training for PAD utilization. As part of the study protocol, Srebnik and
Russo’s (2008) research team provided training and process support for hospital and crisis center
staff. Although these efforts were not related to the study’s research questions, procedures such
as staff trainings, implementing system prompts (i.e. crisis cards and PAD dog tags), as well as
the inclusion of PADs in the outpatient medical record appeared to increase access rates over
time. This change in PAD access rate led Srebnik and Russo (2008) to conclude that with
additional training, prompts, and organizational reminders, the mental health system grew more
familiar with the documents. Time and exposure also appeared to increase client and clinician
awareness of PADs. The individuals in this sample who had repeat crises were five times more
likely to have their PAD accessed than those who did not (Srebnik & Russo, 2008). Although
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modest, Srebnik & Russo’s (2008) study provides some evidence that training can influence
PAD utilization.
PAD studies in Virginia
Over the past seven years, Virginia has undertaken efforts to implement the amended
Health Care Decisions Act (HCDA) by promoting the use of psychiatric advance directives
among mental health consumers. The purpose of this dissertation was to understand how PADs
were being used in Virginia, and how practices, attitudes, barriers, and knowledge have changed
since 2010. Although this study has implications for PADs in other localities, this study was
highly contextualized and focused on state-specific laws and practices. For this reason, it was
necessary to review prior literature on PADs in Virginia. To date, there were only three prior
studies on this topic. Although these prior studies drew meaningful inferences on PAD utilization
and implementation in Virginia, they were completed early in the implementation process (pre2015). The following section will review prior studies on PADs in Virginia and identify both the
knowledge and methodological gaps that remain in our understanding of this issue.
Stakeholder studies
In 2013, Wilder et al. published a quantitative study examining the knowledge,
experience, and attitudes regarding the use of PADs among five stakeholder groups (clinicians,
consumers, advocates, family members, and administrators). This study collected baseline data
from five stakeholder groups on knowledge, attitudes, and experiences of PADs in the mental
health context. This study utilized cross-sectional quantitative procedures with five stakeholder
groups via an online survey that contained a core set of questions regarding knowledge, attitudes,
and experiences. The core questions allowed for comparison across stakeholder groups. The
survey also included group-specific questions that elaborated on issues about each class of
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stakeholders. Using purposive sampling, survey participants (N=460) included clinicians
(n=268), administrators (n=67), advocates (n=25), consumers (n=40), and family members
(n=60) recruited through professional and advocacy organization mailing lists. The researchers
analyzed data through descriptive statistics, multivariable regression, and t-test of statistical
significance.
Latent demand
Wilder et al. (2013) concluded that based on the survey results, all stakeholder groups
held favorable opinions of PADs. Additionally, all respondent stakeholder groups reported that
they were generally supportive of HDCA's expansion to include all types of incapacity, including
psychiatric emergencies. Less than a fifth of all respondents endorsed any negative attitudes
about PADs. The survey also indicated that PAD demand is greater than PAD completion rates.
Interestingly, Wilder et al. (2013) found that 29% of consumer respondents in Virginia had
completed a PAD. This figure was striking, given that prior studies on PAD completion rates
were somewhere around 3.9-12.9% (Swanson et al., 2006). Nonetheless, Wilder et al. (2013)
concluded that significant barriers have derailed the implementation process in Virginia.
Stakeholder divergence
Attitudes
Wilder et al. (2013) found common ground among stakeholders (e.g. broad support for
PADs under the HDCA) but also identified key group differences. In particular, the study
revealed that baseline knowledge, use, and perception of barriers varied across stakeholder
groups (Wilder et al., 2013). Based on quantitative analysis, clinicians and administrator groups
appeared to underestimate consumer interest in PADs. Likewise, these groups also expressed
more concern regarding consumer comprehension and capacity to complete a PAD. Other
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attitudinal differences included a perception among family members and consumers that
clinicians will not respect PADs. The authors argue that the misperception of consumer interest
by clinicians coupled with the assumption that clinicians will ignore PADs “logically results in
very few [PADs] being completed” (Wilder et al., 2013, p. 237).
Knowledge
Wilder et al. (2013) concluded that a lack of PAD knowledge was a significant issue for
implementation in the state. Survey respondents reported widely different experiences with
training in the legal and clinical aspects of PADs. Of this sample, administrators tended to be
more knowledgeable about PADs than clinicians, while inpatient providers tended be better
informed than their outpatient counterparts. Wilder et al. (2013) also suggested that there was an
inverse relationship between perceived barriers and knowledge about PADs.
Barriers
Perceptions of barriers also appeared to vary among the respondent groups. Clinician and
administrator groups identified the time needed to complete a PAD as the most problematic
resource barrier to PAD completion. Wilder et al. (2013) also noted that 71% of administrators
and 52% of clinicians believed that providers did not have enough time in the workday to help
consumers understand and complete PADs. Clinicians were also more concerned about the
ability of consumers to complete PADs than the consumer stakeholder group. Consumers, on the
other hand, were far more concerned that clinicians would not honor their treatment preferences
than the clinician stakeholder group (Wilder et al., 2013). These findings indicate some
misunderstanding if not mistrust of other stakeholder groups with regard to PAD
implementation.
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PAD implementation studies
In response to the low prevalence rates reported in Wilder et al. (2013), the Commission
on Mental Health Law Reform recommended that Virginia replicate the Swanson, Swartz,
Elbogen, et al. (2006) facilitation study within its public mental health system. This effort was an
attempt to capitalize on the success of this original study in the hopes that the facilitation model
could increase PAD completion rates across the state (Zelle et al., 2015). The results of this
replication attempt were described by Zelle, Kemp, and Bonnie (2015) in a policy paper
published in the peer-reviewed journal World Psychiatry.
Piloting the facilitator model.
In keeping with the Swanson, Swartz, Elbogen et al. (2006) model, case managers at five
CSB vanguard sites were identified as potential facilitators. These case managers were provided
with a one-day training on PAD facilitation and were then asked to provide one-on-one PAD
facilitation with consumers receiving services through the CSB system. Zelle et al. (2015) did
not report any specific quantitative or qualitative data, but instead described the replication
project's failure as it "quickly became evident that case managers' typical caseloads were too
demanding to allow time for thorough facilitation of services" (Zelle et al., 2015, p. 8).
Adapting the facilitator model.
Recognizing the shortcomings of the one-size-fits-all approach to facilitation, Zelle et al.
(2015) suggested three adaptations to the Swanson, Swartz, Elbogen, et al. (2006) model. The
first recommendation mostly follows the standard one-on-one facilitation and education model
used in the Swanson, Swartz, Elbogen, et al. (2006) RCT. However, the researchers point out
that some CSBs found more success in PAD completion when the agencies identified specific
staff, such as a coordinator of clinical services, to provide facilitation rather than placing this
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expectation on all case managers. In the second model, peer-support specialists provided
education and facilitation. Peer support specialists are trained individuals who also have mental
or psychiatric issues. In the third model, consumers of CSB services are provided with general
information on PADs in group settings. Often these concepts are incorporated into the CSB's
Wellness Recovery Action Plan (WRAP) groups. The researchers point out that embedding PAD
content into WRAP groups capitalized on the overlap between these legal documents and crisis
planning, which is a major topic of these psychoeducational groups. Individuals who were
interested in finding out more about PADs are provided with one-on-one facilitation resources or
additional information to help them complete their PAD. Zelle et al. (2015) concluded that each
of the models could be used in other states.
Barriers to implementation
The same research team published a follow-up article on PAD barriers to implementation
later in 2015. Kemp, Zelle, and Bonnie (2015) used qualitative inquiry to identify thematic
challenges that have emerged during the early phases of Virginia's implementation process. The
researchers collected data from feedback on early training attempts, staff experiences at pilot
sites, and the experiences of the work group tasked with implementation.
Systemic barriers. The authors identify several system-level barriers. As mentioned
previously, the public mental health system operates through 40 independently run Community
Service Boards (CSBs) that are funded and run locally. For this reason, the state has limited the
influence within individual CSBs, as there is no governing body to "prescribe interventionspecific cross-site policies" (Kemp et al., 2015, p. 12). In other words, if a CSB happens to be
motivated and interested in PADs, then they can receive help in achieving this goal. But if a CSB
is reluctant or even hostile to PADs, there is little the state can do to impact this organization's
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culture. Other system implementation barriers include challenges with cross-system
communication, limited treatment for clients in crisis (i.e. bed shortages when consumers
specific facility preferences), and difficulty with electronic medical records, which could have
eased the difficulty of accessing a client’s PAD in times of crisis (Kemp et al., 2015).
Lack of access to facilitation. Although PADs do not require facilitation to be valid, for
many people, the legal language included in an PAD, as well as the nature of the decisions made
in this document, can be so daunting that facilitation becomes a practical necessity (Kemp et al.,
2015). Kemp et al. (2015) suggested that low rates of PAD prevalence were due to a lack of
access to facilitation services. The authors identified several factors contributing to the lack of
access to facilitation services in the state. For instance, PAD facilitation is not a billable service.
Kemp et al. (2015) argued that this issue was particularly problematic for healthcare providers
working with community agencies that had been hit hard by Virginia's state budget cuts.
Although other stakeholders groups could potentially serve as PAD facilitators (e.g. peer support
specialists or advocates), the Virginia state bar has ruled that any attempt to help another person
complete a legal document is considered an unauthorized practice of law (UPL), and can lead to
liability or criminal charges. Concerns about UPL have prevented advocates and peer-support
specialists from involvement in PAD facilitation. Kemp et al. (2015) concluded there was limited
access to facilitation services in the state.
Addressing barriers
To address these barriers, Kemp et al. (2015) introduced several recommendations to
increase PAD utilization across the state. One innovation described was the development of
standardized training and orientation materials for both clinicians and facilitators (Kemp et al.,
2015). This recommendation was consistent with prior literature that arguing that knowledge and
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training were enabling factors for increasing PAD utilization (Shields et al., 2010; Srebnik &
Russo, 2008). This strategy also addressed the facilitator shortage in the state. To address the
decentralized CSB system barriers, Kemp et al. (2015) recommended the appointment of an
implementation coordinator who could proactively work with CSBs to provide support and
education on PADs. It was suggested that this point person could develop agency procedures and
champion the inclusion of PAD facilitation in routine agency procedures. A third recommended
measure was the creation of a state registry for PADs to circumvent the challenges of crosssystem communication difficulties (Kemp et al., 2015). The idea of a centralized PAD registry
has long been present in the literature as a way to address a major operational barrier that
discouraged PAD implementation (Sherman, 1994; Srebnik & Russo, 2008; Winnick, 1996).
Kemp et al. (20105) reported that by publication, each of these three initiatives had begun
across the state. However, Kemp et al. (20105) point out that further research would be needed to
determine whether these efforts have had any meaningful impact on how PADs are used in the
state.
Limitations
Despite the promising benefits of PADs, there appear to be some limitations in prior
research on the topic. One of the significant gaps in our knowledge is that there has been little
research on the long-term impact of PAD laws and implementation efforts over time. Most
utilization and implementation studies analyze samples taken over one-to-two year periods. To
fully understand the phenomenon, studies are needed over multiple year periods (Van Dorn et
al., 2003). Another limitation is that much of PADs research emphasizes the clinician
stakeholder group. In prior studies with consumers, the sample size for the group is usually much
smaller than other stakeholders. For this reason, the clinician perspective heavily biases findings
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from previous stakeholder research. As Van Dorn et al. (2013) points out, it is "ironic that,
though PADs are tools for consumer empowerment and autonomy, consumers have had little
involvement in PAD research" (p. 13). In addition to these temporal and sampling concerns,
there is also a lack of methodological diversity in PAD studies, which exacerbates the sense that
consumers have been disempowered within this area of research. Most PAD studies tend to be
quantitative. Although quantitative data are valuable, these studies fail to capture the unique
voice of the consumer. Another significant limitation of prior research concerns the localization
of PAD studies. Because state-specific law heavily influences PADs, a well-executed, robust
study in one state cannot be easily generalized to other areas of the country.
To date, Wilder et al. (2013) is the only study on stakeholder knowledge, experience,
opinions, and obstacles in Virginia; as such, it offers substantive insight into our research topic:
the implementation of psychiatric advance directives in Virginia. But despite the research value
of Wilder et al. (2013) for our understanding of PAD utilization post-HDCA, this study has
several limitations. One concern with this study was the participant recruitment procedures.
Respondents to the survey were self-selected among individuals involved in professional and
advocacy organizations. In other words, respondents were engaged stakeholders, and may not
have been representative of the general population of Virginia. The consumer, family, and
advocate response rates were exceptionally low, which raises the possibility of bias in the data.
The high incidence of PAD completion (49%), when compared with prior studies on PAD
prevalence (3-14% in Swanson, Swartz, Ferron, et al., 2006) also strengthens these bias
concerns. Likewise, there were measurement concerns with some of the items in the original
survey.
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Although there have been several studies on PADs in Virginia, no research has been
conducted as a follow-up to Wilder et al. (2013) to determine how PAD utilization has changed
over time in response to the state's concerted implementation efforts (Kemp et al., 2015; Zelle et
al., 2015). This lack of existing research on PADs following these studies points to a knowledge
gap in our understanding of how these legal tools are used in Virginia. Likewise, there have been
no prior mixed methods studies of PADs in Virginia, as all of the empirical studies have been
quantitative or loosely qualitative. A mixed methods study would capitalize on the strengths of
each tradition while offsetting associated limitations of monomethod design (Creswell & Plano
Clark, 2011). What research has been conducted on Virginia PADs has also failed to capture the
qualitative voice of stakeholders, particularly, mental health consumers. The research of this
dissertation addressed both content and methodological gaps to enhance our understanding of
PADs in Virginia.
Conclusion
This literature review began by establishing a rationale for studying PADs by drawing on
the empowerment movement that has emerged in the literature over the past three decades. By
tracing the history of powerlessness, persons with mental illness have faced oppression within
the mental health care system as they have been denied opportunities for choice and selfdetermination. Advocates and scholars have argued that legally-binding PADs can be tools of
empowerment to remediate the legacy of this oppression. Drawing from the ACA Code of Ethics
(2014) and the ACA Advocacy Competencies, counselors have a vested interested in knowing
about PADs and promoting their use with clients. After establishing an ethical argument for
PADs, the chapter shifted to a systematic review of the extant literature. Beginning with early
theoretical works, and moving on to stakeholder, barrier, and implementation studies, this
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chapter identified significant milestones in our understanding as well as many unanswered
questions regarding these legal tools. I then shifted to a review of prior research on PADs in
Virginia. This examination revealed several limitations in our understanding of PADs in
Virginia. In this sense, our knowledge of this issue remained incomplete from both a content and
methodological perspective. In the following chapter, I propose a research methodology to
address these gaps in our understanding.
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CHAPTER 3
Methods
Philosophical Foundation
Research in the social sciences often begins with a discussion of philosophical
paradigms. Creswell and Plano Clark (2011) suggest there are four major paradigms within
social science research, including post positivism, constructionism, participatory, and
pragmatism. For my study, I adopted an overarching pragmatic worldview with a pluralistic lens.
Onwuegbuzie and Johnson (2006) argue that mixed methods researchers can achieve this
pluralistic lens by making "Gestalt switches from qualitative to a quantitative, going back and
forth, again and again" (p. 59). In this sense, mixed methods research can "transcend the forced
dichotomy" (Feilzer, 2010, p. 4) by creating a third viewpoint that "[is] informed by, is separate
from, and goes beyond what is provided by either a pure qualitative viewpoint or a pure
quantitative viewpoint" (Onwuegbuzie & Johnson, 2006, p. 59). Researchers adopt mixed
methods approaches because they can provide more complete answers than could be obtained
through monomethod designs (Creswell & Plano Clark, 2011). Greene, Caracelli, and Graham
(1989) elaborated on this point by suggesting that mixed methods enables the triangulation,
complementarity, initiation, development, and expansion of research findings.
Johnson and Onwuegbuzie (2004) argue that mixed methods research always begins with
the problem statement. The problem statement generates a series of investigative questions,
which in turn, inform methodological decisions (Creswell & Plano Clark, 2011). As mentioned
in my problem statement, the goal of this research study was to address methodological and
knowledge gaps in our understanding of PADs in Virginia. After reviewing the literature, it was
clear that prior research had generated an incomplete picture of PADs in Virginia. Previous
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research on PADs in Virginia had failed to consider the subjective layer of the phenomenon.
However, an exclusively qualitative study would also fail to capture the more objective aspects
of the topic such as whether or not statewide PAD implementation efforts had been effective in
improving utilization. I chose a mixed methods design to answer my research question because it
would enable triangulation through convergence and corroboration of data, complementarity
through an elaboration of strand results in mixed analysis and interpretation, and expansion
through a breadth of methods (Greene, Caracelli, & Graham, 1989). I was also interested in
discovering what works and how (Creswell & Plano Clark, 2011) with the hope that the results of
this study could be used to inform effective practice (Johnson & Onwuegbuzie, 2004). A mixed
methods paradigm with a pluralistic lens afforded the tools necessary for accomplishing these
research goals.
Design
A hybrid convergent parallel mixed method design was used with an equal emphasis on
the qualitative and quantitative strands ([QUAN + qual] + QUAL = more complete
understanding). Quantitative and qualitative data were collected to obtain different but
"complementary data on the same topic" (Morse, as cited in Creswell & Plano Clark, 2011, p.
77). These databases were analyzed separately, and results were compared for converge and
divergence. The advantage of the convergent parallel mixed method design was that it
capitalized on the strengths while minimizing the weaknesses of monomethod approaches
(Creswell & Plano Clark, 2011). The quantitative strand enabled generalization, while the
qualitative strand captured the respondents' categories and understanding (i.e. the emic
viewpoint) and identified contextual factors that related to the phenomenon (Johnson &
Onwuegbuzie, 2004). The weaknesses of each strand were offset by the strengths of the other
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(Johnson & Onwuegbuzie, 2004). Collecting qualitative data from two sources, the survey and
in-depth interviews, enhanced the study by providing detailed insight into the research questions.
The in-depth interviews also enhanced the clinical significance of the study by capturing the
unique experiences of clinician stakeholders. Through Gestalt switches between quantitative and
qualitative lenses across the two phases, the study generated a more complete, valid, and
clinically useful picture of PADs in Virginia (Johnson & Onwuegbuzie, 2004).
Although the convergent parallel design was selected for its comprehensiveness and
applicability to practice (Creswell & Plano Clark, 2011), the design was not without
complications. Creswell and Plano Clark (2011) suggest that convergent parallel designs
generate methodological and practical hurdles that must be addressed at the outset of this
study. The first challenge was that this method required a significant amount of effort since the
data were collected concurrently from multiple sources. A second challenge was the issue of
disparate samples, sample sizes, and types of data that problematizes data merging. To address
these concerns, I paid attention to the timing, weighting, and mixing of the two approaches.
Regarding timing, both strands of data were collected concurrently. To manage the time demands
of concurrently collection, I staggered the start data of the phases by a period of six weeks.
Regarding weighting, qualitative and quantitative data were given equal emphasis in the
study. To support this choice, I ensured that both strands addressed the same concepts through
parallel qualitative and quantitative questions (weighting). And finally, the data were mixed at
the level of interpretation, as is depicted in Figure 1. I included the same participants (e.g.
samples and sample sizes) in both strands to facilitate the comparison of the data sets (mixing).
I refer to the quantitative strand of this research as the stakeholder survey, which was
used to answer research question one. The stakeholder survey adapted a questionnaire developed
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by O’Connell and Stein (2002) to measure stakeholder PAD attitudes, knowledge, utilization,
and barriers. The second strand of the study is referred to as the experience study, and aimed to
answer research questions 2, 3, and 4. The experience study collected qualitative data through
two sources: topical semi structured follow-up interviews with clinicians and open-ended
questions nested in the stakeholder survey.
The participants, recruitment, study procedures, data collection, analyses, and
legitimization considerations for each of these strands are discussed in the following section. In
keeping with the mixed methods tradition, I also outline the procedures used for mixing the data
alongside a description of the analysis used as well as my mixed method legitimization
strategies.
Quantitative strand
The stakeholder survey addressed research question one (RQ1) of this dissertation: Is
there a statistically significant difference on measures of knowledge, attitudes, experience, and
barriers regarding PADs among five stakeholder groups (clinicians, consumers, administrators,
advocates, and family members) in Virginia?
To answer research one, I administered an online stakeholder survey designed to measure
four themes: PAD knowledge, attitudes, experience, and barriers. The cross-sectional survey
contained a core set of questions that were relevant to all stakeholder groups, as well as
additional items targeting more specific issues that applied to each stakeholder category. These
core questions enabled comparison of responses across groups while the group-specific questions
provided further elaboration of each group's interest, knowledge, and needs.
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Participants and recruitment
This study was approved by the James Madison University IRB as well as the University
of Virginia's Health Sciences IRB. Nonrandom purposive sampling was used to identify study
participants. To qualify for participation in the stakeholder survey, individuals had to report
employment as a facility administrator or clinician (e.g., psychiatrist, psychologist, social
worker, or counselor) at a Virginia CSB, psychiatric hospital, or residential mental health
treatment facility. Other inclusion criterion was self-identification as a mental health service
recipient, family member, or mental health advocate residing in Virginia.
I submitted survey information and URL links to professional and advocacy
organizations that had stakeholder members, including the Department of Behavioral Health and
Developmental Services (DBHDS). These organizations emailed the link to members, posted the
link to their website, or included the link within their newsletter. Wilder et al. (2013) had a low
response number for mental health consumers, family members, and advocates (n=40, n=60, and
n=25, respectively), which raised the possibility of selection bias. To increase responses and
reduce the likelihood of selection bias, I employed also snowball sampling procedures for these
three stakeholder groups. Snowball or chain sampling involves locating a few participants who
meet criteria for participation, and then ask them to refer you to other respondents (Merriam &
Tisdell, 2015). Snowball sampling has been identified as a way to increase the participation of
traditionally marginalized or hard-to-reach subgroups (Sadler, Lee, Lim, & Fullerton, 2010). To
employ this sampling procedure, I contacted case managers at several Virginia CSBs who were
willing to forward the survey on to their clients and family members. To increase advocate
responses, I contacted an area mental health advocate to ask for her assistance with the research
study.
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Study procedures
To answer RQ1, recruited participants who were willing to complete the stakeholder
survey were provided with an online consent letter providing information about the study. All
data gathered from the stakeholder survey were anonymous and confidential. Study participants
completed the questionnaire online through Qualtrics. Participants took between 15-25 minutes
to complete the survey.
The online survey was divided into four sections that measured respondent
demographics, familiarity with PADs, experience with PADs, and PAD attitudes and perceived
barriers. The survey also contained three open-ended items that were used for qualitative
analysis. The demographic section asked participants questions on age, gender, ethnicity,
profession, working setting, years of experience, and highest education completed. The
familiarity with PADs asked participants, “Prior to this survey, how familiar would you say you
were with psychiatric advance directives?” Respondents answered on a five point Likert scale
that ranged from no knowledge to very knowledgeable. Experience with PAD was measured by
four questions regarding organizational practices around PADs, including “PADs are discussed
with consumers,” “PAD forms are provided to consumers,” “Consumers are assisted in
completing PADs,” and “There is written documentation of whether someone has a PAD.”
Respondents were asked to select an answer that best described practice at his or her current
organization on a five-point Likert Scale with items ranging from No Consumers to All
consumers. Consumers, family members, and advocates were asked questions regarding whether
or not they have a PAD or would have an interest in completing one if given guidance.
Stakeholder attitudes towards PADs were then assessed through the Opinions on Psychiatric
Advance Directives Questionnaire (OPADQ) (O’Connell, 2002). The OPADQ contains three
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subscales: Obstacles to Success, Utility and Benefits, and Decision-Making Capacity.
Respondent scores were calculated and treated as dependent variables while stakeholder groups
were treated as categorical independent variables.
Instrumentation
The stakeholder survey contained forced choice and Likert-scale questions measuring
four themes: PAD knowledge, attitudes, experience, and barriers. Experience items were based
on the Wilder et al. (2013) stakeholder survey, while PAD familiarity and attitudes were
measured by the Opinions on Psychiatric Advance Directives Questionnaire (OPADQ)
(O’Connell, 2002). The OPADQ contains 60 items concerning the perceived barriers and
benefits of PADs. Following procedures from O’Connell (2002), participants were then asked to
rate how strongly they agreed with each statement on a five-point Likert Scale ranging from
strongly disagree to strong agree. These 60 items are grouped into three subscales: Obstacles to
Success (OS), Utility and Benefits (UB), and Decision-Making Capacity (DM). The OS subscale
included 26 items that identify concerns regarding the use of PADs, from their implementation,
to access issues, to whether or not the instructions will be followed. The UB subscale was
comprised of 20 items that regarding beliefs about the benefits of PADs, such as improved
clinical outcomes and professional communication. The DM subscale contained 14 items that
suggest consumers have the capacity to make decisions regarding their mental health care
treatment. The OPADQ was selected for its strong psychometric properties. O’Connell (2002)
reports Cronbach's alpha for each of the three subscales: Obstacles to Success α=.90, Utility and
Benefits, α=.88, Decision-making capacity, α=.81.
The Wilder et al. (2013) survey was developed from pre-existing questionnaires had that
been used in prior studies conducted in North Carolina (Elbogen et al., 2006). Items from the
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Elbogen et al. (2006) survey were adapted to reflect the specifics of Virginia PAD law. The
study’s Coordinating Committee of content experts then reviewed the instrument. Changes were
made based on the committee's recommendations. The survey was then piloted with a group of
10 individuals, including consumers, clinicians, and administrator volunteers. Final changes
were made to the survey based on feedback from the pilot study respondents. The stakeholder
survey (Wilder et al., 2013) demonstrates content validity based on the formal validation
processes used in its development (Neukreg & Fawcett, 2015). Wilder et al. (2013) did not report
formal psychometric properties for external validity or reliability. This issue is discussed further
in the section on trustworthiness.
For use in this study, changes to the Wilder et al. (2013) survey language were made to
reflect current understanding and practices surrounding PAD utilization. Specifically, the phrase
“the new Health Care Decisions Act (HDCA)” was replaced with the phrase “advance directives
for mental health.” These changes were made to increase the clarity of items and reduce
confusion on the part of study participants, who are likely not aware of the HDCA. Likewise,
double barrel and leading questions were removed and new items were constructed to replace the
problematic items. Members of the researcher team as well as content experts reviewed these
changes to ensure validity.
Data analysis
Data were collected in the quantitative strand to test the hypotheses associated with RQ1.
During this phase of analysis, I used a quantitative lens to apply appropriate deductive
techniques. Quantitative data were cleaned and entered into the Statistical Package of Social
Sciences (SPSS Version 24.0, 2017). These data were then analyzed for frequency distribution,
and descriptive statistics. Between group differences on measures of OPADQ total scores and
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subscales were calculated using multiple one-way ANOVAs. Statistical significance was
determined at a p-value of ≤0.05. Tukey's Honestly Significant Difference post hoc tests were
conducted where differences occurred. Post hoc power analyses were carried out for
nonsignificant findings.
Qualitative strand
The experience study addressed three research questions in this dissertation:
RQ2: “What encourages the use of PADs in Virginia?”
RQ3: “What discourages the use of PADs in Virginia?”
RQ4: “What can be done to increase PAD utilization?”
To answer these questions, I collected qualitative data from two sources. The first source
of qualitative data came from responses to open-ended questions nested in the quantitative
stakeholder survey. The second source of qualitative data was collected through one-on-one
telephone interviews with clinicians. These data were collected concurrently with the QUAN
strand to enhance understanding of what has continued to promote or thwart the use of PADs in
Virginia.
Sources of qualitative data
Open-ended questions
Qualitative data were collected through open-ended questions nested in the online
stakeholder survey. All survey participants were provided with an online informed consent letter
before completing the questionnaire. Anonymous surveys required between 5-20 minutes for
completion. Three open-ended questions were nested into the quantitative stakeholder survey to
gather perspectives from these respondents. These three questions asked about use, encouragers,
and discouragers of PADs in Virginia. Members of the research team reviewed the open-ended
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questions. Reviewers were instructed to respond to questions as if they were a participant and
then comment on the content, grammar, and understandability of each prompt. To ensure that the
categories of the researchers did not influence qualitative responses, the open-ended questions
were asked at the beginning of the survey.
Follow-up interview script
A semi-structured interview guide was developed to elaborate on recommendations for
increasing PAD utilization. The semi-structured interview was designed such that all participants
were asked a core set of questions developed to elicit information regarding critical experiences
with PADs. Participants were first asked a grand tour question to build rapport and provide
context regarding the interviewee’s clinical experience (Merriam & Tisdale, 2015). Participants
were then asked about experience, behavior, opinions and values regarding PADs in Virginia
(Patton, 1990). In a closing question, participants were asked if they had any specific
recommendations for increasing PAD utilization. Although the questions were used flexibly,
optional probes were included to evoke specific information based on the participant’s emerging
worldview (Merriam & Tisdale, 2015).
After developing the interview guide, members of the research team reviewed the
questions. Reviewers were instructed to respond to prompts as if they were a participant and then
comment on the content, grammar, and understandability of each item. After some revisions, the
script was piloted with a mental health clinician. Minor changes were made to the script
following the pilot interview.
Participants were scheduled at a mutually-convenient time for a telephone interview,
which was designed to take less than 30 minutes to complete. On the date of the interview,
verbal informed consent and audio recording permission were obtained over the phone and
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recorded in the study's audit trail. For consistency, I conducted all of the clinician follow-up
interviews. All recordings were transcribed verbatim using Dragon for Mac transcription
software. Participants who consented to audio recording were provided with copies of interview
transcripts to ensure accuracy. After confirming transcript accuracy through member checking,
these data were then entered into NVivo software for coding and analysis.
Ethics
Unlike the open-ended responses, which collected only anonymous data from
respondents, the one-on-one interviews necessarily involved the collection of identifiable data
through interview procedures. The collection of identifiable data increases the risk of harm to
study participants due to the potential for confidentiality breaches. Because this study involved
vulnerable populations, I decided, in consultation with my research team, to only include the
clinician stakeholder group in this portion of the study. In addition to concerns regarding harm
through breach of confidentiality, there were additional harm concerns related to the sensitive
nature of the questions. The interview protocol was designed to elicit critical participant
experiences with PADs. For the advocate, family, and consumer stakeholder groups, these
critical experiences might well involve prior traumatic or unwanted hospitalizations. Without a
prolonged engagement with me as a researcher, I had concerns that sharing these stories could be
traumatizing or upsetting to interview subjects. Although I am a trained mental health clinician
who regularly works with advocates, consumers, and family members, in my capacity as a
researcher, I felt that the benefits of interviewing all five stakeholder groups did not outweigh the
risk of harm. Out of concern for the well-being of participants, I elected to collect only
anonymous qualitative data from these vulnerable stakeholder groups.
Participants and recruitment
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To qualify for participation in the follow-up interviews, individuals had to report
employment as a clinician (e.g., psychiatrist, psychologist, social worker, or counselor) at a
Virginia CSB, psychiatric hospital, or residential mental health treatment facility or self-identify
as a mental health advocate. Participants for interviews (N=8) were recruited through the
clinician stakeholder survey through an additional question that asked if the participant would be
willing to complete a follow-up interview on PADs. If interested (as indicated by a yes to this
question), this item directed the participant to a separate website or survey that was not
connected to the main instrument to preserve anonymity. The respondent was then led to an
informed consent agreement before submitting contact information. Interested participants were
then contacted via email within two weeks of the closure of the stakeholder survey. Participants
selected for follow-up interviews were chosen using maximum variation sampling to enhance the
trustworthiness of these data. Maximum variation sampling identifies and seeks out patterns
from participants who represent the widest possible range of characteristics (Merriam & Tisdell,
2015).
Data analysis
All QUAL data were entered verbatim into NVivo for coding and analysis. Qualitative
responses were later analyzed using inductive content analysis. Inductive content analysis is a
coding and categorization approach that examines textual information to “describe who says
what, to whom, and with what effect” (Vaismoradi, Turunen, & Bondas, 2013, p. 400). The goal
of inductive content analysis is to “attain a condensed and broad description of a phenomenon …
[through] categories” (Elo & Kyngas, 2008, p. 8). Inductive content analysis is considered ideal
for qualitative research on topics, such as psychiatric advance directives, where there is an
absence of prior studies examining a phenomenon (Vaismoradi et al., 2013). Inductive content
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analysis also lends itself well to mixed methodology since it enables the quantification of
qualitative data through the measurement of frequencies of categories and themes (Gbrich,
2012). This quantification of qualitative data can support comparisons of QUAL and QUAN
findings (Vaismoradi et al., 2013).
During open coding, segments of texts were labeled with codes or headings that
described a text’s content or meaning (Creswell & Plano Clark, 2011). These headings were then
collected onto coding sheets to generate broad categories that could capture the codes. These
categories were then grouped into higher order headings (Elo & Kyngas, 2008). Using
comparison procedures in which codes were interpreted not only for similarities, but also for
whether they belonged together, a process called horizontalization (Mousakas, 1994), this
grouping strategy reduced the overall number of categories. In the next step, the categories were
abstracted into “content-characteristic words” (Elo & Kyngas, 2008, p. 111) that offered a
general description of the phenomenon. These categories were then organized and reported in a
conceptual map. An audit trail and memoing were used to guide decisions throughout the QUAL
analysis.
Mixed methods
Quantitative and qualitative data were mixed in this convergent parallel study at the level
of interpretation. The goal of mixing was to seek convergence, complementarity, and
enhancement to develop a more complete, valid, and clinically useful understanding of PADs in
Virginia (Creswell & Plano Clark, 2011).
Procedures
In keeping with the tradition of convergent parallel mixed method research, qualitative
and quantitative data were collected both concurrently, analyzed separately, and were then
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integrated for a mixed analysis. This mixed method analysis was guided by two sensitizing
questions: to what extent do the qualitative and quantitative results converge, and in what ways
do they diverge. Combined database results were analyzed and later reported through a joint
display of themes and quantitative results across each of these phases. After completing the
mixed methods analysis, the findings were interpreted through a pragmatic lens to draw metainferences (Teddlie & Tashakkori, 2009).
Analysis
The merged data analysis strategy used in this study was based on the seven-step model
of Teddlie and Tashakkori (2009). Teddlie and Tashakkori’s (2009) process-oriented model
involves seven stages of data analysis including 1) data reduction, 2) data display, 3) data
transformation, 4) data correlation, 5) data consolidation, 6) data comparison, and 7) data
integration. Steps one and two (data reduction and data display) of this process were completed
through the concurrent data collection and analysis. In steps three and four (data transformation
and data correlation), qualitative data were converted into numerical codes and correlated with
the quantitative data. In step five (data consolidation), quantitized qualitative data and
quantitative data were combined to create a new data set. In step six (data comparison), data sets
were compared through both a qualitative and quantitative lenses. In step seven (data
integration), the merged results were reported both through the correlations and in a joint table
displaying themes and quantitative results.
Trustworthiness
Quantitative legitimization
Merriam and Tisdell (2015) argue that for research to be considered trustworthy, studies
must be "rigorously conducted" (p. 238). In quantitative research, trustworthiness is evaluated by

71
the study’s validity (Onwuegbuzie & Johnson, 2006). In one of the seminal texts on quantitative
research, Shadish, Cook, and Campbell (2002) identified four key types of validity: statistical
conclusion validity, internal validity, construct validity, and external validity. Steps were taken
to ensure the validity of the QUAN strand. Statistical conclusion validity refers the extent to
which conclusions are correct or reasonable based on the data. To demonstrate statistical
conclusion validity (Shadish et al., 2002), I conducted power analyses to ensure that statistical
tests had a power of greater than 0.8 in value and sought consistency in implementation
procedures from the 2010 administration (Wilder et al., 2013). Content validity refers to the
degree to which a test measures what it claims to be measuring (Shadish et al., 2002).
To demonstrate content validity, I administered the Wilder et al. (2013) stakeholder
survey, a content valid measure of PAD knowledge, attitudes, barriers, and experience. Although
the stakeholder survey appeared to demonstrate content validity based on the formal validation
processes described in Wilder et al. (2013), the developers did not report any specific
psychometric properties (e.g. validity or reliability). The failure to report validity or reliability
measures was likely because the instrument was developed without exploratory or confirmatory
factor analysis. The absence of psychometric data on the stakeholder survey presents a limitation
for the trustworthiness of the quantitative findings of this dissertation. However, in keeping with
a pragmatist philosophical orientation, I used the Wilder et al. (2013) survey for data collection
with the expectation that clinically useful results would nonetheless emerge.
Qualitative legitimization
Firestone (1987) argues that rigorous qualitative research "provides the reader with a
depiction in enough detail to show that the author's conclusions ‘make sense'" (p. 19). To make
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sense to a reader, qualitative research must be credible, transferable, dependable, and
confirmable (Lincoln & Guba, 1985).
Methodological rigor was ensured through credibility, transferability, dependability, and
confirmability. Credibility suggests that the data are believable from the perspective of the
participants and that there is congruence between the findings and reality (Merriam & Tisdell,
2015). Creswell and Plano Clark (2011) point out one possible threat to credibility generated by
the study’s design. These authors suggest that qualitative questions nested in a quantitative
survey do not generate “rich content and detailed information” (Creswell & Plano Clark, 2011, p.
276). To address this threat to credibility, I collected multiple sources of QUAL data to enable
triangulation (Merriam & Tisdell, 2015) between the two QUAL databases. Credibility was also
ensured through member checking with interview participants (Merriam & Tisdell, 2015).
Transferability suggests that the findings of a study allow for application by the reader to other
contexts (Merriam & Tisdell, 2015). To increase transferability, I utilized maximum variation
sampling in the follow-up interviews. Additionally, I attempted to provide an emic account in my
reporting, which would facilitate the application of findings to other contexts. Dependability is
the sense of consistency between the data collected and the results (Merriam & Tisdell, 2015).
To increase dependability, I kept an audit trail to ensure that others could trace the logic of
decisions and conclusions. Finally, confirmability refers to the process of verifying the data
collection and analysis by others (Merriam & Tisdell, 2015). To increase confirmability, I
utilized peer review of interview protocols, transcripts, coding, analysis, and interpretation.
These deliberate methodological decisions were intended to increase the rigor and
trustworthiness of the qualitative strand of this study.
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Mixed methods legitimization
Attention was paid to issues of rigor and trustworthiness in this mixed methods analysis.
Onwuegbuzie & Johnson (2006) suggest a typology of legitimization for mixed methods
research. Several elements of their typology were incorporated in this study: sample integration,
weakness minimization, and paradigmatic mixing. Sample integration as a rigor strategy implies
that the same sample is used for both strands. Because both the QUAN and QUAL strand used
the same individuals, it was possible to combine strand inferences and construct meta-inferences.
Weakness minimization refers to the extent to which the weakness of one strand is compensated
by the strengths of the other (Onwuegbuzie & Johnson, 2006). Weaknesses were minimized in
this study by collecting data qualitatively and quantitatively to accurately capture both the emic
and the etic perspective within the study. Qualitative data were also collected from two sources,
which minimized the weakness of the open-ended nested questions (Creswell & Plano-Clark,
2011). Onwuegbuzie & Johnson (2006) also suggest that paradigmatic mixing can enhance
trustworthiness. Although I sought to develop an overarching pragmatic worldview for this
research, paradigm shifts between post positivism and constructivism occurred when I moved
between the QUAN and QUAL strands. In conducting this study, I adopted the epistemological,
ontological, axiological, methodological, and rhetorical practices of each strand through "Gestalt
switches from a quantitative to a qualitative lens" (Onwuegbuzie & Johnson, 2006, p. 57). These
choices were made with the goal of increasing the trustworthiness of the mixed methods
findings.
Conclusion
This chapter began with a discussion of philosophical foundations. After discussing the
philosophical underpinnings of this inquiry, I introduced mixed methods research, and explained
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how my research questions motivated design choices. I then outlined the strengths and
weaknesses of the multiphase mixed methods design before transitioning to the procedures used
in the convergent parallel design. Attention was paid in these sections to issues of sampling and
analysis. The chapter concluded with a discussion of the mixed methods analysis as well as steps
that were taken to enhance trustworthiness of the study.
In the following chapter, the results of quantitative, qualitative, and mixed method
analysis are reported. In chapter five of this dissertation, the mixed methods results are
interpreted with an eye towards whether or not there was convergence among the findings, and
what meaning can be derived from these connections (Creswell & Plano Clark, 2011).
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CHAPTER 4

Results
Introduction
In keeping with the convergent parallel mixed methods design outlined in the previous
chapter, quantitative and qualitative data were collected concurrently though two sources, the
online stakeholder study and follow-up interviews. Data were analyzed separately using
appropriate deductive and inductive techniques to answer the corresponding research questions.
The quantitative strand sought to define how PADs were currently being used in the state (RQ1);
the qualitative strand sought to clarify the enabling factors and obstacles that influence PAD
utilization in the state (RQ2 & RQ3), and identify strategies for increasing the use of PADs in the
future (RQ4). Results from both strands were then mixed at the level of interpretation to evaluate
the extent to which the quantitative and qualitative results converged or diverged (RQ 5). In this
chapter, I report study results organized by strand and conclude with a discussion of the
integrated analysis results. I also discuss study limitations and suggestions for future research on
the topic.
Quantitative strand results
Data were collected in the quantitative strand to test the hypotheses associated with RQ1.
Participants completed the Opinions on Psychiatric Advance Directives Questionnaire (OPADQ)
online (see Appendix A). Quantitative data were cleaned and entered into the Statistical Package
of Social Sciences (SPSS Version 24.0, 2017). These data were then analyzed using descriptive
and inferential statistical procedures. During this phase of analysis, I used a quantitative lens to
apply appropriate deductive techniques.
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Sample Characteristics
Completed surveys were received from 150 respondents. Due to recruitment procedures,
it was not possible to calculate response rate for this study. Seventy-two percent of respondents
identified as female (n=110), while 16.4% (n=25) identified as male [see Table 1]. Over threequarters of the sample identified as White (n=120), while 7% identified as Black (n=10) [see
Table 2]. Professionally, 47% (n=71) of respondents identified as clinicians, 13% (n=20) as
consumers, 20% (n=31) as administrators, 3% (n=5) as family members, and 7% (n=11) as
advocates [see Table 2]. Of the respondents who identified as clinicians, 30% (n=46) identified
as Mental Health Counselors (LPC) while 18% (n=28) identified as social workers [Table 3].
The next largest professional group was of case managers, who comprised 6% (n=9) of the
clinician group. Only one psychiatrist and one psychologist completed this survey. More than
half of survey respondents (n=88) reported working for a public agency or organization, while
18% (n=27) reported working at a private not-for-profit organization. Respondents working in
outpatient settings comprised 71% of the sample (n=108), while 6% (n=9) worked in an inpatient
setting. Respondents had an average age of 45 years old (SD=10.80). Participants had worked an
average of 14.41 (SD=10.36) years in their current profession. Sixty percent of respondents
(n=89) reported a professional degree as their highest level of education (see Table 4).
Opinions on Psychiatric Advance Directives Questionnaire (OPADQ)
The first theme of the study considered stakeholder attitudes towards PADs. To measure
stakeholder attitudes towards PADs, study participants were asked to complete the 60-item
Opinions on Psychiatric Advance Directives Questionnaire (OPADQ). The OPADQ contains
three subscales Obstacles to Success (OS), Utility and Benefits (UB), and Decision-Making
Capacity (DM). Item responses to the Likert Scale questions of the OPADQ [Appendix A] were
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entered as ordinal variables. Total OPADQ scores and subscale scores (OS, UB, DM) were
calculated for each participant as continuous variables [see Table 10]. The mean total score for
OPADQ was calculated to be 183.84 (SD= 11.52). The mean OS Score was 63.95 (SD= 11.46).
The mean UB Score was 68.28 (SD= 8.95), and the mean DM Score was 51.60 (SD= 3.86). A
series of one-way ANOVAs were planned to compare mean scores on the three factors of the
OPADQ. Before conducting these tests, the dataset was analyzed to ensure conformity to the
pertinent statistical assumptions of ANOVA. The Levene’s test of homogeneity yielded
nonsignificant results for each of the four dependent variables (Total, p = 0.85; OS, p = 0.08;
UB, p = 0.19; DM, p = 0.30) suggesting that the assumption of equality of variance had not been
violated. The skew and kurtosis were also calculated for the dataset suggesting the assumption of
normality was also not violated. Likewise, there was no clustering outside of the independent
variable of stakeholder group, indicating that the assumption of independence of samples had not
been violated.
After determining that the dataset conformed to the assumptions noted above, a one-way
ANOVA was conducted to evaluate the differences between stakeholder group and Total score
on the OPADQ. The independent variable, Simple Group, contained five levels: administrators,
clinicians, advocates, consumers, and family members. The dependent variable was Total Score
on the OPADQ instrument. Statistical significance was determined at a p-value of ≤ 0.05. The
omnibus ANOVA was nonsignificant, F(4, 138) = 2.32, p =.06. The effect size of the difference
between stakeholder group and Total Score on the OPADQ was very small, as evidenced by
partial eta-squared, with stakeholder group accounting for 6.5% of the variance in Total Score.
Due to the nonsignificant result, a post-hoc power analysis was conducted for the previous
omnibus ANOVA. The observed power for this one-way omnibus ANOVA was determined to
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be 0.66, suggesting that if there were truly an effect of stakeholder group on Total OPADQ
scores, this result would be found 66.1% of the time.
Similar one-way ANOVAs were conducted to evaluate the difference between
stakeholder groups on the three subscales of the OPADQ. The independent variable in these tests
contained five levels: administrators, clinicians, advocates, consumers, and family members. The
dependent variable was the total score for each of the OPADQ’s three subscales, Utility and
Benefits, Obstacles to Success, and Decision-Making Capacity. The ANOVA for the Utility and
Benefits subscore, F(4, 138) = 2.21, p= 0.07, indicated there was no statistically significant
difference in mean UB scores among stakeholder groups [see Table 11]. Likewise, analysis of
variance on the Decision-Making Capacity subscale yielded no statistically significant
differences between stakeholder groups, F(4, 138) = 0.21, p = 0.93.
However, the omnibus ANOVA for the Obstacles to Success subscale was found to be
statistically significant, F(4, 138) = 2.93, p = 0.02. The strength of this relationship as evidenced
by partial eta-squared was found to be small with stakeholder group accounting for 8.1% of the
variance in Obstacles to Success scores. Follow-up tests were conducted to evaluate pairwise
differences among the means [see Table 12]. There was a statistically significant difference in
the means of OS scores between participants who were administrators and clinicians (mean
difference = 6.76, SE = 2.4) with clinicians having higher OS scores than administrators. There
were no statistically significant differences found between the family member, advocate, or
consumer stakeholder groups.
Interpretation. I hypothesized that there would be a statistically significant difference in
OPADQ scores between stakeholder groups. However, the results suggest no statistically
significant differences between the five groups on Total OPADQ scores, but there was an effect
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of stakeholder group on the Obstacles to Success subscale. Specifically, there was a statistically
significant difference between clinicians and administrators on measures of Obstacles to Success,
with clinicians identifying more obstacles than administrators.
Familiarity with Psychiatric Advance Directives (PADs)
To measure Familiarity with Psychiatric Advance Directives, respondents were asked to
rate how familiar they were with PADs prior to completing this survey. The familiarity item was
designed to measure both PAD awareness (e.g. Have you heard of PADs before?) and PAD
knowledge (e.g. Do you know how PADs are used in the community?). Respondents rated
themselves on a Likert Scale ranging from “I have never heard of PADs” to “I would consider
myself very knowledgeable on PADs and how they work in my community.” Overall, more than
half of respondents (59%) rated themselves as having some awareness but limited knowledge on
PADs work in the community. Fourteen percent (n=21) of respondents reported that they had
never heard of PADs before taking the survey, 16% (n=25) reported having heard of the term but
knowing little about them, 15% (n=23) reported knowing that PADs had something to do with
treatment planning, but would be unable to describe how they were used, and 13% (n=19)
reported being able to describe PADs to someone else, but being unsure of how they apply in the
community. However, 41% of respondents (n=61) rated themselves as “Knowledgeable on
PADs and how they work in the community.”
Familiarity with PADs was then entered as a continuous, dependent variable in multiple
ANOVAs with demographic information as the independent variables. No significant differences
were found in familiarity with PADs as a function of stakeholder group, profession, professional
setting, gender, education level, or race.
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Interpretation. I hypothesized that PAD familiarity would be low for all stakeholder
groups. The results of the survey suggest that more than half of respondents rated themselves
have being less than very familiar with PADs, which confirmed my hypothesis. I also
hypothesized that there would be a statistically significant difference in PAD familiarity between
stakeholder groups; however, no effects were found.
Experience with PADs
The second theme, Experience with PADs, asked respondents five questions regarding
how PADs were used in their current agency. The first question asked what percentage of
consumers in your agency had PADs. The second question asked whether PADs were discussed
with consumers. The third question asked if PAD forms were provided to consumers. The fourth
question asked if consumers were provided assistance in completing PAD forms, and the fifth
question asked whether there was written documentation of whether consumers have PADs.
Responses to question one were entered as a continuous ratio variable, while data for
questions 2-5 were entered as ordinal data. Histograms of responses suggest that data were not
normally distributed. The mean response (n=20) for the item “What percentage of consumers in
your setting have completed a PAD?” was 14.6 with SD of 15.97. The median response to this
item was 10%, suggesting that only a small number of consumers had completed a PAD.
Twenty-nine percent of respondents (n=44) reported that they did not know if PADs were
discussed with consumers in their agencies while only 16% reported (n=24) that PADs were
discussed with most consumers, and only 15% of respondents (n=22) indicated that PADs were
discussed with all consumers [see Table 6]. For the remaining three items regarding PAD
experience, the most common response was “Don’t know” (38% for “PADs are provided to
consumers”) [see Table 7]; 36% for “Consumers are assisted in completing PAD forms” [see
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Table 8]; and 31% for “There is written documentation of whether consumers have PADs” [see
Table 9]). Only 2.6% (n=4) respondents reported that PAD forms were provided to all
consumers, while only 4.6% of respondents (n=7) reported that all consumers were provided
assistance in completing PADs. Notably, “All consumers” was the second most frequent
response on the item of whether there was written documentation of PADs [see Table 9].
Interpretation. I hypothesized that Experience with PADs would be low for all
stakeholder groups. The results of the survey that a small percentage of consumers appear to
have completed PADs. Likewise, results indicated that PAD practices within agencies very
greatly. Some agencies consistently documented the presence of a PAD, while others appear to
provide minimal support for consumers wanting to complete a PAD. My hypothesis regarding
the lack of Experience with PADs was confirmed.
Qualitative strand results
The experience study is the secondary focus of this dissertation and addressed three
research questions:
RQ2: “What encourages the use of PADs in Virginia?”
RQ3: “What discourages the use of PADs in Virginia?”
RQ4: “What can be done to increase PAD utilization?”
During this phase of analysis, I used a qualitative lens to apply appropriate inductive techniques.
Participant characteristics
Data for the qualitative strand of this dissertation were drawn from two sources: nested
open-ended questions in the stakeholder survey and one-on-one telephone interviews with
clinicians who agreed to a follow-up through a recruitment request in the stakeholder survey.
Interviews were semi-structured in nature, but followed a general interview script [See Appendix
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B] to answer each of the qualitative research questions. The average time of the follow-up
interview was 22 minutes in length.
Demographic characteristics for respondents to the qualitative portion of the stakeholder
survey (N=150) were described in the previous section [see Tables 1-4]. Eight clinicians agreed
to participate in follow-up interviews; however, only 7 individuals met the inclusion criteria of
having heard of PADs prior to study recruitment. Five of these 7 participants worked in
outpatient settings, while two participants reported working in inpatient settings such as private
or state hospitals. Two interview participants were licensed as professional counselors (LPCs),
three identified as social workers (LCSW), one identified as a case manager, and one participant
was a psychiatrist (MD). Interview participants reported having careers in the mental health field
for 5-34 years, with the mean of 21 years of experience. Three participants were male, and four
were female. Six identified as White, and one participant identified as Asian.
Interview summary
PAD knowledge
All seven interviewees rated themselves as extremely familiar with PADs. Four of the
seven clinicians interviewed during this strand had been certified as Advance Directives
Facilitators through the Department of Behavioral Health and Disability services. This
certification requires 18 hours of class time, as well as the successful demonstration of
facilitation skills and PAD knowledge.
PAD Attitudes
Overall, interview participants expressed optimism for the potential value of PADs within
the mental health system. Six of seven interview participants expressed aspirational hopes that
every consumer of mental health services would eventually have a PAD. Two of the interview
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participants indicated their belief that PADs would be beneficial for everyone, including those
who did not currently have a psychiatric diagnosis. In these instances, the participants noted the
possibility of unexpected psychiatric incapacity due to unexpected medical issues or dementia
later in life. One participant said that she had completed her own PAD, and that the process had
facilitated a meaningful conversation with her family members about her desire for future
treatment. In this sense, she indicated that the process generated its own benefits even if she
never needed to make use of her PAD.
However, one participant indicated that he did not think PADs would be useful for all
consumers. This participant suggested that PADs would not be helpful for individuals who had
substance use issues or a dual-diagnosis. In these instances, this participant suggested that they
“wouldn’t be very useful and might be a way to avoid treatment.” When asked to elaborate, this
participant suggested that PADs would likely inhibit clinical decision-making, and force
treatment providers to seek out judicial authorization over objections.
PAD utilization
Each participant was asked how and when they had encountered PADs in their clinical
work. Only three of the clinicians reported encountering a PAD in the course of their work
outside of offering facilitation services. Of these three participants, no one reported encountering
a PAD at the time of a behavioral emergency. One clinician reported encountering a PAD prior
to a civil commitment special hearing, and another mentioned accessing a consumer’s PAD
during the course of an involuntary hospitalization. No participants had encountered a PAD at
the time of hospitalization to avoid involuntary treatment through the activation of the Ulysses
Clause. Interviews indicated that PADs are infrequently used in Virginia.
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Analysis Stages
Using NVivo 11 for Mac (2017), I employed the following methodology to answer the
qualitative research questions. First, the research team open-coded interview transcripts and
qualitative survey responses to find initial codes. During this initial phase, coders attended to the
text closely and considered to what extent the content provided an answer to the research
question. Interview transcripts were weighted more heavily; open-ended survey responses were
used to enrich the interview data and to provide multiple stakeholder perspectives.
Following this initial open coding stage, codes were reorganized based on similar
content. The research team paid particular attention to ensuring that each code emerged more
than once in the data. This prevented a single perspective, including those of the more heavily
weighted interviews, from dominating the common experiences across stakeholder perspectives.
In the next stage, horizontalization (Moustakas, 1994) was applied through which all codes
within a research questions were considered without regard to the frequency of references. In this
stage, the research team considered how each code uniquely contributed to the research question.
This yielded a set of categories, which were then organized into content related themes. In the
next step, the categories were abstracted into “content-characteristic words” (Elo & Kyngas,
2008, p. 111) that offered a general description of the phenomenon. These themes were then
organized and reported in a conceptual map.
Analysis details. As outlined in the previous section, the research team began by opencoding the open-ended responses and the interview transcripts. This phase of open coding
generated 190 initial codes. Following the initial codes, the research team reorganized the data
into 146 codes. In the next phase of axial coding, the 146 codes were organized into 20
categories. During the horizontalization phase, these categories were considered, regardless of
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the number of times they appeared in the data, based on how well they reflected the research
questions. Members of the research team were consulted to ensure trustworthiness. Four themes
emerged for RQ2; four themes emerged for RQ3, and two themes emerged for RQ4. Figure 2
depicts these themes in a conceptual map.
RQ2 Results
Related to the second research question (i.e., “What encourages the use of PADs in
Virginia?”), four themes were discovered: Encouraged by person-related benefits, Encouraged
by clinical-related benefits, Encouraged by PAD champions, and Awareness. Each theme is
described below.
Encouraged by person-related benefits. Participants indicated that there were two types
of benefits that encourage the use of PADs. The first type were the benefits to the person, namely
the consumer. These person-centered benefits included features such as personal-empowerment,
fostering autonomy, and giving voice to a person. One interview respondent pointed out that,
“[Consumers] feel good about the fact that they have an avenue to express their desires and their
preferences.” Another survey respondent stated, when it comes to a PAD, “you're your own
expert of yourself.” A third respondent suggested, “I think it's useful for everybody. I filled one
out, and I liked the conversation that it sparked with my family.”
Encouraged by clinical-related benefits. Participants identified a second type of
encouragement related to PAD benefits, namely clinical benefits. Both survey and interview
participants suggested that PADs should be encouraged because they could improve clinical
outcomes by informing clinicians of what works well in crisis situations. Another interviewee
suggested that PADs could also help with cultural understanding in clinical settings. She stated,
“When it comes to cultural issues—you know, different people have different ways of dealing
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with mental health and it’s not always through the same lens as a psychiatrist.” Other participants
identified the fact that PADs might even be preventative in that they help people to identify the
signs of crisis, or expedite the treatment process. One survey respondent stated that PADs could
“connect people with treatment, especially in times of crisis, and take out many middle steps, and
ensuring the client is getting care that they want, whether or not they can articulate it at that
time.”
Encouraged by PAD champions. Participants suggested that PADs were encouraged by
the presence of PAD champions. PAD champions could be clinicians, administrators, consumers,
or advocates. These PAD champions function within organizations to encourage the
incorporation of PADs into clinical practice. Champions also encouraged consumers to complete
their own PADs. Several interview respondents stated that they were champions in their
organization. One interviewee referred to herself as the “the golden child of Advanced
Directives” after becoming certified as a facilitator. Interestingly, several participants
commented that they were interested in finding a consumer champion who could speak to the
value of having a PAD. As one survey respondent suggested, “one of our peer support specialists
has been very instrumental,” and many other respondents in both sets of qualitative data
expressed a desire to identify just such a consumer champion.
Awareness. Awareness also emerged as an important encourager for PADs. Awareness
included the idea of knowing what a PAD was, how to complete one, and how they operate in
crisis situations. Both survey and interview participants suggested that awareness of PADs was a
critical enabling factor. To support this theme, a number of interview participants stated that
receiving training on PADs or facilitation made them more likely to discuss the tools with clients
and colleagues. One interview participant stated, “I was trained as a facilitator and was involved
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in the committee to try to bring the Advanced Directives more into client awareness and staff
awareness.” Another survey respondent suggested that with “ongoing exposure to the idea…
People get more familiar with [PADs].”
RQ3 Results
Four themes -- Not knowing, Lack of capacity, Client-related obstacles, and Power
struggles -- emerged that were related to the research question: “What discourages the use of
PADs in Virginia?” Each theme is described below.
Not knowing. Many participants endorsed the idea that not knowing about PADs was a
significant discourager. One respondent stated that PADs were discouraged by
“Ignorance/unfamiliarity, especially on the part of providers.” Another interview respondent who
worked in an inpatient setting stated, “I don’t think people are aware of psychiatric advanced
directives to be quite honest.” Another survey respondent pointed out that, “I think people do not
know what PADs are or how to explain their purpose, and how or when to discuss this with
services users. A lot of the time it’s our own limitations on knowledge that hold us back.” In
fact, many participants stated that they themselves did not know enough to describe how PADs
should be used in their community.
Lack of resources. Many participants identified a lack of resources as a significant barrier
to PAD utilization. These scarce resources included time, trained personnel, facilitation services,
and reimbursement for PAD completion. One participant commented, “There are so many other
higher prioritizations coming across our desk between… meeting [a person’s] needs first and
foremost, but then the various regulatory bodies wanting their form of paperwork their way.”
Another identified resource issue was the inability to access a PAD in a crisis situation if the
person or the agent did not have a copy of the PAD on hand. Several respondents noted that the
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PAD registry was not terribly useful in practice because, “it is not helpful to ensure [the PAD] is
enforced.”
Client-related obstacles. Some participants had concerns about the ability of consumers
to understand and complete the complicated 10-page PAD form. Several survey respondents
stated that the legal language in the document was difficult for clients to comprehend. Other
survey and interview respondents cited a lack of demand from consumers. As one survey
respondent wrote, “Clients don’t want them.” Related to a lack of demand from consumers, both
survey and interview participants cited comprehension difficulties that stemmed from the clinical
features of the behavioral health disorders. As one interview participant stated, “We are talking
about groups of people [who] may have some very significant impairments and disabilities.”
Other clinicians suggested that consumers would not have enough social support to identify an
appropriate agent. Another interviewee stated, “It’s been hard for quite a few of our clients to
identify an agent that they really trust or that even have access to.”
Power struggles. Participants suggested that issues of control and power also thwart the
utilization of PADs. At the heart of these power struggles were skeptical attitudes towards the
intentions and behaviors of other stakeholder groups. A number of consumer respondents
suggested that they believed that clinicians would simply ignore their instructions while one
clinical respondent mentioned, “when a patient has more control over what they choose… the
doctor may feel like their hands are tied.” The idea that a PAD would tie a clinician’s hands also
came up during several interviews. An interviewee pointed out that in the one clinical case where
he had seen with a PAD, the document’s instructions were contraindicated by standard medical
advice. The respondent summarized these concerns by stating: “[The PAD] wasn’t very well
written and it didn’t make great sense and the treatment team had major problems with it.” This

89
interviewee went on to suggest that PADs could even lead to treatment delays because doctors
would be forced to seek judicial authorization to override contraindicated treatment instructions,
which can take several days to obtain.
RQ4 Results
Two themes -- Need for education and training and Technological solutions – emerged
that were related to the research question: “What can be done to increase their utilization?”
Each theme is described below.
Need for education and training. Given that a lack of knowledge was identified as a
discourager and the possession of knowledge was identified as an encourager, the theme of
needing more education and training emerged in the data as a strategy for increasing their use.
Three interviewees suggested that it would be particularly helpful to have a peer educator who
could speak to other clients about the benefits of PADs. As one interview participant suggested,
“[We want to find] someone whose actually had a successful usage of their PAD that, you know,
that kind of played out the way they wanted it and they had identified on their PAD and how that
was beneficial and helpful.” Likewise, other participants indicated a need to train and educate
mental health and medical staff in hospitals and organizations. Several participants stated that
education was particularly needed in hospitals among the emergency room staff. As one
interview participant (1) pointed out, “At least in the hospitals, we all are educated on advanced
directives and went to a training for it, so, you know, why not have that same type of training
like in hospitals and like in the community services board or behavioral health systems?”
Technological solutions. Several participants proposed technological solutions to some of
the system barriers that present access issues. One interview participant suggested distributing
bracelets containing digitized medical records that could be accessed in crisis situations. This
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participant stated that these USB drives could contain a copy of the PAD. This participant stated
that consumers could “have a USB drive on that you could plug in and read the information they
wanted a clinician to know if they showed up somewhere in an emergency.” Another interviewee
pointed to the need to share data across systems. This interviewee participant suggested that
PADs might be more readily utilized if it was possible for a crisis clinician to “pick up the
phone, enter in their ID, and their entire medical record flows into the provider’s computer, in
which could include the PAD.”
Mixed methods results
In keeping with the convergent parallel mixed methods design, data were analyzed
separately and merged at the level of interpretation to answer a mixed method research question
(RQ5). This mixed method analysis was guided by two sensitizing questions: (1) to what extent
do the qualitative and quantitative results converge, and (2) in what ways do they diverge. In
order to perform the most robust analysis possible, I shifted between quantitative and qualitative
lenses.
Quantitative lens on mixed data
Following Teddlie and Tashakkori’s (2009) mixing procedures outlined in the previous
chapter, I initially quantitized my qualitative data and then compared it to the quantitative data
set. To do this, 7 new dichotomous variables were created for each of the qualitative themes
addressing the encouragers and discouragers. The final two themes of ways of increasing PAD
utilization were not present as items in the QUAN strand, and thus did not have a basis for
mixing at the level of interpretation. Among the remaining seven qualitative themes, if a theme
was presented in a respondent’s case, that person was given a ‘1’; if the theme was not present,
the person assigned a ‘0’. This created a new data set of variables. These quantitized qualitative
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data were correlated with the respective subscale scores on the OPADQ. The encouragers themes
(RQ2) were correlated with the Utility and Benefits (UB) subscale scores, and the discouragers
(RQ3) were correlated with the Obstacles to Success (OS) to subscale scores.
No statistically significant relationships were found between the quantitized qualitative
variables and the UB and OS subscale scores (see Tables 13 &14), suggesting that the study
strand results diverged when viewed quantitatively.
Qualitative lens on the mixed data
In the next phase, the quantitative and qualitative strands were mixed through a
qualitative lens. Although the attitudinal items in the OPADQ did not entirely align with the
qualitative research questions, several themes in the qualitative data also emerged in the
quantitative data, suggesting convergence between the strand results. For RQ2 (“What
encourages PADs in Virginia?”) all four themes (Awareness of PADs, PAD Champions, Clientrelated Benefits, and Clinical Benefits) converged with items found in the quantitative results
that had lower standard deviations across respondents. These points of intersection as viewed
through the qualitative lens were displayed in joint table (see Table 15). Similarly, convergent
data was also identified across the strands for RQ3 (“What discourages PADs in Virginia?”)
Each of the four themes identified for RQ3 (Lack of awareness, Lack of Bandwidth, Power
Struggles, and Client-related Obstacles) were present among items in the quantitative results.
These intersections were identified by having lower standard deviations in mean scores. These
convergent QUAN and QUAL results were depicted in a joint display table of stakeholder survey
variables and the qualitative themes (see Table 16).
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Metainferences of mixed data
As suggested by Teddlie and Tashakkori (2009), gestalt-shifting between the qualitative
and quantitative lenses enabled the drawing of meaningful metainferences across the strands. By
iteratively comparing the results, additional insights were generated from the original data sets.
Metainference 1. Clinician advocates as PAD champions. During the interview portion
of the QUAL strand, several participants shared that they were certified as PAD facilitators.
Certification as a facilitator appeared to be a specific way in which individuals served as PAD
champions within their organizations — a theme that emerged in the QUAL strand. While I did
not ask survey participants if they were facilitators, participants were permitted to indicate a
secondary stakeholder group in the demographic section of the online survey. Seventy-three
participants (48%) selected “Advocate” as a secondary stakeholder choice. Although being a
PAD champion and identifying as an Advocate may differ in meaningful ways, for instance, a
person could champions PADs for liability reasons rather than for the empowerment of
consumers, this secondary identity could be a useful proxy for drawing metainferences.
To explore the dimension of PAD champions in the survey results, I compared mean
scores for individuals who identified as Advocates and those who did not. Statistically significant
differences (t = -2.00, p = .047) were found between the advocates (M = 69.7; SD = 9.15) and
the Non-advocates (M = 66.68; SD = 8.51) on the UB subscore (See Table 17). Post hoc Tukey
tests of pairwise differences suggested that these variations were especially pronounced among
clinicians. Non-Advocate clinicians (n=38; M = 63.87; SD = 8.68) scored significantly lower on
the UB score (t = -2.091, p = .04) in comparison to Clinician Advocates (n=14; M = 69.43; SD =
7.98) [see Table 18 &19].
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Interpretation. In general, respondents who identified as Advocates tended to have higher
scores on the UB subscale. Based on these data, it appears that when people see themselves as
advocates within the mental health system, they view PADs more favorably than those who do
not see their role as that of an advocate. This difference is particularly pronounced among
clinicians who strongly endorsed empowerment as a reason for using PADs in the community.
Metainference 2. PAD Awareness is associated with higher Utility and Benefit
subscores. Another relevant area of intersection between the QUAN and QUAL results involved
the concept of PAD Awareness. PAD Awareness emerged twice in the QUAL strand, first as a
theme in RQ2 (“What encourages PADs in Virginia?”) and then again as a theme in RQ3 (“What
discourages PADs in Virginia?”). PAD Awareness also emerged in the quantitative strand
through the ordinal variable of PAD Familiarity (“Never heard of PADs” to “Knowledgeable on
PADs and how they work in my community”). The variable of PAD Familiarity was constructed
to measure both knowledge and awareness. For instance, a person could endorse “I’ve heard of
the term, but knew little about them” (e.g. awareness, but not knowledge) or “I would be able to
describe PADs to someone else, but am not sure how they apply in my community” (e.g.
awareness and some knowledge).
To evaluate the dimensions of PAD Familiarity and PAD Awareness, I compared the
OPADQ scores of survey respondents based on their self-reported familiarity [see Table 20].
Statistically significant differences based on familiarity were found among UB scores (F(133, 4)
= 3.48, p = .10). Post hoc tests indicated significant differences between respondents with
Awareness/Some knowledge (e.g. “I knew PADs had something to do with treatment planning,
but would not be able to describe how they were used” {n=20; M = 63.15; SD = 9.81}) and those
who reported being Very Aware/Knowledgeable (n=60; M = 70.9; SD = 8.51) and between those
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with Awareness with Minimal Knowledge (“I’ve heard of the term but knew little about them”
{n=24; M = 66.5; SD = 6.19}) and Very Aware/Knowledgeable Respondents (n=60; M = 70.9;
SD = 8.51).
Interpretation. In general, respondents with more knowledge scored higher on the UB
subscale, indicating that knowing more about PADs appeared to increase a participant’s belief
that these tools had greater utility and benefits. In other words, the QUAN and QUAL strands
appear to converge around the notion that knowledge was a mediating factor in a respondent’s
positive perceptions of PADs.
Limitations
Although this study was the first of its kind in Virginia, there were limitations to the
generalizability of this research. One limitation is the relatively small sample (n=150), which
yielded low power in several inferential tests. Other limitations include high rates of attrition
during the administration of the stakeholder survey. While the OPADQ reports strong
psychometrics, over 125 participants did not complete the full battery of questions. These
incomplete scores were not included in the final data set. It is possible that the conclusions drawn
from these data were based on either very interested or highly motivated study participants rather
than the general stakeholder population. Another possible limitation is the fact that many of the
survey participants indicated that they had either no or minimal knowledge of PADs prior to the
survey. Although a lack of knowledge of the study topic among respondents has meaningful
implications for evaluating the success of the implementation process over the past seven years,
it does raise concerns regarding the reliability of these data.
Another potential limitation to this study was a lack of alignment between the
quantitative and qualitative strands. The quantitative strand involved an attitudinal instrument,
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while the qualitative strand considered more process-oriented aspects of the research. As such,
the mixed analysis – particularly the quantizing of the qualitative data – did not generate any
statistical correlations. It is possible that the quantizing of the qualitative data would have
yielded more statistically significant convergence if the quantitative instrument and the
qualitative questions were better aligned.
Likewise, the interviews were limited in number and only provided rich descriptions of
the phenomenon from the perspective of one stakeholder group. Indeed, in the QUAL analysis,
the stakeholder survey responses, which came from all five stakeholder groups, were weighted
less heavily than the clinician interviews. Although this methodological choice was made based
on the assumption that open-ended survey questions generated less useful pieces of data for
qualitative analysis (Creswell & Plano-Clark, 2011), it does raise the prospect that the qualitative
themes were biased towards the clinician perspective.
Because this research was designed as a mixed methods study, these concerns were
largely neutralized through the triangulation of data. For instance, although the interviews were
few in number and conducted only with clinicians — the QUAN strand coupled with the nested
qualitative questions (N=150) made it possible to gather representative perspectives from all of
the stakeholder groups. The study’s key findings, which are discussed in Chapter 5, emerged
across the strands and through multiple data sources. In this sense, the mixed methods approach
offsets the weaknesses generated by the stands in isolation (Creswell & Plano-Clark, 2011).
Overall, the legitimization strategy of triangulation generated a more complete understanding of
PADs in Virginia.
The mixed methods approach also enabled the generation of metainferences across the
stands. Examined in isolation, the lack of knowledge among respondents might pose a threat to
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the study’s validity. Because there was a qualitative strand, I was also able to identify that lack of
awareness was a theme that emerged in the RQ4 as a discourager. In other words, the lack of
familiarity and low rates of consumers with PADs (M=14.6, SD=15.7) in the quantitative strand
provided data triangulation for the qualitative theme. The issue of PAD knowledge among
respondents once again highlights how the mixed method approach enabled a more complete,
valid picture to emerge.
Future directions
Although this study provided a more complete, valid and clinically useful understanding
of PADs in Virginia, there remains abundant opportunity for future research in this area. As
mentioned in the mixed methods results section, the attitudinal instrument of the OPADQ did not
entirely align with the experience-oriented qualitative questions nested in the stakeholder survey
and posed to interview participants. Building a better instrument to measure not only stakeholder
attitudes, but also some of the process obstacles, would likely improve future research on PADs
in Virginia.
Future studies might also disentangle why it is that consumers of mental health services
are not interested in PADs. At present, all implementation efforts have started from the
assumption that PADs were useful, and therefore would be desired by consumers. However, this
study identified the surprising fact that consumers may not be interested in completing a PAD,
even if they have access to facilitation. To fully understand the low PAD utilization rates around
the state, it would be beneficial to explore this factor in more depth through further mixed
methods research.
Another area of future research would be to explore the clinician-advocate group in
further depth. This hybrid identity emerged unexpectedly, and would be worth studying in the
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future. Additional insights into this stakeholder group could provide actionable strategies for
PAD utilization, and more broadly, a meaningful contribution to the literature of the helping
professions, such as counseling, which have formally adopted advocacy as a component of
training programs (Toporek et al., 2010). Addressing the limitation of the current study, crafting
more effective instruments, and building stronger studies could yield relevant implications for
policy makers and stakeholders around the state.
Conclusion
This study found evidence that PADs remain limited in their use in Virginia. The study
also suggested that there was not widespread disagreement among stakeholder attitudes.
However, there do appear to be significant barriers that remain to completion and utilization
across the state. These results are discussed in depth in the following chapter with an eye towards
how this study is positioned within the context of previous research on the topic.
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CHAPTER 5

Discussion
Introduction
Since the 1980s, psychiatric and legal literature have proposed the idea of the psychiatric
will, or the psychiatric advance directive (PAD). PADs were theorized as a way to empower
individuals, improve clinical outcomes, and reduce coercion (Scheyett et al., 2007; Swanson,
Swartz, Ferron et al., 2000). In the 1990s, the federal government passed legislation to support
the use of PADs among mental health consumers. In 2007, Virginia’s General Assembly enacted
the Healthcare Decisions Act (HDCA), which enabled individuals to craft legally-binding
advance care planning documents. Since that time, Virginia’s Commission for Mental Health
Reform has promoted PADs as part of a series of reforms to the mental health care system that
advocates say make the system more consumer-oriented. As part of this initiative, the
Commission has funded the Virginia Advance Directives, which offers education and training on
PADs to healthcare professionals and oversees outreach to consumers, community services
boards, and advocacy groups throughout the state.
The convergent parallel mixed methods study discussed in this dissertation had four
primary goals. The first goal was to understand how PADs were currently being used in the state
(RQ1), the second goal was to clarify the enabling factors and obstacles that influence PAD
utilization in the state (RQ2 & RQ3), and the third goal was to identify strategies for increasing
the use of PADs in the future (RQ4). Finally, the fourth goal was to understand to what extent
the quantitative and qualitative strands converged and diverged (RQ5). Overall, this research
study achieved these ends. Bolstered by the mixed methods design that guided the process of
data collection, analysis, and interpretation, this dissertation provided a valid, more complete
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understanding of PADs in Virginia. In this conclusion chapter, I discuss key findings and
connect them to the broad body of prior research on PADs. I also discuss the methodological
implications of this study, and conclude with a discussion of what these findings mean for the
field of counselor education.
Key Finding 1. Stakeholders agree in their attitudes towards PADs. At the outset of this
study, I hypothesized that there would be statistically significant differences between stakeholder
groups on each of the subscales of the OPADQ. This hypothesis was based on prior research,
which had found statistically significant differences between stakeholder groups when asked
about their attitudes and perceptions of barriers (Swanson, Swartz, Ferron et al., 2006; Wilder et
al., 2013). In previous literature, clinicians held less positive attitudes towards PADs and
perceived more barriers to use compared to other groups, particularly compared to consumers
(Srebnik et al., 2003; Swanson, Swart, Ferron et al., 2006). The results of this study contrast with
previous literature in that PAD Attitudes, as measured by the OPADQ, were consistent across
stakeholder groups.
The only statistically significant difference among the stakeholder groups identified in
this study was in the area of Obstacles to Success. This finding suggests that, on aggregate, this
study is consistent with previous literature on PADs in Virginia (Wilder et al., 2013). Post hoc
results indicated that this difference was between clinicians and administrators. This finding was
also consistent with the previous literature, which had identified key differences between
clinicians and administrators on perceptions of PAD barriers (Wilder et al., 2013). Wilder et al.
(2013) had previously hypothesized that this difference was due to the fact that administrator
attitudes often reflect organizational values rather than actual practice. A clinician, on the other
hand, may be less aware of the organizational values, but more aware of the practical barriers. To
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support this explanation of key differences, numerous clinician respondents cited the burden of
large caseloads and a lack of time in their responses to the qualitative questions on PAD barriers.
It is likely that this difference in perspective between administrators and clinicians (e.g.
aspirational versus practical, respectively) could explain the statistically significant difference
found in the survey results.
Surprisingly, no statistically significant differences were found between the clinician and
the consumer stakeholder groups as hypothesized in the planning stages of this study. This
hypothesis was based on previous studies that found significant differences between clinicians
and consumers (Swanson, Swartz, Ferron et al., 2006; Wilder et al., 2013). However, consumer
participation was low in this study, which meant that the study’s inferential tests were
underpowered for identifying statistically significant difference between these groups. Given that
the Wilder et al. (2013) study suffered similar limitations, one could conclude that consumers of
mental health services in Virginia remain a challenging group to recruit for research.
Another possible explanation for the lack of attitudinal differences between clinicians and
consumers could be due to the distinctive feature of this study’s sample. In general, most of the
previously conducted studies on PADs have involved higher proportions of psychologists and
psychiatrists in comparison to this study (Elbogen et al., 2003; Swanson, Swartz, Ferron et al.,
2006). Prior research has highlighted significant differences in PAD attitudes between highstatus (psychiatrists) and low-status (counselors and social workers) mental health professionals
(Van Dorn et al., 2006). This study’s clinician sample was primarily comprised of licensed
professional counselors and social workers, which could account for why this study’s results
were inconsistent with previous research on PAD attitudes.
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A third possible explanation for the lack of statistically significant differences between
stakeholder groups could also be attributed to variations in mean scores over time. Although
Wilder et al. (2013) is the only other study on PADs in Virginia, it would be difficult to compare
mean scores with this study due to differences in study instrumentation. However, comparisons
can be made to other studies that have made use of the OPADQ. For instance, comparing the
mean item responses for each subscale found by O’Connell and Stein (2005) (Obstacles to
Success=2.78, SD=.48; Utility and Benefits=3.56, SD=.42; Self-Determination=3.20, SD=.50),
this study’s clinician sample had comparatively lower mean item responses. Having a lower
mean item responses (Obstacles to Success=2.55, SD=.40; Utility and Benefits=3.31, SD=.45;
Self-Determination=2.57, SD=.21) might account for the lack of statistically significant
differences between stakeholder groups in this study, which sets the results apart from previous
literature on the topic.
Key Finding 2. PAD utilization remains low. Overall, this study indicated that
utilization of PADs remains low in Virginia. During the study’s seven interviews, only 3 of the
participants reported encountering a PAD in the course of their work as clinicians. The
remaining 4 interviewees, although familiar with the tools, reported no clinical experience with
PADs. Similar results emerged in the QUAN strand, with the stakeholder study indicating that
PADs were uncommon among consumers. Respondents reported a mean of 14.6% (SD = 15.88;
median=10) of consumers having PADs within their agencies. These findings were consistent
with previous research, which has found low PAD utilization rates in other states (Srebnik et al.,
2003; Swanson, Swartz, Ferron et al., 2006; Swanson, Swartz, Hannon et al. 2003).
However, this study’s results were inconsistent with the Wilder et al. (2013) study in
Virginia, which had found that that 29% of consumers in the state had completed a PAD. A
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direct comparison of reported utilization rates between Wilder et al. (2013) and this study raises
the alarming prospect that there were currently fewer PADs in use than there were in 2013. To
untangle this unexpected finding, quantitative and qualitative data were triangulated. As
mentioned previously, only 3 interview participants reported having encountered PADs during
the course of their clinical work. The remaining 4 clinicians, who had an average career length of
21 years, had never encountered a PAD in their work – a result that could indicate that the
Wilder et al. (2013) finding of a 29% utilization rate is misleading. Without a reliable baseline
measurement, it would be impossible to conclude whether utilization has decreased or not.
Key Finding 3. PAD awareness remains low. Overall, this study indicated that lack of
PAD awareness was common among stakeholders around the state. As reported in Chapter 4,
58.7% of respondents reported “Never heard of PADs” or “I have heard of PADs but know little
about them” of PADs. Lack of awareness of PADs also emerged in the qualitative data source.
Surprisingly, when compared in aggregate to the results of Wilder et al. (2013), this study’s
results indicated a decline in PAD awareness over the past several years. Specifically, more
study respondents indicated low awareness (“Never heard of PADs” or “I have heard of PADs
but know little about them”) than in Wilder et al. (2013), in which a strong majority of
respondents reported that they were familiar with PADs. Again, evidence of a decline in PAD
knowledge was unexpected given that the state has invested in a formal implementation process
over the past several years (Zelle et al., 2015). Once again, these results must prompt questions
about the reliability of the baseline measure from the Wilder et al. (2013) study given that,
typically, more training means more awareness.
If the awareness decline were taken at face value, however, one contributing factor could
be that implementation has not kept pace with employee turnover within the CSB system. It is
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plausible to have trained a majority of staff members only to have those employees leave the
organization and, in so doing, take with them the organization’s institutional PAD awareness.
Again, triangulating the quantitative results of a decline in knowledge with the qualitative
interviews, the interview transcripts supported the idea of high staff turnover as an explanation
for the decline in awareness over time.
Key Finding 4. PAD attitudes and awareness are related. Determining whether low
utilization was due to lack of awareness or another factor is beyond the scope of this dissertation.
However, it is clear from the mixed methods design of this study that awareness played some
role in mediating the PAD attitudes. During the mixed methods analysis portion of this study, a
metainference suggested that higher familiarity with PADs was associated with more positive
attitudes. In general, this finding was consistent with the bulk of previous studies examining the
relationship between knowledge and attitudes (Elbogen et al., 2003; O’Connell & Stein, 2005;
Swanson et al., 2003). Given disparities in awareness, continued training of all stakeholder
groups appeared critical to future implementation efforts.
Key Finding 5. We may need PAD nudges. Three of the interview respondents made
mention that even when their organizations offered free facilitation services, few or no
consumers appeared interested in completing a PAD. Several survey respondents also
commented simply that consumers “don’t want PADs.” This apparent lack of consumer interest
in PADs set this study in sharp contrast to previous research on PADs (Swanson, Swartz,
Elbogen, et al., 2006; Zelle et al., 2015a). Nearly all prior studies have pointed to high latent
demand among consumers; moreover, researchers have suggested that when provided with
facilitation services, consumers were much more likely to complete the documents. In a
randomized controlled trial of facilitation in North Carolina, 61% of consumers elected to
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complete a PAD when provided with facilitation as compared to 5% who were not offered this
service (Swanson, Swartz, Elbogen, et al., 2006).
Based on both the qualitative themes and low utilization results from the QUAN strand, it
would be easy to conclude that perhaps consumers were not as interested in PADs as prior
researchers had suggested (Srebnik et al., 2003; Swanson, Swartz, Hannon, et al., 2003).
However, a more nuanced interpretation of this study’s results might suggest that, given the
many challenges facing mental health consumers, completing a PAD was a low priority.
Although the current integrated form used in Virginia was crafted at a fourth-grade reading level,
the 10-page legal document requires at least several hours to complete, possibly spread over
multiple appointments to which a client may or may not have transportation. Add in the
diagnostic features of serious mental illness (e.g. impaired executive functioning and limited
future-oriented insight), and to some potential consumers, completing a PAD might seem nearly
impossible. Indeed, prior studies on barriers have made similar arguments (Shields et al., 2014;
Van Dorn et al., 2008).
Clarifying what could be done about consumer ambivalence for PADs would be a useful
area for future study. One possible intervention for addressing low consumer demand for PADs
can be drawn from the field of behavioral economics, which has coined the term “nudges” to
refer to the use of subtle biases by policy makers to influence individual behavior. The concept
of the “nudge” stems from the behavioral economics principle that people often fail to act
“rationally” by making choices that are contrary to their own best interest. Examples of
“irrational behavior” might include failing to save for retirement, or continuing to smoke despite
the health consequences. In the case of this study, not completing a PAD when one has a serious
mental illness and access to facilitation services might be considered an “irrational behavior.”
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To promote better (e.g. more rational) choices, behavioral economists recommend that
policy makers introduce “nudges” into system processes to help consumers make choices that are
in their best long-term interest (Thaler & Sunstein, 2003). The qualitative interviews offered
some options of PAD nudges. One nudge would be to find a charismatic peer champion who
could encourage other consumers to adopt PADs rather than relying on clinicians or case
managers to make the case. Another nudge would be to streamline Virginia’s electronic health
record system to allow for greater access to medical files such as PADs by emergency
department staff and crisis evaluators. A third option would be to create a PAD template that
defaults to a consumer’s crisis or Wellness Recovery Action Plan (WRAP). Most crisis plans
contain all of the information needed to complete a PAD; plus, crisis plans include the added
“nudge” of the requirement from Medicare and Medicaid that they be completed for an agency to
be reimbursed. Although some of these nudges are more practical than others, it would likely be
worthwhile for policy makers to be open to investing in ways that make it easier for people to
compete these advance planning documents. Given the human impulse to behave irrationally
discussed above, training and education simply might not be enough.
Key Finding 6. CSBs might not be the optimal setting for implementation. Although
this study suggests that PADs have not reduced coercive treatment in the way that they have
been theorized to do (e.g., no one in the study reported encountering a PAD at the time of a
hospital admission), there is still reason to be optimistic that options such as the Ulysses Clause,
which grants voluntary consent to hospitalization even over objection, could reduce reliance on
coercive treatment (Bonnie, 2012). However, this study’s findings cast doubt on the Community
Service Board (CSB) system’s capacity for achieving this goal. In multiple interviews, study
participants emphasized their strong desire as administrators and clinicians to “do the right
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thing.” However, given the clinical demands and high staff turnover rates, “doing the right thing”
has become increasingly difficult for those working in community mental health. As one
interviewee put it, “PADs are just one more unfunded mandate” for already over-extended CSBs.
One interview subject shared that she had “over 100 clients on her caseload,” and that she
“doesn’t have the time to do my ISPs and my quarterly reports.” Both comments were indicative
of the lack of capacity for undertaking PAD implementation within the CSB system.
Unfortunately, the issue of CSBs being over-extended is likely to get worse before it gets
better. In 2016, the General Assembly passed what has been dubbed the Virginia Behavioral
Health System Transformation Excellence and Performance (STEP Virginia) legislation, which
increases the number of mandated services at CSBs to include primary care screening, same day
access to services, and outpatient treatment (Department of Behavioral Health and Disability
Services, 2016). Researchers studying mental health policy in Virginia have anticipated
significant workforce shortfalls due to the newly mandated STEP Virginia requirements
(DBHDS, 2016). If the ability of CSBs to implement PADs is low now, it will likely only get
worse with this requirement of expanded services. Thus, the findings of this study – particularly,
from the qualitative interviews – called into question whether the CSBs were the best venues for
achieving the state’s implementation goals (Zelle et al., 2015).
If outpatient CSBs are not the appropriate context, then where else could PAD
implementation occur? One option would be to incorporate PAD facilitation at the time of
discharge from an acute hospitalization. I inquired about this solution during the interviews, and
most participants indicated that patients were rarely stable enough at the time of discharge to
complete a PAD. An alternative that emerged during interview recruitment was to promote
PADs within the state’s crisis stabilization units (CSUs). The CSUs in Virginia are used as
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alternatives to hospitalization for low-acuity patients or as step-down facilities for high-acuity
patients to ease the transition back into the community. CSUs are residential, but not locked
facilities. Consumers can remain in treatment for up to two weeks. The longer window of
treatment as well as the CSU emphasis on crisis management and relapse prevention might
provide the ideal setting for discussing and completing PADs with consumers. One CSU
employee, who did not meet inclusion criteria for a follow-up interview,3 expressed his belief
that PADs would work well at his CSU setting, and requested additional information on the
tools. A useful future pilot study might examine the use of CSUs for PAD implementation in
Virginia to see if this setting offered a more appropriate context than the outpatients CSBs.
Key Finding 7. Clinician advocates as a new stakeholder group. In the design of the
online survey instrument, participants were permitted to identify a secondary stakeholder group
in addition to their primary group affiliation. Fourteen study participants identified themselves as
clinician-advocates. Compared to participants who only identified as clinicians, clinicianadvocates held notably different attitudes towards PADs. Post hoc testing suggested that
clinician-advocates viewed the utility and benefits of PADs more favorably than their clinicianonly counterparts.
Prior literature on PADs has drawn strong boundaries between stakeholder groups
(Swanson, Swartz, Hannon, et al., 2003). This study’s findings revealed the possibility that these
affiliations were more complex than previous researchers posited. Based on the data collected for
this study, it would be difficult to say why these respondents viewed themselves through an
intersectional lens rather than through their license or job description. However, it was clear that

3

Individual was excluded from the follow-up interviews because he reported never having heard of a
PAD before the survey, and thus could not provide answers to the IRB-approved interview questions.
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viewing oneself as an advocate and a clinician positively influenced participants’ attitudes
towards PADs. In the future, it would be worthwhile to explore this topic to understand key
features of clinician-advocates. Understanding more about the clinician-advocate identity would
likely be a meaningful contribution to the social justice advocacy literature, as was introduced in
Chapter 2 of this dissertation.
Methodological implications
Only two previous studies on PADs have made use of the mixed methods approach
(Scheyett & Rooks, 2012; Srebnik et al., 2003). Both studies, however, failed to formally mix the
strands during the analysis or interpretation phase. In other words, their study was mixed
methods only in the sense that both qualitative and quantitative data were collected under the
umbrella of a single study. Due to these methodological shortcomings, the research of this
dissertation is possibly the first mixed methods study of PADs in the United States.
The particular strategy adopted for this dissertation was also novel within the field of
mixed methods research. Generally, mixed methods research reports findings in the format of a
joint display table of themes and results (Creswell & Plano-Clark, 2011). Teddlie and Tashakkori
(2009) recommended either transforming qualitative data into quantitized variables or qualitizing
quantitative data. In other words, mixed methods researchers elect to do one or the other, but
generally not both. However, the analysis phase of this dissertation involved a two-step data
transformation process, which enabled interpretation of mixed data through using both
quantitative and qualitative lenses.
This study benefited greatly from the second round of data transformation. The iterative
analytic process generated two key meta-inferences: the first meta-inference suggested that
higher familiarity with PADs was associated with more positive attitudes; the second meta-
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inference pointed to a statistically significant difference between clinicians and the clinician
advocates. In the absence of the iterative mixing process, these novel insights would otherwise
not have emerged. The iterative analytic procedure undertaken in this dissertation demonstrates a
novel way to bridge the quantitative-qualitative research divide that can sometimes plague
conversations about mixed method design (Creswell & Plano-Clark, 2011). Likewise, the twostep mixed analytic procedure format provides evidence that this approach works rather well
when trying to evaluate public policy.
Implications for Counselor Education
In Chapter 2 of this dissertation, I pointed out that PADs do not appear in the broader
counseling literature. Although the key findings of this study are relevant to these other
disciplines, the unique characteristics of the sample also suggest that this study offers a novel
glimpse into the world of counselors working in Virginia’s CSB system. In particular, this study
identified an emergent professional identity – that of the clinician-advocate — among Virginia’s
master-level mental health professionals.
Within the field of counseling, much has been said about the role of counselors as
advocates (ACA, 2014; Lewis et al., 2012; Toporek et al., 2010). Likewise, the Counselor
Education literature has extensively examined advocacy within the context of training programs
(Chang, Crethar, & Ratts, 2010; Osborne, Collison, House et al., 1998). However, less has been
written regarding the extent to which practicing professional counselors in the community
ascribe to the role of an advocate. The findings of this study point to the conclusion that indeed
some practicing counselors in community mental health settings in Virginia see themselves as
both clinicians and advocates. The advocate-clinician identity had a statistically significant
impact on perceptions of utility and benefits of PADs. Although this notion of the clinician-

110
advocate is tangential to the research questions of this study, the concept calls out for further
exploration. Understanding the extent to which practicing counselors view themselves as
advocates has implications for the overall efforts on the part of counselor educators to develop
advocacy competencies during training programs.
Conclusion
In this chapter, I discussed the key findings of this dissertation and explored how the
results compared to previous literature on the topic. I identified eight key findings and
highlighted the study’s implications for methodology and the field of Counselor Education. By
utilizing multiple sources of data in a convergent parallel mixed method design, I was able to
provide a more valid, complete understanding of the attitudes towards, and implementation of,
PADs among various stakeholder groups in Virginia. By gathering in-depth interviews with
clinicians and open-ended responses from other stakeholder groups, I was also able to evaluate
previous implementation efforts and make suggestions on what could be done to foster the use of
PADs here in the state.
Although the study does not offer an encouraging picture of widespread PAD utilization
across the state, this study identified a number of critical barriers to realizing the theorized
potential of these legal tools. Ultimately, understanding the complex nature of these barriers is
critical to addressing them in the future. This dissertation offered new insights on what works,
what does not work, and why. It also identifies what we might do differently in the future to
increase the number of mental health consumers in the state who have access to these
empowering tools.
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Table 1
Survey Respondent Demographics by Gender
What is your gender?

Missing
Total

Male
Female
Prefer to self-describe
Prefer not to say
Total
System

Frequency Percent Valid Percent
25
16.4
18.1
110
72.4
79.7
1
.7
.7
2
1.3
1.4
138
90.8
100.0
14
9.2
152
100.0

Cumulative
Percent
18.1
97.8
98.6
100.0
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Table 2
Stakeholder Group Demographics by Race/Ethnicity

Group

Total

Which of the following best describes your racial
background?
Prefer not
White
Black
Asian
Other
to answer
Consumer
19
0
0
1
0
Administrator27
3
1
0
0
Family
4
0
0
0
1
Clinician
63
5
0
3
0
Advocate
7
2
0
0
2
120
10
1
4
3

Total
20
31
5
71
11
138
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Table 3
Survey Respondent Demographics by current profession and setting
What is your current profession and what setting do you work most often?
Please select the setting where you work
most often - Selected Choice
Inpatient
Outpatient
Other
Social worker
2
25
1
Nurse
1
0
0
Psychiatrist
1
0
0
Clinical Psychologist
1
0
0
Mental Health Counselor 2
40
4
Addictions Counselor 0
1
0
Case Manager
1
8
0
Other
0
7
1
Total
8
81
6

Total
28
1
1
1
46
1
9
8
95
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Table 4
Survey Respondent Demographics by Education
What is your highest level of education?

Missing
Total

Some college
2-year degree
4-year degree
Professional degree
Doctorate
Prefer not to answer
Total
System

Frequency
7
5
33
89
3
1
138
14
152

Percent
4.6
3.3
21.7
58.6
2.0
.7
90.8
9.2
100.0

Valid Percent
5.1
3.6
23.9
64.5
2.2
.7
100.0

Cumulative
Percent
5.1
8.7
32.6
97.1
99.3
100.0
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Table 5
Survey Respondents by Familiarity with PADs
Familiarity with PADs

I’ve never heard of PADs

Frequency
21

Percent
13.8

I’ve heard of the term but knew little about them

25

16.4

I knew PADS had something to do with planning for treatment, but 23
would not have been able to describe how they were used

15.1

I would be able to describe PADs to someone else, but am not sure 19
how they apply in my community

12.5

I would consider myself knowledgeable on PADs and how they
work in my community
N/A
Total
MissingSystem
Total

61

40.1

1
150
2
152

.7
98.7
1.3
100.0
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Table 6
PADs are discussed with consumers.

Missing
Total

Don't know
No consumers
A few consumers
Some consumers
Most consumers
All consumers
Total
System

Frequency
44
6
20
16
24
22
132
20
152

Percent
28.9
3.9
13.2
10.5
15.8
14.5
86.8
13.2
100.0

Valid Percent
33.3
4.5
15.2
12.1
18.2
16.7
100.0

Cumulative
Percent
33.3
37.9
53.0
65.2
83.3
100.0
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Table 7
PAD forms are provided to consumers.

Missing
Total

Don't know
No consumers
A few consumers
Some consumers
Most consumers
All consumers
Total
System

Frequency
57
21
24
15
11
4
132
20
152

Percent
37.5
13.8
15.8
9.9
7.2
2.6
86.8
13.2
100.0

Cumulative
Valid Percent Percent
43.2
43.2
15.9
59.1
18.2
77.3
11.4
88.6
8.3
97.0
3.0
100.0
100.0

118
Table 8
Consumers are assisted in completing PAD forms.

Missing
Total

Don't know
No consumers
A few consumers
Some consumers
Most consumers
All consumers
Total
System

Frequency
54
21
21
18
11
7
132
20
152

Percent
35.5
13.8
13.8
11.8
7.2
4.6
86.8
13.2
100.0

Valid Percent
40.9
15.9
15.9
13.6
8.3
5.3
100.0

Cumulative
Percent
40.9
56.8
72.7
86.4
94.7
100.0
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Table 9
There is written documentation of whether consumers have PADs.

Missing
Total

Don't know
No consumers
A few consumers
Some consumers
Most consumers
All consumers
Total
System

Frequency
47
11
16
13
15
30
132
20
152

Percent
30.9
7.2
10.5
8.6
9.9
19.7
86.8
13.2
100.0

Valid Percent
35.6
8.3
12.1
9.8
11.4
22.7
100.0

Cumulative
Percent
35.6
43.9
56.1
65.9
77.3
100.0
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Table 10
Descriptive Statistics for OPADQ Scores

OS_Score
UB_Score
DM_Score
Total_Score
Valid N (listwise)

N
138.00
138.00
138.00
138.00
138.00

Minimum
35.00
37.00
38.00
159.00

Maximum
94.00
90.00
65.00
228.00

Mean
63.95
68.28
51.60
183.83

Std. Deviation
11.46
8.95
3.86
11.52

121

Table 11
Univariate Tests for OPADQ Total & subscale scores
Partial
Dependent
Sum of
Mean
Eta
Observed
Variable
Squares
df
Square
F
Sig. Squared
Power
OS
1455.95 4.00
363.99 2.93 .02*
.08
.77
UB
684.87 4.00
171.22 2.21
.07
.06
.64
SD
12.99 4.00
3.25
.21
.93
.01
.09
Total
1184.69 4.00
296.17 2.32
.06
.07
.66
The F tests the effect of Simple Group. This test is based on the linearly independent pairwise
comparisons among the estimated marginal means.
*. The mean difference is significant at the .05 level.
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Table 12
Post Hoc Comparisons of Stakeholder groups
Tukey HSD
(I) Simple
Group
Consumer

Mean
Difference
(I-J)
1.15
-10.30
-5.61
-3.12
-1.15
-11.45
-6.76*
-4.27
10.30
11.45
4.69
7.18
5.61
6.76*
-4.69
2.49
3.12
4.27
-7.18
-2.49

(J) Simple
Group
Std. Error
Administrator
3.20
Family
5.57
Clinician
2.82
Advocate
4.19
Administrator Consumer
3.20
Family
5.37
Clinician
2.40
Advocate
3.91
Family
Consumer
5.57
Administrator
5.37
Clinician
5.16
Advocate
6.01
Clinician
Consumer
2.82
Administrator
2.40
Family
5.16
Advocate
3.61
Advocate
Consumer
4.19
Administrator
3.91
Family
6.01
Clinician
3.61
Based on observed means.
*. The mean difference is significant at the .05 level.

Sig.
1.00
.35
.28
.95
1.00
.21
.04
.81
.35
.21
.89
.75
.28
.04
.89
.96
.95
.81
.75
.96

95% Confidence Interval
Lower
Upper
Bound
Bound
-7.69
10.00
-25.72
5.12
-13.42
2.20
-14.69
8.46
-10.00
7.69
-26.31
3.41
-13.40
-.12
-15.09
6.55
-5.12
25.72
-3.41
26.31
-9.58
18.96
-9.45
23.81
-2.20
13.42
.12
13.40
-18.96
9.58
-7.50
12.48
-8.46
14.69
-6.55
15.09
-23.81
9.45
-12.48
7.50
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Table 13
Correlations between RQ2 themes and Utility and Benefits subscoresb
Variables
1.
2.
3.
1. UB_Score
1
-.045
-.069
2. Awareness
-.045
1
.018
3. Client Benefits
-.069
.018
1
4. Clinical Benefits
.117
.153
.277**
5. PAD Champions
.116
.088
.090
**. Correlation is significant at the 0.01 level (2-tailed).
b. Listwise N=138

4.
.117
.153
.277**
1
.079

5.
.116
.088
.090
.079
1
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Table 14
Correlations between RQ3 themes and Obstacles to Success subscoresc
Variables
1.
2.
3.
1. OS_Score
1
-.104
.036
2. Client obstacles
-.104
1
-.622**
**
3. Lack of Awareness
.036
-.622
1
4. Lack of bandwidth
-.015
.185*
-.164
5. Power struggles
.064
.098
-.129
**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
c. Listwise N=138

4.
-.015
.185*
-.164
1
.358**

5.
.064
.098
-.129
.358**
1
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Table 15
Joint Display Table of Themes and Quantitative Results – RQ2
QUAL dimensions
PAD
Champions

Dimension: QUAN variables

Advocacy
(n=73)

Very
Knowledgeable
(n=60)
UB_1.PADs will
help mental
health
professionals
make better
decisions about
the care of
people with
mental illness.
(M=4.33;
SD=.74)
UB_50. PADs
will help people
with mental
illness feel more
in control of their
lives.
(M=4.17;
SD=.67)

Awareness

Clinical
Benefits

Client
Benefits

217
“I’m the
golden child
of [P]Ads at
my agency”
54
“Just ongoing
exposure to
the idea. I
think it's a
process.”
121
“It helps me
give me some
direction as to
what their
preferences
would be
when they
can’t give me
those
preferences.”
124
“The process,
I think does
help them feel
empowered
and listened
to.”
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Table 16
Joint Display Table of Themes and Quantitative Results – RQ3
QUAL dimensions
Lack of
Awareness

Dimension: QUAN variables

No Knowledge –
Basic Knowledge
(n=78)

OS_15. Mental
health
professionals in
my community are
so busy that they
will not take the
time to see if a
person has an
advance directive
on file. (M=2.72;
SD=.94)

Psychiatric
advance directives
will only interfere
with the jobs of
the mental health
professionals.
(M=2.03; SD=.69)

OS_19. People
with mental illness
in my community
would not be
interested in
filling out a PAD.
(M=2.43; SD:.77)

Lack of
Bandwidth

Power Struggles

Client related
obstacles
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“I’m an ES
clinician, and I
don’t know how
I would use
them.”
221
“Another
challenge is
having the
time to work
with folks,
that's a really
huge
challenge.”

83
“People
misinterpreted
empowerment.
They had the
power to make
the decision but
no responsibility
associated with
the results.”
172
“We've tried
every trick in
the trade to
get folks
excited about
it.”
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Table 17
Tests of Between-Subjects Effects For All Groups Advocacy and UB Scores
Dependent Variable: UB_Score
Type III
Sum of
Squares
313.95a

Intercept
Advocate

639484.73
313.95

Error
Total
Corrected Total

Source
Corrected
Model

df
1.00

Mean
Square
313.95

F
4.00

1.00
1.00

639484.73
313.95

8157.32
4.00

10661.59 136.00
654266.00 138.00
10975.54 137.00

78.39

a. R Squared = .029 (Adjusted R Squared = .021)

Partial Eta Observed
Sig.
Squared
Power
.05
.03
.51
.00
.05

.98
.03

1.00
.51
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Table 18
Descriptive statistics for Clinicians and Clinician Advocates
Group Statistics

OS_Score
UB_Score
SD_Score
Total_Score

Aggregate group
Clinician
Clinician-Advocate
Clinician
Clinician-Advocate
Clinician
Clinician-Advocate
Clinician
Clinician-Advocate

N
38
14
38
14
38
14
38
14

Mean
68.03
66.43
63.87
69.43
51.37
50.29
183.26
186.14

Std.
Deviation
10.33
12.54
8.68
7.98
3.91
4.87
12.02
17.14

Std. Error
Mean
1.68
3.35
1.41
2.13
.63
1.30
1.95
4.58
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Table 19
T-test comparing Clinician and Clinician-Advocate OPADQ scores
Independent Samples Test

t
OS_Score
UB_Score
SD_Score
Total_Score

.467
.426
-2.091
-2.176
.828
.747
-.680
-.578

t-test for Equality of Means
Mean
df
Sig. (2-tailed) Difference
50
.643
1.59774
19.877
.674
1.59774
50
.042*
-5.56015
25.135
.039
-5.56015
50
.411
1.08271
19.500
.464
1.08271
50
.499
-2.87970
17.934
.570
-2.87970

*. The mean difference is significant at the .05 level.

Std. Error
Difference
3.42207
3.74631
2.65865
2.55529
1.30690
1.44871
4.23281
4.97792
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Table 20
Familiarity does seem to influence UB Scores
Univariate Tests
Dependent Variable: UB_Score by Familiarity
Sum of
Mean
Partial Eta
Observed
Squares
df
Square
F
Sig.
Squared
Power
Contrast
1040.649
4
260.162 3.483**
.010
.095
.851
Error
9934.887
133
74.698
The F tests the effect of Prior to this survey, how familiar would you say you were with
psychiatric advance directives (PADs)?.
**. The mean difference is significant at the .01 level.
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Table 21
Post Hoc Tests for Familiarity Effect on UB Scores
Dependent Variable: UB_Score
Tukey HSD
(I) Prior to this
survey, how
familiar would
you say you
(J) Prior to this
were with
survey, how familiar
psychiatric
would you say you
advance
were with
Mean
directives
psychiatric advance Difference
(PADs)?
directives (PADs)?
(I-J)
No knowledge Minimal Knowledge
.56
Some Knowledge
3.91
Basic Knowledge
-1.60
Very knowledgeable
-3.84
Minimal
No knowledge
-.56
Knowledge
Some Knowledge
3.35
Basic Knowledge
-2.17
Very knowledgeable
-4.40
Some
No knowledge
-3.91
Knowledge
Minimal Knowledge
-3.35
Basic Knowledge
-5.52
Very knowledgeable
-7.75*
Basic
No knowledge
1.60
Knowledge
Minimal Knowledge
2.17

Very
knowledgeable

Some Knowledge
Very knowledgeable
No knowledge
Minimal Knowledge
Some Knowledge
Basic Knowledge

5.52
-2.23
3.84
4.40
7.75*
2.23

Based on observed means.
The error term is Mean Square(Error) = 74.698.
*. The mean difference is significant at the .05 level.

95% Confidence
Interval

Std.
Error
2.79
2.90
2.97
2.43
2.79
2.62
2.69
2.09
2.90
2.62
2.81
2.23
2.97
2.69
2.81
2.32
2.43
2.09
2.23
2.32

Sig.
1.00
.66
.98
.51
1.00
.70
.93
.22
.66
.70
.29
.01
.98
.93

Lower
Bound
-7.15
-4.10
-9.82
-10.56
-8.28
-3.89
-9.62
-10.17
-11.93
-10.59
-13.28
-13.92
-6.61
-5.29

Upper
Bound
8.28
11.93
6.61
2.89
7.15
10.59
5.29
1.37
4.10
3.89
2.25
-1.58
9.82
9.62

.29
.87
.51
.22
.01
.87

-2.25
-8.66
-2.89
-1.37
1.58
-4.19

13.28
4.19
10.56
10.17
13.92
8.66
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Figure 1
Methodology for Convergent Parallel Mixed Method Design
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Figure 2
Qualitative Themes by Research Questions
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Appendix A. Stakeholder Survey

Stakeholder Survey
Start of Block: Administrator Survey Informed Consent letter

Q1.1 Study: Hear me when I'm well: a mixed methods study of advance directives in
Virginia
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Anne Metz, MA/EdS and A.
Renee Staton, PhD from James Madison University, and Heather Zelle, J.D., Ph.D. of the
University of Virginia.
The purpose of this study is to examine the use of psychiatric advance directives in Virginia and
how Virginia’s Health Care Decisions Act is being implemented across the state. This study will
contribute to the researcher’s completion of a doctoral dissertation.
Research Procedures
This study consists of a survey that will be administered to individual participants in
Virginia. You will be asked to provide answers to a series of questions related to psychiatric
advance directives.
Time Required Participation in this study will require less than 20 minutes of your time.
Risks
The investigator does not perceive more than minimal risks from your involvement in this study
(that is, no risks beyond the risks associated with everyday life).
The investigator perceives the following are possible risks arising from your involvement with
this study: Breach of confidentiality in which participant’s identities could be connected to their
responses. Subjects could become upset by the survey questions or in response to questions. To
minimize these risks, this survey is anonymous and confidential to reduce the possibility of
breach of confidentiality. Likewise, participants are not required to answer any question that
might be upsetting.
Benefits
Potential benefits from participation in this study include findings that may inform advocacy
efforts such as improving continuity of care for persons with mental health care needs. For all
involved, becoming more familiar with the statute may improve the likelihood that advanced
directives will be completed as the value of the process becomes clear in the survey.
Confidentiality
The results of this research will be presented in dissertation format. While individual
responses are obtained and recorded anonymously and kept in the strictest confidence,
aggregate data will be presented representing averages or generalizations about the
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responses as a whole. No identifiable information will be collected from the participant
and no identifiable responses will be presented in the final form of this study. All data
will be stored in a secure location accessible only to the researcher, her JMU advisor, and
the UVA researcher.
The researcher retains the right to use and publish nonidentifiable data. At the end of the study, all de-identified records will be retained and
stored on a secure server.
Participation & Withdrawal Your participation is entirely voluntary. You are free to
choose not to participate. Should you choose to participate, you can withdraw at any
time without consequences of any kind. However, once your responses have been
submitted and anonymously recorded you will not be able to withdraw from the study.
Questions about the Study
If you have questions or concerns during the time of your participation in this study, or
after its completion or you would like to receive a copy of the final aggregate results of
this study, please contact:
Anne Metz, LPC
A. Renee Staton, Ph.D.
Department of Graduate Psychology Department of Graduate Psychology
James Madison University
James Madison University
metzal@jmu.edu
statonar@jmu.edu
Telephone: (540) 568-6211
Questions about Your Rights as a Research Subject Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu

Q1.2 Please select the appropriate consent statement below.
• I understand the study described above. I am 18 years of age or older and I agree
to participate. (1)
• I am not 18 years of age or older, and/or, I do not agree to participate. (2)
End of Block: Administrator Survey Informed Consent letter
Start of Block: Your experience with advance directives for mental health

Q3.1 We appreciate your helping to complete this questionnaire. It is designed to elicit your
opinions on advance directives for mental health care or psychiatric advance directives (PADs).
Although these two terms are interchangeable, Virginia’s integrated AD will be referred to as a
PAD in this survey. This categorization references the psychiatric portion of the integrated AD,
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rather than the medical or end-of-life instructions. Please review each item carefully and provide
candid responses. Your answers are confidential. Base your answers on your personal experience
and judgment. Please answer all questions. Thank you in advance for your help.

Q5.1 Prior to this survey, how familiar would you say you were with psychiatric advance
directives (PADs)?
• I've never heard of PADs (1)
• I've heard of the term but knew little about them (2)
• I knew PADs had something to do with planning for treatment, but would not
have been able to describe how they were used (3)
• I would be able to describe PADs to someone else, but am not sure how they
apply in my community (4)
• I would consider myself knowledgeable on PADs and how they work in my
community (5)
• Do not know / prefer not to answer (6)

Q3.3 How do you think PADs should be used in your community?
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________

Q3.4 In your opinion, what encourages the use of PADs?
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
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Q3.5 In your opinion, what discourages the use of PADs?
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
End of Block: Your experience with advance directives for mental health
Start of Block: Respondent type

Q4.1 There are a number of groups that have an interest in psychiatric advance directives
(PADs). Please select all of the stakeholder groups of which you consider yourself a member.
You may choose more than one answer.
• Health care administrator (1)
• Clinician (2)
• Mental health consumer/client (3)
• Family member of a mental health consumer/client (4)
• Mental Health advocate (5)
• Other (please specify) (6) ________________________________________________
End of Block: Respondent type
Start of Block: Clincians - Current practice

Q4.2 How many years of professional mental health work experience (administrative and/or
clinical) have you had, excluding time spent primarily in training? Please enter number of years
below.
________________________________________________________________
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Q4.3 Have you ever worked primarily as a clinician? If you work at more than one organization,
please base your answers to the following questions on the organization where you work most
often.
• Yes (1)
• No (2)

Q61 What is your current profession?
• Social worker (LCSW, MSW, QMHP) (1)
• Nurse Practitioner (APRN, PMHNP, or FNP) (2)
• Nurse (RN, LPN) (3)
• Psychiatrist (4)
• Clinical Psychologist (5)
• Mental Health Counselor (LPC, LMHC, LMFT, Resident in Counseling, QMHP)
(6)
• Addictions Counselor (7)
• Case Manager (8)
• Other (9) ________________________________________________

Q4.4 Please select the setting where you work most often
• Inpatient psychiatric hospital or unit (1)
• Outpatient behavioral health or CSB (2)
• Other (please specify) (3)
________________________________________________

Q4.5 Please select the type of organization where you work most often
• Public (county, state, or federally operated) (1)
• Private for profit (2)
• Private not for profit (3)
• Other (please specify) (4)
________________________________________________
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Q4.6 How many consumers received services from your organization in the past year?
________________________________________________________________

Q22 Please select the answer that best describes your current practice in your organization. If
your current practice is to do something "when appropriate" (for example, to discuss PADs with
families when appropriate, please estimate the percent of consumers considered appropriate).
Most
All
Some
A few
consumers
No
Don't
consumers
consumers consumers
(More
consumers know
(100%)
(Less than (Less than
than 50%)
(0%) (2)
(1)
(6)
50%) (4)
10%) (3)
(5)
PADs are
discussed with
consumers. (1)

•

•

•

•

•

•

PAD forms are
provided to
consumers. (2)

•

•

•

•

•

•

Consumers are
assisted in
completing
PAD forms. (3)

•

•

•

•

•

•

There is
written
documentation
of whether
consumers
have PADs. (4)

•

•

•

•

•

•

Q5.3 What percentage of consumers in your setting have completed a psychiatric advance
directive (PAD)?
Don't know
0 10 20 30 40 50 60 70 80 90 100
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Please move slider to indicate percentage
of consumers with PADs in your agency.
(1)

End of Block: Clincians - Current practice
Start of Block: OPADQ
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Q6.1 We would like to get an understanding of your opinions and beliefs about psychiatric
advance directives (PADs). Please answer the degree to which you agree with the following
statements.
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Strongly
agree (5)

Agree (4)

Neither
agree nor
disagree (3)

Disagree (2)

Strongly
Disagree (1)

1.
Psychiat
ric advance
directives will
help mental
health
professionals
make better
decisions about
the care of
people with
mental illness.
(Q6.1_1)

•

•

•

•

•

2.
Psychiat
ric advance
directives will
help to improve
communication
between people
with mental
illness and their
families.
(Q6.1_2)

•

•

•

•

•

3.
Psychiat
ric advance
directives will
open up too
many new legal
issues in mental
health
treatment.
(Q6.1_3)

•

•

•

•

•

143
4.
It will be
difficult to find
people willing
to be agents or
proxy decision
makers
(someone
appointed to
make decisions
on behalf of the
person) for
people with
mental illness.
(Q6.1_4)

•

•

•

•

•

5. The
directives
outlined in a
psychiatric
advance
directive should
be followed,
even if they go
against a
mental health
provider’s
professional
opinion.
(Q6.1_5)

•

•

•

•

•

6.
Doctors
would follow
psychiatric
advance
directives if
they knew they
would not be
held legally
responsible if
something went
wrong. (Q6.1_6)

•

•

•

•

•
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7.
Police
officers in my
community
would refer to a
psychiatric
advance
directive before
deciding what
to do with a
person with
mental illness.
(Q6.1_7)

•

•

•

•

•

8.
Psychiat
ric advance
directives will
help reduce the
costs of
hospitalizing
people against
their will.
(Q6.1_8)

•

•

•

•

•

Please move
slider to
indicate
percentage of
consumers with
PADs in your
agency.
(Q6.1_x1)

•

•

•

•

•

Page Break
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Q43 We would like to get an understanding of your opinions and beliefs about psychiatric
advance directives (PADs). Please answer the degree to which you agree with the following
statements.
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Strongly
agree (5)

Neither
agree nor
disagree
(3)

Agree (4)

Strongly
Disagree
(1)

Disagree
(2)

9.
People
with mental
illness should not
be allowed to
make decisions
about how they
will be treated.
(1)

•

•

•

•

•

10. It will be
difficult for
mental health
professionals to
help people fill
out a psychiatric
advance directive
in an unbiased
manner. (2)

•

•

•

•

•

11.
The
wishes of people
with mental
illness should
always be
followed, even
when it goes
against medical
advice. (3)

•

•

•

•

•

•

•

•

•

•

12.

Psychiatric
advance
directives should
be put to use in
my community.
(4)
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13.
People
with mental
illness can make
appropriate
treatment
decisions for
themselves. (5)

•

•

•

•

•

14.
Judges in
my community
would likely
uphold
professional
recommendations
for treatment
over the
directives of the
person with the
mental illness. (6)

•

•

•

•

•

15. Mental health
professionals in
my community
are so busy that
they will not take
the time to see if a
person has an
advance directive
on file. (7)

•

•

•

•

•

•

•

•

•

•

16.

Psychiatric
advance
directives will
give family
members a sense
of how to handle
difficult situations
with their loved
one. (8)
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17.
People
with mental
illness will make
unreasonable
requests in their
psychiatric
advance
directives. (9)

•

•

•

•

•

18.
Only
people
specifically
trained in
treating mental
illness should be
allowed to make
treatment
decisions. (10)

•

•

•

•

•

19.
People
with mental
illness in my
community
would not be
interested in
filling out a
psychiatric
advance directive.
(11)

•

•

•

•

•

Page Break
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Q44 We would like to get an understanding of your opinions and beliefs about psychiatric
advance directives (PADs). Please answer the degree to which you agree with the following
statements.
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Strongly
agree (5)

Agree (4)

Neither
agree nor
disagree (3)

Disagree (2)

Strongly
Disagree (1)

20.
In
times of crisis,
professionals
will not want
to hear about a
person’s
psychiatric
advance
directive. (1)

•

•

•

•

•

21.
Psychia
tric advance
directives will
help judges
make better
decisions
about
involuntary
commitment.
(2)

•

•

•

•

•

22.
People
with mental
illness will not
take
responsibility
for updating
their
psychiatric
advance
directive over
time. (3)

•

•

•

•

•

23.
People
with mental
illness can
complete a
psychiatric
advance
directive on
their own. (4)

•

•

•

•

•
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24.
Psychia
tric advance
directives will
help people
with mental
illness get
treatment
faster. (5)

•

•

•

•

•

25.
People
with mental
illness will not
understand
what
psychiatric
advance
directives are
or how they
can work for
them. (6)

•

•

•

•

•

26.
Psychia
tric advance
directives will
make it more
difficult for
people with
mental illness
to change their
mind about
treatment. (7)

•

•

•

•

•

27. It is
dangerous to
have people
with mental
illness make
decisions
about their
mental health
treatment. (8)

•

•

•

•

•
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28.
Psychia
tric advance
directives will
be difficult to
locate at the
time
treatment
decisions need
to be made.
(9)

•

•

•

•

•

29.
People
with mental
illness who
have
completed a
training on
psychiatric
advance
directives can
help other
people with
mental illness
fill out the
documents.
(10)

•

•

•

•

•

Page Break
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Q45 We would like to get an understanding of your opinions and beliefs about psychiatric
advance directives (PADs). Please answer the degree to which you agree with the following
statements.
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Strongly
agree (5)

Neither
agree nor
disagree (3)

Agree (4)

Strongly
Disagree
(1)

Disagree
(2)

30.
Family
members in my
community
would find
psychiatric
advance
directives
helpful in caring
for their loved
ones. (Q45_1)

•

•

•

•

•

31.
Psychiatri
c advance
directives will
force
professionals to
make decisions
that go against
their
professional
judgment.
(Q45_2)

•

•

•

•

•

32.
Professio
nals would be
more inclined to
support advance
directives if they
heard
testimonies
about the
directives from
people with
mental illness
themselves.
(Q45_3)

•

•

•

•

•
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33.
Storing
psychiatric
advance
directives in a
central location
within a
community
poses a
significant threat
to
confidentiality.
(Q45_4)

•

•

•

•

•

34.
Doctors in
my community
would not follow
the directives
outlined in
psychiatric
advance
directives.
(Q45_5)

•

•

•

•

•

35.
Psychiatri
c advance
directives will
help police
officers make
better decisions
about what to do
with people who
are in a crisis.
(Q45_6)

•

•

•

•

•

36.
Psychiatri
c advance
directives can be
used as a way to
justify treatment,
even when
clients are
refusing
treatment.
(Q45_7)

•

•

•

•

•
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37.
In times
of crisis, there
would not be
enough time to
consult the
psychiatric
advance
directive.
(Q45_8)

•

•

•

•

•

38.
Psychiatri
c advance
directives will
undermine the
expertise of
mental health
professionals.
(Q45_9)

•

•

•

•

•

39.
Psychiatri
c advance
directives will
help
professionals
provide better
services to
people with
mental illness.
(Q45_10)

•

•

•

•

•

Page Break
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Q46 We would like to get an understanding of your opinions and beliefs about psychiatric
advance directives (PADs). Please answer the degree to which you agree with the following
statements.
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Strongly
agree (5)

Agree (4)

Neither
agree nor
disagree (3)

Disagree (2)

Strongly
Disagree (1)

40.
Psychia
tric advance
directives
should be
completed
only with the
assistance of a
trained mental
health
professional.
(1)

•

•

•

•

•

41.
Proxy
decision
makers
(agents)
would be
reluctant to
make
decisions for
fear of making
a wrong
decision. (2)

•

•

•

•

•

•

•

•

•

•

42.

Mental
health
professionals
should
educate the
community
about
psychiatric
advance
directives. (3)
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43.

Mental
health
professionals
in my
community
would not
support the
use of
psychiatric
advance
directives. (4)

•

•

•

•

•

44.
Even
though a
person may
have a
psychiatric
advance
directive, it is
unlikely that
mental health
professionals
would follow
it. (5)

•

•

•

•

•

45.
When
people with
mental illness
are sick, it is
OK for them to
be treated
against their
will. (6)

•

•

•

•

•

46.
In a
time of crisis,
people with
mental illness
will not be
able to inform
professionals
that they have
an advance
directive. (7)

•

•

•

•

•

160
47.

Mental
health
professionals
would follow a
psychiatric
advance
directive if a
specific
procedure
were
implemented
at their agency
to do so. (8)

•

•

•

•

•

48.
People
with mental
illness will
likely include
appropriate
medications in
their
psychiatric
advance
directives (9)

•

•

•

•

•

49.
Most
people with
mental illness
are unable to
make
appropriate
treatment
decisions for
themselves.
(10)

•

•

•

•

•

Page Break
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Q47 We would like to get an understanding of your opinions and beliefs about psychiatric
advance directives (PADs). Please answer the degree to which you agree with the following
statements.
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Strongly
agree (5)

Agree (4)

Neither
agree nor
disagree (3)

Disagree (2)

Strongly
Disagree (1)

50.
Psychia
tric advance
directives will
help people
with mental
illness feel
more in
control of
their lives. (1)

•

•

•

•

•

51.
Psychia
tric advance
directives will
prevent
professionals
from
intervening
when they
should. (2)

•

•

•

•

•

52.
People
with mental
illness should
have the
opportunity to
write a
psychiatric
advance
directive, if
they so
choose. (3)

•

•

•

•

•
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53.
When
in crisis,
people with
mental illness
will not want
to follow the
directives they
outlined in
their
psychiatric
advance
directive. (4)

•

•

•

•

•

54.
A
lawyer should
be present
when a person
is completing a
psychiatric
advance
directive. (5)

•

•

•

•

•

55.
People
with mental
illness are
capable of
teaching each
other about
psychiatric
advance
directives. (6)

•

•

•

•

•

56.
Psychia
tric advance
directives will
only interfere
with the jobs
of the mental
health
professionals.
(7)

•

•

•

•

•
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57.
Proxy
decision
makers
(agents) will
be difficult to
locate at the
time
treatment
decisions need
to be made.
(8)

•

•

•

•

•

58.
In a
psychiatric
advance
directive, a
person with
mental illness
will likely
direct to have
no treatment
at all. (9)

•

•

•

•

•

59.
Psychia
tric advance
directives
would not
work in my
community.
(10)

•

•

•

•

•

60.
People
with mental
illnesses
should be
allowed to
make
decisions
about their
mental health
treatment.
(11)

•

•

•

•

•

End of Block: OPADQ

165

Start of Block: Demographics

Q7.1 How old are you?
________________________________________________________________

Q7.2 What is your gender?
• Male (1)
• Female (2)
• Non-binary/ third gender (3)
• Prefer to self-describe (4)
________________________________________________
• Prefer not to say (5)

Q7.3 Which of the following best describes your racial background?
• White (1)
• Black or African American (2)
• American Indian or Alaska Native (3)
• Asian (4)
• Native Hawaiian or Pacific Islander (5)
• Other (6) ________________________________________________
• Prefer not to answer (7)

Q7.4 What is your highest level of education?
• Less than high school (1)
• High school graduate/GED (2)
• Some college (3)
• 2 year degree (4)
• 4 year degree (5)
• Professional degree (6)
• Doctorate (7)
• Prefer not to answer (8)
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Q41 Do you reside or work in the state of Virginia?
• Yes (1)
• No (2)
• Prefer not to answer (3)
End of Block: Demographics
Start of Block: Unique code

Q2.1 Although this study on advance directives for mental health is anonymous, we would like
to collect longitudinal data on this topic. To protect your anonymity, we ask that you enter a
unique code that we will later use to match responses over time.

Q2.2 What are the first two initials of your high school's name?
________________________________________________________________

Q2.3 What day of the month were you born?
________________________________________________________________

Q2.4 What is the last letter of your first name?
________________________________________________________________

Q2.5 Combine your responses from 1-3 in order here (e.g., FA19A)
________________________________________________________________
End of Block: Unique code
Start of Block: Family/advocates
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Q52 Have you ever helped a family member or someone you care for create a legal document
with instructions about their health treatment in the future if they became very ill and were
unable to make decisions for themselves?
• Yes (1)
• No (2)

Q56 If someone showed you how, would you want to help a family member or someone you
care for create a legal document with your instructions about your health and mental health
treatment in the future if you become very ill and are unable to make decisions for yourself?
• Yes (1)
• No (2)
• The person I'm thinking of already has one (3)
• Don't know (4)

Q60 Has anyone ever created a legal document identifying you to make decisions about their
general and mental health care treatment in the future if they couldn't make decisions for
themselves (e.g. proxy decision-maker or healthcare power of attorney)?
• Yes (1)
• No (2)

Q64 If someone showed you how, would you want to help a family member or someone you
care for create a legal document identifying a person they trust to make decisions about their
health treatment in the future if they can't make decisions for themselves?
• Yes (1)
• No (2)
• Already have one (3)
• Don't know (4)
End of Block: Family/advocates
Start of Block: Consumers
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Q50 Have you ever created a legal document with your instructions about your health treatment
in the future if you become very ill and are unable to make decisions for yourself?
• Yes (1)
• No (2)

Q54 If someone showed you how, would you want to create a legal document with your
instructions about your health and mental health treatment in the future if you become very ill
and are unable to make decisions for yourself?
• Yes (1)
• No (2)
• Already have one (3)
• Don't know (4)

Q58 Have you ever created a legal document that identifies a person you trust to make decisions
about your general and mental health care treatment in the future if you can't make decisions for
yourself (e.g. proxy decision-maker or healthcare power of attorney)?
• Yes (1)
• No (2)

Q62 If someone showed you how, would you want to create a legal document that identifies a
person you trust to make decisions about your health treatment in the future if you can't make
decisions for yourself?
• Yes (1)
• No (2)
• Already have one (3)
• Don't know (4)
End of Block: Consumers
Start of Block: Interview?
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Q63 Would you be interested in participating in a follow-up interview with the researcher
regarding advance directives?
• Yes (1)
• No (2)
End of Block: Interview?
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Appendix B. Interview Script
Interview Script
Interview Script
VERBAL CONSENT DOCUMENTATION FOR PARTICIPATION.
SUBJECT: Hear me when I’m well: a mixed methods study of psychiatric advance directives
in Virginia.
Oral consent serves as an assurance that the required elements of informed consent have been
presented orally to the participant or the participant’s legally authorized representative.
Verbal consent to participate in this telephone survey has been obtained by the participant’s
willingness to continue with the telephone survey by providing answers to a series of questions
related to what the participant has heard about psychiatric advance directives.
* Phone Script:
Introduction:
Hello! Thank you so much for agreeing to speak with me today. My name is Anne Metz,
and I am a doctoral student in Counselor Education at James Madison University. I’m
conducting this research for my dissertation under the direction Dr. Renee Staton of
James Madison University’s department of Graduate Psychology.
I’m inviting you to do a one-on-one telephone interview that will take about 20-30
minutes. I will ask you questions about psychiatric advance directives here in Virginia.
Consent to Participate in Research
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Anne Metz, MA/EdS
and A. Renee Staton, PhD from James Madison University, and Heather Zelle, J.D.,
Ph.D. of the University of Virginia. The purpose of this study is to examine the use of
advance directives in Virginia and how Virginia’s new Health Care Decisions Act is
being implemented across the state. This study will contribute to the researcher’s
completion of doctoral dissertation.
Research Procedures
Should you decide to participate in this research study, you will be asked to verbally
agree to this this consent form once all your questions have been answered to your
satisfaction. This study consists of an interview that will be administered to individual
participants over the telephone. You will be asked to provide answers to a series of questions
related to psychiatric advance directives. During our interview, I will take handwritten notes to
record your answers. However, I would also like to use an audio recorder to make sure I don’t
miss what you say. After our interview, I will send you a copy of your interview transcript to
ensure that your comments are accurate. This audio recording will be destroyed after
transcription, but de-identified transcripts will be retained for future research.
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Are you willing to consent to audio recording at this time?
[If yes, continue the informed consent and recorder.]
[If no, continue the informed consent without recording.]
Please know that you may request that the recording stop at any time.
Time Required : 20-30 minutes.
Risks
The investigator does not perceive more than minimal risks from your involvement in
this study (that is, no risks beyond the risks associated with everyday life).
The investigator perceives the following are possible risks arising from your involvement
with this study:
• Breach of confidentiality in which participant’s identities could be connected to
their responses.
• Subjects could become upset by the survey questions or in response to questions.
To minimize these risks, interview transcripts will be de-identified. All human
subjects data and associated study documentation will be regarded as confidential,
and will be stored in a secure manner. Following transcription, all recordings will be
destroyed to reduce the possibility of breach of confidentiality. Likewise,
participants are not required to answer any interview question that might be
upsetting.
If subjects do become distressed by any questions, participants will be provided with
contact information for the local emergency services department the interviewer (540885-0866). Participants will be encouraged to contact these mental health professionals to
access counseling and support services.
Benefits
Potential benefits from participation in this study include findings that may inform
advocacy efforts associated with providing more continuity of care for persons with
mental health care needs, insight into the relevance of the law, which can aid in selfefficacy. For all involved, becoming more familiar with the statute may improve the
likelihood that advanced directives will be completed as the value of the process becomes
clear in the interview
Confidentiality
The results of this research will be presented in my dissertation, to my colleagues, at
conferences and publications. The results of this project will be coded in such a way that
the respondent’s identity will not be attached to the final form of this study. The
researcher retains the right to use and publish non-identifiable data. While individual
responses are confidential, aggregate data will be presented representing averages or
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generalizations about the responses as a whole. All data will be stored in a secure
location accessible only to the researcher, her JMU advisor, and the UVA
researcher. Upon completion of the study, all information that matches up individual
respondents with their answers, including audio recordings will be destroyed.
Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to
participate. Should you choose to participate, you can withdraw at any time without
consequences of any kind.
Questions about the Study
If you have questions or concerns during the time of your participation in this study, or
after its completion or you would like to receive a copy of the final aggregate results of
this study, please contact:
Anne Metz, MA/EdS
Department of Graduate Psychology
James Madison University
metzal@jmu.edu
statonar@jmu.edu

A. Renee Staton, Ph.D.
Department of Graduate Psychology
James Madison University
Telephone: (540) 568-6211

Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
Giving of Consent
I have heard this consent form and I understand what is being requested of me as a
participant in this study. I freely consent to participate. I have been given satisfactory
answers to my questions. I certify that I am at least 18 years of age.
[If yes, begin the interview.]
[If no, thank the participant for his/her time.]
Attestation of verbal consent
I attest that the aforementioned written consent has been orally presented to the human
subject and the human subject provided me with an oral assurance of their willingness to
participate in the research.
Surveyor’s Name (Printed)
Questions:

Surveyor

Grand tour question [present]:
Could you describe a typical day in your clinical work?
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Background [past]:
Can you tell me about the time that you first heard about psychiatric advance directives?
Knowledge [past]:
What did you learn about PADs in that instance?
Experience & Behavior [past]:
Could you tell me about an experience have you had with psychiatric advance directives
in your work?
●
Probes: some clinicians have helped clients complete a PAD, whereas others have
asked about them during an intake or an assessment. Others may have seen that a client
has a PAD in their EHR.
If you haven’t, could you tell me about how you might use them in your clinical work?
Opinions & Values [past]:
What do feel were the advantages of the PAD in that instance?
●
Probe: What do you imagine are the advantages of PADs in other circumstances?
Opinions & Values [past]:
What do feel were the disadvantages of the PAD in that instance?
●
Probe: What do you imagine are the disadvantages of PADs in other circumstances?
Thinking [present]:
What do you think encourages you to use PADS with clients?
Experience & Behavior [past]:
Can you think of a specific time when you felt encouraged to use a PAD?
Probe: accessing it during crisis work? Creating one in routine outpatient work or case
management? In hospital discharge planning?
Thinking [present]:
On the other hand, what might discourage you from using PADs with clients?
Experience & Behavior [past]:
Can you think of a time where you felt discouraged from using a PAD?
●
Probe: accessing it during crisis work? Creating one in routine outpatient work or
case management? In hospital discharge planning?
Presuppositional opinions & values [future]:
What policy or systemic recommendations do you have about ways to increase the
utilization of PADs in Virginia?
Knowledge [present]:
Is there anything else that you feel I should know about PADs here in Virginia?
●
Probe: imagine it is a half-hour after the end of our interview, what might you
wished you had said about PADs in Virginia
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